Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035797	s-mkomp-2	g/l (g/l)	9682	21733	0.00%
3035797	s-mkomp-2	— (—)	1341	1760	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Metabolic disorders

2414

6105

2.47

318.33

2.4

2.1

0.03

0.02

g/l

0.56

2211

5577

Implicit bacterial Sepsis

1429

4236

3.13

316.91

2.7

2.1

0.02

0.03

g/l

0.37

1280

3835

Autoimmune diseases excluding thyroid diseases

2640

6154

2.39

315.49

2.0

2.4

0.02

0.03

g/l

1.21

2441

5576

Primary_lymphoid and hematopoietic malignant neoplasms

1266

2666

5.24

307.65

8.2

1.4

0.13

0.02

g/l

3.03

1195

2390

ILD medications: prednisolone, methylprednisolone, prednisone

3103

5749

3.11

307.65

2.2

1.7

0.03

0.02

g/l

0.25

2855

5208

Other bacterial diseases

2826

6816

2.88

307.65

2.8

2.0

0.04

0.03

g/l

0.42

2595

6205

Implicit Sepsis

2371

6534

2.74

307.65

2.4

2.1

0.03

g/l

0.04

2138

5975

Malaise and fatigue

1577

3953

3.33

307.65

2.3

2.1

0.05

0.02

g/l

0.79

1423

3581

Fever of other and unknown origin

1700

4453

3.52

307.65

3.7

2.0

0.06

0.02

g/l

1.22

1587

4050

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3803

6336

4.35

307.65

2.5

2.1

0.03

0.02

g/l

0.50

3467

5788

ILD medications: immunosuppressive drugs

2203

5067

4.23

307.65

4.1

1.7

0.03

0.02

g/l

0.23

2052

4609

Inflammatory bowel disease treatment related agents

3043

6652

2.62

307.65

2.0

2.3

0.03

g/l

0.18

2804

6037

ILD medications

3225

5769

3.12

307.65

2.8

1.7

0.03

0.02

g/l

0.29

2971

5228

Condition for Implicit Sepsis (Organ dysfunction codes)

2336

6567

2.58

307.65

2.4

2.1

0.03

g/l

0.12

2114

6010

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

655

468

21.05

307.65

7.4

1.3

0.18

0.00

g/l

6.21

612

423

Other and unspecified anaemias

2015

4541

4.56

307.65

2.5

2.2

0.06

0.03

g/l

0.95

1812

4105

Renal tubulo-interstitial diseases

2895

6719

3.34

307.65

2.4

2.2

0.03

g/l

0.14

2650

6121

Other anaemias

2027

4570

4.54

307.65

2.5

2.2

0.06

0.03

g/l

0.93

1823

4130

Implicit bacterial Sepsis

1546

4500

3.10

307.65

2.7

2.1

0.03

g/l

0.09

1384

4076

Renal failure

2260

4612

4.69

307.65

2.5

2.2

0.04

g/l

0.05

2086

4137

Multiple myeloma, including Hilmo

455

444

13.55

307.65

18.0

1.5

0.21

0.04

g/l

2.41

426

400

All chronic kidney diseases

2344

4514

4.52

307.65

2.4

2.1

0.05

0.03

g/l

0.72

2181

4087

Polyarthropathies

2115

4481

3.19

307.65

2.4

2.3

0.02

0.04

g/l

0.88

1964

4072

Anaemias

776

450

11.85

307.65

2.3

1.3

0.00

g/l

0.10

713

427

Implicit Sepsis

2274

6334

2.80

307.65

2.5

2.2

0.03

g/l

0.05

2041

5784

Bacterial infection, other or unspecified

2067

5341

3.43

307.65

3.1

2.1

0.04

0.03

g/l

0.19

1893

4825

Chronic kidney disease

1635

3316

5.31

307.65

2.4

2.2

0.03

0.04

g/l

0.19

1529

2958

Condition for Implicit Sepsis (Organ dysfunction codes)

2387

6440

2.62

307.65

2.4

2.1

0.04

0.02

g/l

0.55

2174

5899

Other systemic involvement of connective tissue (FG)

994

2302

4.53

307.65

1.8

2.5

0.01

0.05

g/l

2.77

905

2065

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

310

246

17.85

307.65

21.7

1.5

0.25

0.03

g/l

2.20

293

223

Examination and observation for other reasons

1780

3267

3.25

307.65

2.3

2.2

0.03

0.02

g/l

0.53

1657

2988

Polyneuropathies and other disorders of the peripheral nervous system

1114

2479

4.95

307.65

2.4

2.2

0.06

0.04

g/l

0.34

1029

2238

Tramadol

2182

4744

2.91

307.65

2.3

1.9

0.02

g/l

0.15

2004

4301

All kidney diseases

3025

6664

3.21

307.65

2.4

2.1

0.03

0.02

g/l

0.34

2788

6074

Dialysis, with operation codes

660

1154

6.38

307.65

4.1

2.0

0.01

0.03

g/l

1.19

616

1047

Heart failure, not strict

2293

5662

2.85

307.65

2.4

2.3

0.02

g/l

0.02

2098

5163

Aplastic and other anaemias

2119

4801

4.42

307.65

2.5

2.2

0.06

0.03

g/l

0.94

1906

4343

First line medication for Crohn's disease

2949

5693

2.87

307.65

2.9

1.6

0.03

0.02

g/l

0.63

2723

5161

Bacterial Sepsis

1611

4598

3.13

307.65

2.9

2.1

0.02

0.03

g/l

0.32

1454

4171

Multiple myeloma

310

246

17.85

307.65

21.7

1.5

0.25

0.03

g/l

2.20

293

223

Bacterial infection, other or unspecified

1950

5133

3.46

307.65

3.2

2.0

0.04

0.03

g/l

0.09

1783

4638

Second line medication for Crohn's disease

1764

5945

3.08

307.65

4.7

1.7

0.03

0.02

g/l

0.22

1629

5443

L04AX Other immunosuppressants

1741

5800

3.12

307.65

4.7

1.7

0.03

g/l

0.20

1607

5306

Liquid cancers, helper endpoint

2010

3543

5.41

307.65

6.4

1.3

0.12

0.00

g/l

7.23

1877

3199

Multiple myeloma and malignant plasma cell neoplasms

455

511

11.60

307.65

18.0

1.5

0.20

0.01

g/l

3.05

425

465

Oral corticosteroids

2965

6612

2.73

307.65

2.1

2.3

0.02

0.03

g/l

0.26

2730

6001

General symptoms and signs

2564

5070

2.59

307.65

2.4

1.9

0.04

0.02

g/l

1.51

2346

4624

Acute renal failure

943

2279

4.47

307.65

2.7

2.2

0.02

0.04

g/l

0.50

860

2035

Other bacterial diseases

2865

6612

2.83

307.65

2.7

2.0

0.04

0.03

g/l

0.56

2629

6012

Other and unspecified polyneuropathies, also in other diseases

1032

2155

5.32

307.65

2.1

2.2

0.06

0.04

g/l

0.31

951

1946

Systemic connective tissue disorders

1354

3745

3.84

307.65

1.9

2.3

0.01

0.04

g/l

3.47

1242

3376

Autoimmune diseases excluding thyroid diseases, strict definition

2546

5937

2.40

306.69

2.0

2.4

0.02

0.04

g/l

1.25

2355

5375

Pneumonias (Asthma/COPD co-morbidities)

2497

7260

2.36

306.66

2.9

2.0

0.04

0.02

g/l

1.25

2296

6634

All pneumoniae

2506

7282

2.35

304.64

2.9

2.0

0.04

0.02

g/l

1.44

2302

6657

Pain in limb

2116

5699

2.55

304.26

2.2

0.03

g/l

0.19

1967

5173

Other systemic involvement of connective tissue

1016

2893

3.72

302.65

1.8

2.3

0.01

0.04

g/l

2.36

925

2613

Pneumonia, organism unspecified

2323

6924

2.41

300.77

2.9

2.0

0.04

0.02

g/l

1.57

2121

6329

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2444

7320

2.33

291.97

2.9

2.0

0.04

0.02

g/l

1.33

2243

6694

Influenza and pneumonia

2527

7177

2.29

284.86

2.9

2.0

0.04

0.02

g/l

1.42

2321

6565

2259

5796

2.41

283.35

3.0

1.9

0.04

0.02

g/l

1.56

2082

5294

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2259

5796

2.41

283.35

3.0

1.9

0.04

0.02

g/l

1.56

2082

5294

Glomerular diseases

769

1902

4.36

281.88

2.7

2.2

0.07

0.03

g/l

0.43

727

1733

Other soft tissue disorders, not elsewhere classified

2306

5785

2.39

280.32

2.3

2.2

0.03

g/l

0.26

2137

5249

Gout

1027

2738

3.48

268.64

3.0

2.4

0.03

0.06

g/l

0.62

947

2460

Nephropathy related operations

584

1228

5.24

264.45

4.2

2.1

0.01

0.03

g/l

0.97

547

1120

Unspecified kidney failure

517

998

5.73

258.46

2.5

2.1

0.04

0.06

g/l

0.30

474

892

Finngen Rheumatological endpoints

2192

5421

2.35

254.76

2.0

2.3

0.02

0.04

g/l

0.89

2019

4941

Heart failure,strict

1586

4353

2.67

250.24

2.1

2.3

0.06

0.03

g/l

0.76

1441

3937

Disorders of lipoprotein metabolism and other lipidaemias

2103

5702

2.34

247.47

2.3

2.2

0.03

0.02

g/l

0.37

1929

5195

Heart failure and antihypertensive medication

773

1254

4.22

242.76

2.1

2.3

0.03

0.04

g/l

0.24

702

1152

Codeine

2068

4871

2.35

238.69

2.1

1.9

0.04

0.02

g/l

0.80

1895

4422

Erysipelas

1830

5993

2.39

237.62

2.1

0.02

0.03

g/l

0.64

1687

5437

Abnormal findings on examination of blood, without diagnosis

1435

5173

2.65

236.75

2.5

2.3

0.04

0.03

g/l

0.40

1300

4722

Oedema, not elsewhere classified

936

2933

3.27

231.87

2.4

2.1

0.02

g/l

0.12

861

2667

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

441

818

6.08

231.51

3.2

2.1

0.08

0.03

g/l

0.82

389

743

Infections, IBD-co-morbidities

433

479

6.72

231.33

3.9

2.1

0.01

0.05

g/l

0.67

392

439

Gout, FINNGEN

1027

3476

3.10

229.32

3.0

2.3

0.03

0.05

g/l

0.42

947

3132

Asthma, unspecified (mode), excluding more controls

1219

3284

2.85

224.42

2.1

1.8

0.03

0.01

g/l

1.48

1120

3004

Pure hypercholesterolaemia

1900

5463

2.33

223.79

2.3

2.2

0.03

g/l

0.23

1737

4977

Reimbursement for rheumatic diseases

1529

6359

2.47

223.73

1.7

2.4

0.01

0.03

g/l

3.29

1420

5770

Opioids

2108

4900

2.27

223.28

2.3

1.9

0.04

0.02

g/l

0.52

1932

4449

Care involving dialysis

408

727

6.27

222.95

2.6

2.0

0.00

0.02

g/l

0.66

380

673

Other heart diseases

968

1959

3.30

220.15

2.3

2.0

0.01

0.02

g/l

0.73

883

1829

Hypertension, essential

1695

3978

2.46

218.38

2.1

2.2

0.02

g/l

0.13

1561

3652

Other and unspecified iron deficiency

1045

3668

2.97

218.32

2.0

2.3

0.02

0.04

g/l

1.29

933

3316

Persons encountering health services for specific procedures and health care

2412

7072

2.08

213.83

2.5

2.1

0.03

0.02

g/l

0.16

2241

6431

Glomerular disorders in diseases classified elsewhere

515

1164

4.82

213.06

2.8

2.2

0.04

0.03

g/l

0.03

485

1068

Autoimmune diseases related-to ILD

2024

8184

2.16

212.78

2.1

2.2

0.01

0.03

g/l

1.22

1876

7443

Hypertensive diseases (excluding secondary)

1045

1976

3.14

211.51

2.2

2.0

0.01

0.02

g/l

0.94

974

1838

Other diseases of blood and blood-forming organs, wide

776

2348

3.50

210.66

3.2

2.2

0.05

0.04

g/l

0.19

719

2137

Nutritional anaemias

1417

5655

2.49

210.50

2.0

2.3

0.02

0.04

g/l

0.73

1267

5123

Certain infectious and parasitic diseases

2109

4858

2.21

207.27

2.4

1.9

0.03

g/l

0.11

1935

4421

Heart failure, strict

1709

5331

2.34

204.78

2.1

2.4

0.05

0.03

g/l

0.62

1554

4814

Osteopathies and chondropathies

1500

5985

2.40

204.77

2.9

2.1

0.02

0.03

g/l

0.73

1358

5444

Diseases of arteries, arterioles and capillaries (FINNGEN)

670

1199

4.02

203.16

2.5

2.2

0.01

0.03

g/l

0.85

620

1118

Iron deficiency anaemia

1235

4824

2.61

202.46

2.0

2.3

0.02

0.04

g/l

0.57

1101

4364

Implicit viral Sepsis

896

3020

3.10

201.63

2.7

2.1

0.02

0.03

g/l

0.70

817

2739

Asthma, unspecified (mode)

1267

3718

2.63

200.86

2.1

1.9

0.03

0.01

g/l

1.38

1163

3395

Septicaemia

1182

4313

2.65

197.93

2.8

2.0

0.05

0.04

g/l

0.31

1081

3888

Hypertensive diseases

1655

4013

2.37

197.36

2.1

2.2

0.01

0.02

g/l

0.69

1525

3682

Hypertension

1651

4012

2.37

195.85

2.1

2.2

0.01

0.02

g/l

0.68

1521

3682

Explicit Sepsis

1210

4496

2.59

194.24

2.8

2.1

0.05

0.03

g/l

0.36

1107

4079

Pain in joint

1383

3572

2.52

193.83

2.0

2.2

0.02

0.03

g/l

0.33

1264

3255

Exposure to unspecified factor

2274

8288

2.01

191.40

2.2

0.02

0.03

g/l

0.18

2059

7587

All-cause Heart Failure

1655

5258

2.29

190.37

2.1

2.4

0.05

0.03

g/l

0.59

1506

4748

Ulcer of lower limb, not elsewhere classified

597

1641

3.92

189.03

2.4

2.2

0.01

0.05

g/l

1.49

549

1480

Asthma, excluding more controls

1556

3428

2.41

187.70

2.0

1.8

0.03

0.01

g/l

1.38

1435

3140

Codeine or tramadol medication

2529

7211

1.95

183.85

2.1

2.2

0.04

0.03

g/l

0.39

2319

6559

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2516

7112

1.96

183.66

2.2

0.03

g/l

0.11

2341

6449

Other arthritis (FG)

814

2753

3.06

181.46

2.2

2.5

0.02

0.04

g/l

0.79

760

2505

L04AA Selective immunosuppressants

684

2108

3.40

179.62

1.8

2.2

0.01

0.02

g/l

1.41

656

1930

Covid-19 confirmed case

1068

4201

2.64

178.81

2.8

2.1

0.04

0.03

g/l

0.32

981

3800

Dental caries

745

2316

3.21

178.20

3.3

2.1

0.06

0.02

g/l

0.53

692

2121

Codes for special purposes

1332

5805

2.35

176.25

2.8

2.1

0.06

0.03

g/l

0.82

1224

5275

Cardiovascular diseases (excluding rheumatic etc)

1066

2239

2.78

176.18

2.2

1.9

0.01

0.02

g/l

0.57

1003

2086

Provisional assignment of new diseases of uncertain etiology

1330

5800

2.35

175.72

2.8

2.1

0.06

0.03

g/l

0.82

1223

5269

Erysipelas

1404

5500

2.32

175.41

2.1

0.02

0.03

g/l

0.52

1296

4989

Gout, idiopatic and unspecified

864

3106

2.93

174.33

2.1

2.4

0.03

0.04

g/l

0.70

796

2812

Autoimmune diseases

2353

6176

1.97

172.31

2.0

2.4

0.02

0.03

g/l

0.86

2161

5597

Cerebrovascular diseases (FINNGEN)

707

1516

3.39

171.51

2.4

2.1

0.01

0.03

g/l

1.22

651

1411

Used for control exclusion in common control thyroid runs

2218

5668

2.01

171.47

2.1

2.4

0.02

0.04

g/l

0.84

2040

5135

Asthma

1637

3885

2.25

169.59

2.1

1.9

0.03

0.01

g/l

1.39

1512

3552

Acute tubulo-interstitial nephritis

1443

5638

2.26

169.57

2.2

0.03

g/l

0.07

1293

5105

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

326

378

6.42

165.64

2.3

2.2

0.07

0.06

g/l

0.03

307

340

Asthma (mode)

1605

3918

2.23

164.57

2.0

1.8

0.03

0.01

g/l

1.36

1480

3584

Diverticular disease of intestine

1796

5602

2.09

163.20

2.5

2.2

0.04

0.03

g/l

0.37

1634

5110

L04AD Calcineurin inhibitors

398

903

4.73

163.17

2.4

0.01

0.02

g/l

0.22

384

840

Any gastric operation

1528

3401

2.29

163.11

2.2

1.9

0.02

g/l

0.14

1409

3110

GASTRO-related operations

1528

3401

2.29

163.11

2.2

1.9

0.02

g/l

0.14

1409

3110

Other septicaemia

1025

3968

2.57

161.84

2.5

2.1

0.05

0.04

g/l

0.15

933

3575

Asthma (only as main-diagnosis), excluding more controls

1381

3428

2.34

161.36

2.1

1.8

0.03

0.01

g/l

1.56

1276

3140

Continuous positive airway pressure

563

1346

3.67

160.01

2.4

2.3

0.04

0.03

g/l

0.30

506

1257

Other specific joint derangements/joint disorders

1516

4549

2.19

156.47

2.0

2.3

0.02

0.04

g/l

0.89

1387

4156

Coagulation defects, purpura and other haemorrhagic conditions

618

1954

3.32

155.91

2.4

2.1

0.06

0.04

g/l

0.22

565

1777

Other specified/unspecified arthritis

725

2505

3.00

155.77

2.1

2.4

0.02

0.04

g/l

0.70

675

2273

Disorders resulting from impaired renal tubular function

227

326

8.17

154.77

2.3

2.7

0.01

0.02

g/l

0.48

217

301

Gout, strict definition

660

2189

3.20

154.57

2.1

2.4

0.03

0.06

g/l

0.73

611

1981

Dyspnoea

2056

8023

1.93

154.42

2.3

2.2

0.04

0.03

g/l

0.49

1865

7330

Gout, unspecified

718

2500

3.04

153.95

2.1

2.3

0.03

0.05

g/l

0.69

664

2266

Persons encountering health services in other circumstances, wide

2526

7150

1.85

153.70

2.2

0.03

g/l

0.15

2339

6476

Caries of dentine

650

2064

3.18

153.61

3.3

2.1

0.07

0.02

g/l

0.54

603

1891

Diseases of arteries, arterioles and capillaries

1714

6315

2.05

152.62

2.1

2.4

0.01

0.04

g/l

2.13

1556

5738

Diseases of oesophagus, stomach and duodenum

2297

7451

1.87

151.45

2.0

2.3

0.02

0.03

g/l

1.16

2074

6825

Other disorders of skin and subcutaneous tissue

1683

7526

2.03

151.20

2.2

2.3

0.02

0.03

g/l

0.83

1543

6829

Abnormalities of breathing

1820

5285

2.03

150.92

2.2

2.1

0.03

0.02

g/l

0.52

1654

4860

Enlarged lymph nodes

465

1248

3.90

150.68

2.1

0.07

0.02

g/l

0.73

437

1148

Non-Hodgkin lymphoma, all, including Hilmo

496

1401

3.78

150.56

2.8

1.5

0.06

0.02

g/l

0.68

473

1259

Certain infectious and parasitic diseases

1499

3440

2.22

148.80

2.2

1.9

0.02

0.03

g/l

0.09

1387

3141

Hypertensive heart and/or renal disease

757

1980

2.96

147.81

2.0

2.3

0.04

g/l

0.06

697

1780

Other heart diseases, wide

1824

5653

2.00

147.51

2.2

0.01

0.03

g/l

0.85

1658

5209

Preparatory care for dialysis

252

424

6.86

147.45

2.3

2.7

0.00

0.03

g/l

1.13

241

394

Polymyalgia rheumatica

520

1542

3.61

146.85

1.8

2.3

0.00

0.06

g/l

2.90

463

1377

Pain, not elsewhere classified

661

2240

3.04

146.61

2.8

2.0

0.06

0.02

g/l

0.70

613

2042

Cardiovascular diseases

917

1819

2.75

145.45

2.1

1.8

0.01

g/l

0.07

860

1698

Pain in throat and chest

1735

5234

2.02

143.24

2.2

2.1

0.02

g/l

0.05

1585

4810

Asthma (only as main-diagnosis)

1437

3885

2.18

142.03

2.1

1.9

0.03

0.01

g/l

1.58

1325

3552

Headache

1244

4527

2.23

141.14

2.1

1.9

0.03

0.02

g/l

0.54

1149

4123

Diabetic nephropathy, excluding more controls

485

1119

3.78

140.59

1.7

2.2

0.01

0.03

g/l

0.63

452

1005

Disturbances of skin sensation

695

2494

2.88

139.24

2.0

2.2

0.01

0.02

g/l

0.56

655

2282

Osteoporosis

802

2887

2.71

138.96

2.3

2.2

0.01

0.04

g/l

1.60

709

2594

Heart failure and bmi 25plus

926

2487

2.60

138.41

2.0

2.5

0.04

0.02

g/l

0.79

834

2227

Oxycodone

957

3609

2.47

138.12

4.4

2.0

0.06

0.03

g/l

0.68

877

3248

Diseases of the skin and subcutaneous tissue

2050

5492

1.90

135.39

2.1

2.2

0.04

0.02

g/l

0.68

1871

4991

Syncope and collapse

1014

3723

2.38

135.34

2.3

2.1

0.02

g/l

0.26

907

3381

Transplanted organ and tissue status

366

903

4.35

134.72

4.2

2.0

0.01

0.02

g/l

0.39

350

825

Abnormalities of gait and mobility

463

1365

3.63

132.01

1.9

2.3

0.02

0.04

g/l

0.44

428

1248

Rheumatoid arthritis

829

2961

2.59

131.91

1.9

2.5

0.01

0.04

g/l

2.38

768

2664

Complications of surgical and medical care, not elsewhere classified

2144

8236

1.81

130.93

2.2

0.04

0.03

g/l

0.25

1949

7516

Other diseases of intestines

2087

6525

1.84

130.18

2.3

2.1

0.04

0.02

g/l

0.62

1906

5970

Viral Sepsis

595

2056

3.02

128.48

3.2

2.0

0.02

0.03

g/l

0.36

544

1850

Symptoms and signs involving the skin and subcutaneous tissue

1569

8025

1.95

128.23

2.2

0.02

0.03

g/l

0.28

1456

7296

Other necrotizing vasculopathies (FG)

253

484

5.71

127.61

1.4

2.9

0.01

0.07

g/l

0.96

233

433

Implicit viral Sepsis

593

2055

3.01

127.38

3.2

2.0

0.02

0.03

g/l

0.35

542

1849

Disorders of thyroid, IBD co-morbidities

331

497

4.79

126.91

1.9

2.2

0.01

0.05

g/l

0.59

298

453

Symptoms and signs involving cognition, perception, emotional state and behaviour

2060

7859

1.81

126.60

2.0

2.3

0.02

0.03

g/l

0.43

1861

7202

Glomerulonephritis

365

941

4.15

126.55

2.8

2.3

0.10

0.02

g/l

0.57

348

869

Medical observation and evaluation for suspected diseases and conditions

1365

3305

2.15

126.13

2.2

0.03

0.02

g/l

0.58

1256

3017

Low back pain

1575

5851

1.96

124.82

2.6

2.1

0.02

0.03

g/l

0.42

1456

5321

Non-ischemic cardiomyopathy

886

2983

2.48

124.70

2.1

2.3

0.07

0.03

g/l

0.61

803

2698

Atrial fibrillation and flutter

645

1445

2.97

123.08

2.6

2.1

0.01

0.03

g/l

0.57

596

1345

Asthma (diagnoses ohter than nonallergic)

1846

8467

1.84

122.62

2.0

2.3

0.03

g/l

0.12

1688

7716

Spondylopathies

1756

5595

1.91

122.33

2.5

2.1

0.03

g/l

0.10

1617

5074

Other pulmonary diagnosis

1551

3924

2.01

120.29

2.4

1.8

0.03

0.01

g/l

1.20

1430

3589

Fall on same level

2271

7156

1.75

119.43

2.3

2.2

0.02

0.03

g/l

0.08

2048

6590

Neurological diseases, wide definition

443

568

3.97

119.25

2.2

2.0

0.01

0.05

g/l

0.52

418

520

Asthma, hospital admission 2, infections

1295

6369

2.03

118.90

2.2

2.3

0.03

g/l

0.21

1191

5774

Asthma-related infections

1295

6369

2.03

118.90

2.2

2.3

0.03

g/l

0.21

1191

5774

Type 2 diabetes, wide definition

1812

6353

1.86

118.27

2.0

2.4

0.03

g/l

0.07

1635

5799

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1557

7449

1.91

117.36

2.3

0.04

0.03

g/l

0.27

1418

6768

Small fibre neuropathy

179

269

7.80

117.23

2.6

2.3

0.00

0.01

g/l

0.50

167

247

Need for other prophylactic measures

248

506

5.36

116.43

2.3

2.4

0.02

g/l

0.16

239

467

COPD/asthma/ILD related infections

2059

5796

1.80

115.91

2.9

1.9

0.04

0.02

g/l

1.31

1899

5294

COPD/asthma related infections

2059

5796

1.80

115.91

2.9

1.9

0.04

0.02

g/l

1.31

1899

5294

Excluding asthma or asthma-COPD overlap

1535

3924

1.99

115.71

2.4

1.8

0.03

0.01

g/l

1.20

1422

3589

Chronic lymphocytic leukaemia, helper endpoint

180

278

7.60

114.98

2.1

1.3

0.05

0.02

g/l

0.42

170

253

Chronic lymphocytic leukaemia

180

278

7.60

114.98

2.1

1.3

0.05

0.02

g/l

0.42

170

253

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

180

278

7.60

114.98

2.1

1.3

0.05

0.02

g/l

0.42

170

253

Other disorders of fluid, electrolyte and acid-base balance

800

3204

2.45

114.88

2.5

2.2

0.04

0.03

g/l

0.30

729

2892

Adjustment and management of implanted device

595

2190

2.85

114.72

2.6

2.1

0.01

0.04

g/l

1.42

540

1948

Symptoms and signs concerning food and fluid intake

327

833

4.13

114.27

2.0

2.2

0.01

0.02

g/l

0.05

299

755

Seropositive rheumatoid arthritis

622

2331

2.74

113.82

1.9

2.6

0.01

0.05

g/l

2.01

579

2094

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

597

979

3.10

113.72

2.2

1.8

0.02

0.01

g/l

0.16

559

914

COPD differential diagnosis

1526

3918

1.98

113.64

2.5

1.8

0.03

0.01

g/l

1.21

1414

3584

ILD differential diagnosis

1526

3918

1.98

113.63

2.5

1.8

0.03

0.01

g/l

1.21

1414

3584

Benign neoplasm of colon, rectum, anus and anal canal

1537

7196

1.90

112.48

2.4

2.3

0.03

g/l

0.08

1385

6548

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

758

1884

2.58

112.20

2.1

2.0

0.04

0.03

g/l

0.24

710

1755

Nephrotic syndrome

169

249

7.74

112.03

2.5

2.8

0.20

0.02

g/l

0.56

163

230

Purpura and other haemorrhagic conditions

429

1340

3.37

110.85

2.5

2.3

0.02

0.03

g/l

0.19

390

1230

Other necrotizing vasculopathies

294

718

4.45

110.38

1.7

2.6

0.01

0.02

g/l

0.75

272

659

Asthma, hospital admissions 3, pneumonia

915

4155

2.26

110.10

2.3

2.2

0.04

0.03

g/l

0.15

843

3728

Asthma-related pneumonia or sepsis

915

4155

2.26

110.10

2.3

2.2

0.04

0.03

g/l

0.15

843

3728

Asthma-related pneumonia

912

4149

2.25

109.26

2.2

0.04

0.03

g/l

0.15

840

3722

Endocrine, nutritional and metabolic diseases

1396

3563

2.01

109.06

2.1

2.2

0.02

g/l

0.17

1286

3285

368

1056

3.63

108.12

2.1

2.2

0.01

0.02

g/l

0.65

330

963

Other CVD (FINNGEN)

331

649

4.14

108.12

2.9

2.2

0.02

0.05

g/l

0.49

296

600

Dorsalgia

1949

5927

1.78

108.00

2.3

2.1

0.02

0.03

g/l

0.26

1785

5388

Extracorporeal dialysis

256

573

4.89

107.71

2.5

2.4

0.00

0.03

g/l

1.15

233

535

Cardiomyopathy

504

1759

2.99

107.01

2.6

2.2

0.01

0.04

g/l

1.65

460

1606

Follow-up examination after treatment for conditions other than malignant neoplasms

939

2781

2.28

106.97

2.3

2.2

0.04

0.02

g/l

0.74

865

2553

Bleeding

1822

7412

1.78

105.35

2.2

2.3

0.04

0.02

g/l

0.77

1648

6765

Hypertensive Renal Disease

181

304

6.61

105.20

1.8

2.5

0.03

0.09

g/l

0.42

172

276

Other and unspecified dermatitis

1138

5726

2.03

104.63

2.0

2.3

0.02

0.03

g/l

0.81

1043

5203

ILD medications: azathioprine

337

936

3.73

103.68

1.8

1.5

0.00

0.01

g/l

0.44

310

867

Other and unspecified diseases of blood and blood-forming organs

156

231

7.84

103.37

5.2

2.6

0.06

0.02

g/l

0.38

148

217

Hyperlipidaemia, other/unspecified

943

4080

2.18

103.10

2.4

2.2

0.03

g/l

0.06

848

3701

Haemorrhage from respiratory passages

849

3448

2.28

102.64

2.3

0.08

0.03

g/l

0.68

764

3138

Pain (limb, back, neck, head abdominally)

1430

3733

1.94

101.68

2.2

2.1

0.03

g/l

0.05

1312

3391

Diaphragmatic hernia

927

4384

2.18

101.56

2.3

2.2

0.03

0.04

g/l

0.27

830

3976

Depression medications

377

485

3.96

101.34

1.7

1.2

0.02

0.00

g/l

0.59

365

461

Soft tissue disorders

1957

5820

1.75

101.23

2.2

0.02

0.03

g/l

0.48

1797

5279

Any reimbursement code in KELA

878

1888

2.36

101.13

2.4

1.5

0.01

g/l

0.02

829

1725

Dermatitis and eczema

2217

8325

1.67

100.73

2.0

2.3

0.02

0.03

g/l

0.80

2038

7586

Symptoms and signs involving the circulatory and respiratory systems

1857

5293

1.78

100.41

2.1

0.03

0.02

g/l

0.38

1697

4868

Lower back pain or/and sciatica

2130

8377

1.68

100.12

2.4

2.2

0.02

0.03

g/l

1.17

1958

7638

Rheumatoid arthritis, including avohilmo

923

4398

2.15

98.97

1.9

2.3

0.01

0.04

g/l

3.32

855

3964

Care involving use of rehabilitation procedures

1322

6519

1.90

98.89

2.3

2.1

0.02

g/l

0.01

1237

5919

Disorders of calcium metabolism

246

572

4.64

98.24

3.9

2.2

0.04

0.02

g/l

0.77

212

531

Diabetic nephropathy

488

1736

2.92

98.11

1.7

2.1

0.01

0.03

g/l

0.95

454

1561

Symptoms and signs involving the urinary system

1669

7267

1.78

98.10

2.2

2.3

0.03

g/l

0.11

1533

6598

Intestinal infectious diseases

2309

8095

1.65

98.00

2.6

2.1

0.02

0.03

g/l

0.58

2100

7388

Disorders of mineral metabolism

285

739

4.10

97.94

3.6

2.3

0.03

g/l

0.15

248

687

Secondary hypertension

221

464

4.94

97.26

2.3

2.2

0.01

0.07

g/l

0.86

210

432

Diarrhoea and gastroenteritis of presumed infectious origin

1428

7120

1.83

96.00

2.7

2.1

0.02

0.03

g/l

0.65

1311

6475

Chronic gastritis

739

3274

2.33

95.38

2.2

2.4

0.01

0.05

g/l

2.29

660

2979

Other disorders of white blood cells

224

498

4.90

94.95

2.1

2.5

0.14

0.02

g/l

0.43

204

462

Cardiac arrhythmias

1048

3332

2.07

94.88

2.3

2.2

0.01

0.03

g/l

1.09

955

3098

Non-follicular lymphoma

350

1068

3.51

94.72

2.6

2.4

0.06

0.03

g/l

0.35

336

973

Constipation

1870

7674

1.71

94.52

2.7

2.2

0.06

0.02

g/l

0.96

1676

7021

Atrial fibrillation and flutter with reimbursement

533

1224

2.84

93.85

2.6

2.2

0.01

0.04

g/l

0.71

492

1139

Heart failure and coronary heart disease

1124

4066

2.01

93.63

1.9

2.5

0.03

0.04

g/l

0.28

1022

3668

Other disorders of urethra and urinary system

1429

5691

1.84

93.36

2.2

0.01

0.04

g/l

2.32

1303

5179

Symptoms and signs involving the nervous and musculoskeletal systems

1264

6847

1.88

93.06

2.0

2.3

0.02

0.03

g/l

0.93

1164

6211

Other dorsopathies, not elsewhere classified

1923

5933

1.72

93.00

2.2

2.1

0.03

g/l

0.13

1757

5394

Bacterial pneumonia, not elsewhere classified

909

3849

2.13

92.73

3.3

2.0

0.08

0.02

g/l

0.95

846

3484

Bacterial pneumoniae

940

4041

2.10

92.35

3.3

2.0

0.08

0.02

g/l

0.94

873

3666

Dermatitis

1291

7030

1.86

92.31

2.0

2.3

0.02

0.03

g/l

0.62

1182

6393

Diseases of liver

827

3882

2.19

92.27

1.8

2.4

0.01

0.03

g/l

1.68

731

3550

Other diseases of urinary system

1988

6697

1.69

92.16

2.2

0.02

0.03

g/l

0.42

1815

6133

Intestinal infectious diseases

1870

8506

1.69

92.06

2.7

2.1

0.02

0.03

g/l

0.34

1715

7757

Lymphoid leukaemia

238

573

4.54

91.36

2.8

2.6

0.03

0.02

g/l

0.35

226

524

Antihypertensive medication - note that there are other indications

855

2034

2.25

90.61

2.0

0.01

0.02

g/l

0.61

792

1888

Hypertensive Heart Disease

598

1886

2.56

90.54

2.1

2.3

0.04

g/l

0.07

543

1697

Parasetamol

1334

3582

1.91

90.51

2.2

1.9

0.02

g/l

0.05

1229

3285

Benign neoplasm: Colon

1297

6822

1.86

90.30

2.4

0.03

g/l

0.04

1161

6217

Valvular heart disease excluding rheumatic fever

1037

3767

2.03

89.83

2.5

2.3

0.03

g/l

0.16

935

3448

896

4344

2.08

89.10

2.4

2.1

0.02

0.03

g/l

0.18

832

3941

Neoplasms

1236

3420

1.94

88.59

2.5

1.2

0.02

0.00

g/l

2.40

1150

3132

Non-rheumatic valve diseases

1031

3760

2.02

88.17

2.5

2.3

0.03

g/l

0.16

930

3441

STROKE

1144

4068

1.95

87.28

2.5

2.4

0.01

0.03

g/l

2.22

1043

3727

Complications of procedures, not elsewhere classified

1648

8057

1.72

87.22

2.1

2.3

0.04

0.03

g/l

0.38

1494

7349

Other disorders of kidney and ureter

410

1442

2.99

86.51

2.4

2.3

0.01

0.03

g/l

1.43

391

1315

Diseases of the musculoskeletal system and connective tissue

872

2011

2.20

85.94

2.2

2.1

0.02

0.04

g/l

0.55

817

1818

Chronic lower respiratory diseases

2295

7710

1.60

85.79

2.0

2.3

0.03

0.02

g/l

0.09

2109

7026

Kidney transplant status

190

402

5.11

85.31

1.7

2.5

0.00

0.02

g/l

0.56

183

379

Hypothyroidism (congenital or acquired)

315

471

3.83

85.22

2.3

1.2

0.02

0.00

g/l

0.61

302

447

Azathioprine

337

1063

3.28

85.03

1.8

2.4

0.00

0.01

g/l

1.12

310

985

Unspecified privation

326

1018

3.37

84.37

1.9

2.2

0.01

0.02

g/l

0.40

297

943

Hypothyroidism, levothyroxine purchases

311

470

3.79

83.11

2.3

1.2

0.03

0.00

g/l

0.61

298

446

Hypothyroidism and >3 levothyroxin purchases

311

470

3.79

83.11

2.3

1.2

0.03

0.00

g/l

0.61

298

446

Sicca syndrome [Sjögren]

278

797

3.70

82.65

1.8

2.5

0.00

0.02

g/l

0.88

254

730

Certain disorders involving the immune mechanism

487

1917

2.63

81.91

2.8

2.1

0.03

0.02

g/l

0.09

450

1761

Genitourinary diseases

1029

2585

2.02

81.77

2.0

2.1

0.02

g/l

0.05

960

2349

Neurological diseases

1529

4398

1.77

81.13

2.1

2.3

0.01

0.03

g/l

1.60

1396

4040

Amyloidosis, other/unspecified

118

170

8.22

80.57

8.0

2.5

0.04

0.00

g/l

0.76

113

157

Amyloidosis

129

204

7.29

80.37

7.6

2.4

0.04

0.00

g/l

0.80

124

188

Arthropathies

1598

4712

1.74

80.27

1.9

2.3

0.02

0.04

g/l

0.48

1480

4294

Spondylosis

1169

5225

1.86

80.16

2.2

0.03

g/l

0.01

1069

4741

Other diseases of blood and blood-forming organs

245

660

3.97

80.12

4.4

2.4

0.04

0.02

g/l

0.36

226

611

Complications of medical and surgical care

1519

8308

1.71

79.87

2.3

0.03

g/l

0.04

1395

7557

Other antidepressants

2013

6408

1.63

79.47

2.1

2.3

0.03

g/l

0.02

1821

5881

Venous thromboembolism

1231

6702

1.81

79.45

2.5

2.2

0.02

0.04

g/l

0.54

1129

6065

Cerebrovascular diseases

1628

6864

1.69

79.37

2.4

2.3

0.02

0.03

g/l

0.64

1452

6283

Hypothyroidism, drug reimbursement

220

352

4.50

79.05

2.4

1.3

0.02

0.00

g/l

0.50

206

334

Sulfasalazine

578

2507

2.36

77.95

1.7

2.4

0.01

0.02

g/l

0.74

538

2275

Thrombocytopenia, unspecified

248

688

3.85

77.65

2.0

2.4

0.02

g/l

0.01

218

639

Disorders of other endocrine glands

895

4523

1.98

77.41

2.4

2.2

0.02

0.03

g/l

0.66

819

4103

Persons encountering health services for specific procedures, not carried out

239

646

3.88

77.14

2.1

0.01

0.00

g/l

0.44

221

602

Use of hypnotics and sedatives

2066

7525

1.59

76.88

2.5

2.2

0.04

0.03

g/l

0.29

1866

6898

Peripheral artery disease

1077

4649

1.89

76.68

2.0

2.4

0.01

0.05

g/l

3.12

986

4194

Malignant neoplasm

1618

5725

1.69

76.68

3.8

1.4

0.05

0.01

g/l

2.05

1491

5219

SLE (Finngen)

138

242

6.22

76.52

1.8

2.2

0.00

g/l

0.50

129

229

Spinal stenosis

1145

4799

1.85

76.01

2.1

2.2

0.04

0.03

g/l

0.13

1035

4333

Acquired haemolytic anaemia

132

226

6.67

75.91

3.9

2.2

0.01

0.03

g/l

0.50

122

210

Viral hepatitis, IBD co-morbidity

111

155

7.42

75.61

1.7

0.00

0.01

g/l

0.50

102

147

Malignant neoplasm, wide definition for exclusion

1642

5800

1.68

75.57

3.6

1.4

0.04

0.01

g/l

1.52

1520

5290

Myelodysplastic syndrome, including Hilmo

147

279

5.90

75.52

2.3

1.4

0.22

0.02

g/l

0.50

139

252

Osteoporosis with pathological fracture (FG)

229

613

3.97

75.38

1.7

2.6

0.01

0.10

g/l

1.52

199

539

Haemolytic anaemias

151

293

5.68

75.36

3.6

2.1

0.01

0.03

g/l

0.47

140

269

Infections of the skin and subcutaneous tissue

1126

6223

1.82

75.13

2.4

2.2

0.02

0.03

g/l

1.44

1050

5691

2204

7335

1.57

75.02

3.1

2.0

0.04

0.02

g/l

0.73

2022

6679

Other medical care

1001

4834

1.90

74.76

3.2

2.1

0.07

0.03

g/l

0.61

921

4356

Bacterial pneumonia (organism specified)

1001

4885

1.89

74.39

3.5

2.1

0.08

0.03

g/l

1.04

930

4401

Chronic apical periodontitis

2145

7886

1.57

73.92

2.3

2.2

0.02

0.03

g/l

0.40

1944

7222

Other and unspecified disorders of white blood cells

172

382

4.94

73.28

1.9

2.6

0.17

0.02

g/l

0.46

160

353

COPD (mode)

683

2515

2.18

72.96

1.9

0.07

0.01

g/l

0.80

625

2271

Dorsopathies

1874

5937

1.62

72.88

2.2

2.1

0.04

0.03

g/l

0.48

1718

5397

Gastrointestinal diseases

962

2472

1.97

71.64

2.3

1.9

0.02

0.01

g/l

0.42

892

2276

Diarrhoea and gastroenteritis of presumed infectious origin

1921

8085

1.58

71.55

2.4

2.1

0.02

0.03

g/l

0.83

1751

7378

Paroxysmal tachycardia

391

1206

2.77

71.35

1.8

2.1

0.02

0.03

g/l

0.26

344

1119

Statin medication

1153

3577

1.83

71.22

2.1

2.3

0.01

0.03

g/l

1.12

1061

3258

Disorders of parathyroid gland

543

2363

2.35

71.16

2.4

2.2

0.03

0.04

g/l

0.21

491

2124

Speech therapy

639

3009

2.18

71.05

2.3

2.2

0.02

0.03

g/l

0.50

598

2721

Pulmonary heart disease, diseases of pulmonary circulation

783

3977

2.02

70.74

2.4

2.3

0.03

0.04

g/l

0.39

717

3584

Other diseases of pleura

1069

5235

1.83

70.27

2.4

2.3

0.06

0.03

g/l

0.46

971

4730

Weight loss

302

1007

3.16

70.17

2.3

0.02

0.03

g/l

0.28

278

925

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1272

5958

1.74

70.10

2.1

2.4

0.03

g/l

0.10

1138

5421

Abnormal findings on diagnostic imaging of lung

1109

6039

1.80

69.82

2.3

0.05

0.03

g/l

0.30

1003

5471

Asthma, including avohilmo

2213

8178

1.53

69.75

2.0

2.3

0.03

g/l

0.05

2028

7454

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1824

7550

1.59

69.08

2.6

2.2

0.05

0.02

g/l

0.88

1672

6897

Dialysis

147

300

5.31

69.01

2.6

1.9

0.01

0.03

g/l

0.44

140

279

Other/unspecified dorsalgia

754

3770

2.02

68.93

2.8

2.1

0.03

g/l

0.21

683

3407

Chronic rhinitis, nasopharyngitis and pharyngitis

668

3230

2.11

68.85

2.0

2.2

0.03

0.02

g/l

0.14

605

2945

Dizziness and giddiness

1489

7216

1.66

68.81

2.1

2.3

0.02

0.03

g/l

1.15

1363

6599

Injuries to the head

2074

8343

1.54

68.33

2.2

0.02

0.03

g/l

0.87

1867

7645

DVT of lower extremities and pulmonary embolism

964

5276

1.86

68.26

2.5

2.3

0.03

g/l

0.06

877

4769

Giant cell arteritis

176

424

4.55

67.74

1.5

2.8

0.00

0.02

g/l

0.95

157

386

Persons with potential health hazards related to communicable diseases

617

2885

2.15

67.41

2.1

2.0

0.02

g/l

0.18

582

2677

Other joint disorders

1486

4710

1.68

67.21

2.0

2.3

0.02

0.04

g/l

0.58

1361

4292

Any event in cancer register

1674

6156

1.62

66.96

3.5

1.5

0.04

0.01

g/l

1.47

1541

5621

Diseases of the respiratory system

1185

3339

1.80

66.95

2.5

1.9

0.03

0.01

g/l

1.13

1104

3046

Cough

805

3959

1.96

66.85

2.4

2.2

0.01

0.03

g/l

1.21

734

3615

Other external causes of accidental injury

1494

4504

1.68

66.46

2.0

2.2

0.02

0.03

g/l

0.69

1356

4145

Seronegative rheumatoid arthritis

286

950

3.13

66.45

2.1

2.8

0.01

0.06

g/l

1.49

265

858

Chronic periodontitis, including avohilmo

1882

8165

1.56

66.41

2.2

2.3

0.02

0.03

g/l

0.86

1715

7463

Persons encountering health services for examination and investigation

1173

3305

1.80

66.40

2.1

2.2

0.03

0.02

g/l

0.62

1080

3017

Systemic lupus erythematosus

138

276

5.44

66.39

1.8

1.9

0.00

0.02

g/l

0.51

129

258

Periodontitis

1885

8171

1.56

66.10

2.2

2.3

0.02

0.03

g/l

0.86

1719

7468

Other specified/unspecified systemic involvement of connective tissue

189

487

4.14

65.77

1.8

2.7

0.03

0.01

g/l

0.24

181

449

Vasculitis limited to skin, not elsewhere classified

126

236

5.97

65.68

2.4

2.8

0.03

0.02

g/l

0.10

120

218

Abnormal weight loss

284

951

3.15

65.64

2.1

2.3

0.02

0.03

g/l

0.28

262

872

Non-allergic asthma (mode), excluding more controls

374

1423

2.66

65.54

1.9

1.7

0.04

0.01

g/l

0.53

338

1289

Disorders of eyelid, lacrimal system and orbit

1681

8126

1.59

65.31

2.4

2.2

0.02

0.03

g/l

0.75

1517

7416

Mixed connective tissue disease

208

577

3.84

65.16

1.7

2.5

0.03

0.01

g/l

0.22

198

533

Cystitis

1590

5904

1.62

63.79

2.2

0.03

g/l

0.21

1444

5377

Myalgia

469

2030

2.36

63.72

2.0

2.1

0.01

0.03

g/l

0.56

436

1841

Hard cardiovascular diseases

1608

6011

1.62

63.70

2.3

2.4

0.02

0.03

g/l

1.01

1470

5514

Other disorders involving the immune mechanism, not elsewhere classified

128

249

5.64

63.69

2.4

2.7

0.03

g/l

0.04

119

233

Idiopathic gout

294

1022

3.04

63.68

2.1

2.4

0.01

0.05

g/l

1.55

269

922

Other special examinations and investigations of persons without complaint or reported diagnosis

1151

3305

1.78

63.37

2.0

2.2

0.05

0.02

g/l

0.97

1053

3017

Unspecified haematuria

946

4349

1.84

63.08

2.2

2.4

0.02

0.04

g/l

0.57

870

3922

Atherosclerosis, excluding cerebral and coronary sclerosis

989

4395

1.82

63.04

2.1

2.3

0.01

0.05

g/l

2.89

904

3965

Bronchitis

2011

8392

1.52

62.90

3.2

2.0

0.02

0.03

g/l

0.14

1842

7647

Cardiomyopathy, other and unspecified

235

721

3.43

62.80

2.3

2.1

0.01

0.05

g/l

1.03

211

662

Asthma, hospital admissions , main diagnosis only

1525

8493

1.60

62.80

2.0

2.2

0.03

g/l

0.18

1400

7745

Mood disorders, excluding more controls

1757

6735

1.57

62.71

2.0

2.3

0.02

0.03

g/l

0.42

1583

6210

Pulmonary embolism

705

3602

2.01

62.71

2.4

2.2

0.03

0.04

g/l

0.18

644

3246

Seropositive rheumatoid arthritis, wide

622

3041

2.10

62.66

1.9

2.3

0.01

0.04

g/l

1.63

579

2746

Pulmonary heart disease

705

3614

2.00

62.12

2.4

2.2

0.03

0.04

g/l

0.18

644

3257

Other disorders of veins

850

4606

1.87

61.79

2.2

2.3

0.04

0.03

g/l

0.17

772

4179

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

607

2959

2.11

61.66

1.9

2.3

0.01

0.03

g/l

1.42

564

2673

Viral infections characterized by skin and mucous membrane lesions

1593

8717

1.58

61.52

2.7

2.1

0.05

0.02

g/l

0.63

1473

7950

Fracture of lumbar spine and pelvis

552

2599

2.18

61.27

2.4

2.2

0.03

0.04

g/l

0.04

485

2322

Accidents

1468

4504

1.65

61.12

2.1

2.2

0.02

0.03

g/l

0.72

1333

4145

Explicit bacterial Sepsis

282

977

3.00

60.95

4.2

2.0

0.06

0.04

g/l

0.20

264

885

Other symptoms and signs involving cognitive functions and awareness

999

5202

1.78

60.93

2.0

2.4

0.03

0.04

g/l

0.40

869

4734

Hyperkalaemia

189

515

3.90

60.76

2.4

2.2

0.04

g/l

0.05

165

467

Intracranial trauma

929

3605

1.83

60.32

2.2

0.01

0.04

g/l

2.51

834

3324

Other/unspecified seropositive rheumatoid arthritis

612

3017

2.08

60.30

1.9

2.3

0.01

0.03

g/l

1.40

569

2725

Other acute lower respiratory infections

1043

5776

1.75

60.28

3.2

2.1

0.02

0.03

g/l

0.85

968

5226

Obesity related asthma

703

3633

1.97

60.27

1.9

2.3

0.01

0.03

g/l

1.07

639

3320

Temporal arteritis

154

367

4.61

60.20

1.5

2.8

0.00

0.03

g/l

0.95

137

334

Streptococcal septicaemia

242

775

3.27

60.14

4.1

2.0

0.06

0.05

g/l

0.12

227

698

Pruritus

286

1009

2.95

59.83

1.8

2.3

0.03

0.02

g/l

0.11

268

929

Other and unspecified vasculitis limited to skin

113

210

6.01

59.43

2.5

2.7

0.03

g/l

0.10

108

194

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1854

7836

1.53

59.41

2.2

0.03

g/l

0.08

1691

7143

SLE, strict definition

132

282

5.09

58.87

1.8

0.00

0.02

g/l

0.50

123

263

SLE, ICD10

132

282

5.09

58.87

1.8

0.00

0.02

g/l

0.50

123

263

Injuries to the abdomen, lower back, lumbar spine and pelvis

827

4486

1.86

58.85

2.4

2.2

0.04

0.03

g/l

0.04

739

4058

Secondary and unspecified malignant neoplasm of lymph nodes

244

798

3.21

58.70

1.8

1.4

0.02

g/l

0.17

232

723

Disorders of lens

1382

5334

1.64

58.68

2.4

2.3

0.03

0.02

g/l

0.42

1259

4890

Non-Hodgkin lymphoma, all

167

431

4.19

58.37

3.2

1.4

0.07

0.02

g/l

0.66

159

384

Falls/tendency to fall

1901

6268

1.53

58.31

2.2

0.02

0.03

g/l

0.13

1711

5787

Diseases of the eye and adnexa

1308

3942

1.68

58.25

2.1

2.0

0.01

g/l

0.05

1205

3628

Acute bronchitis

838

4539

1.84

58.04

3.3

2.1

0.02

0.04

g/l

1.05

780

4084

Diabetes, varying definitions

1839

7125

1.53

57.50

2.0

2.3

0.02

0.03

g/l

0.59

1672

6516

Gingivitis and periodontal diseases

1919

6570

1.52

57.32

2.3

2.1

0.02

0.03

g/l

0.69

1744

5980

Insulin medication

1193

6100

1.67

57.17

2.1

2.4

0.01

0.03

g/l

2.61

1083

5558

ILD, hospital admission 2, with pulmonary infections

276

983

2.93

56.92

2.3

1.8

0.07

0.02

g/l

0.72

258

881

Hypercalcemia

170

455

4.06

56.63

4.4

2.5

0.05

0.02

g/l

0.59

151

415

Diabetes mellitus

1840

7131

1.52

56.62

2.0

2.3

0.02

0.03

g/l

0.59

1672

6523

Benign neoplasms

1725

6206

1.55

56.31

2.3

2.1

0.03

g/l

0.12

1568

5682

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1221

7452

1.64

56.09

2.2

2.3

0.04

0.03

g/l

0.09

1120

6766

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

115

228

5.51

56.01

2.2

2.7

0.01

0.00

g/l

0.50

107

213

Fibromyalgia

206

623

3.43

55.97

2.1

1.8

0.01

0.00

g/l

0.43

192

579

Hernia

1735

7701

1.53

55.21

2.5

2.2

0.03

g/l

0.19

1573

7024

Sciatica+with lumbago

947

5048

1.75

55.06

2.0

2.1

0.01

0.02

g/l

1.66

873

4593

Other intervertebral disc disorders

1500

5768

1.58

55.00

2.2

2.1

0.02

0.03

g/l

0.35

1384

5237

Immunodeficiency with predominantly antibody defects

109

210

5.70

54.91

4.8

2.2

0.01

0.02

g/l

0.34

101

199

Nerve, nerve root and plexus disorders

1990

8286

1.48

54.81

2.2

0.02

0.03

g/l

0.83

1829

7541

Disorders of choroid and retina

1622

7564

1.54

54.65

2.4

2.3

0.06

0.02

g/l

1.04

1467

6883

Type 2 diabetes

1800

7003

1.52

54.32

2.0

2.4

0.02

0.03

g/l

0.58

1633

6402

Other arthrosis

1007

4071

1.74

54.29

2.2

2.4

0.02

0.04

g/l

0.78

922

3703

Giant cell arteritis with polymyalgia rheumatica

154

400

4.22

53.70

1.5

2.6

0.00

0.03

g/l

0.95

137

366

Non-allergic asthma (mode)

374

1567

2.42

53.51

1.9

1.8

0.04

0.01

g/l

0.57

338

1422

Viral pneumonia

306

1184

2.67

53.46

3.3

1.8

0.05

0.03

g/l

0.30

283

1076

IgA nephropathy (IgA glomerulonephritis)

100

183

6.03

53.31

1.8

2.8

0.01

0.00

g/l

0.49

171

All influenza

509

2455

2.12

52.98

4.5

1.9

0.03

0.02

g/l

0.28

469

2227

Other arrhythmias

1109

5064

1.67

52.94

2.2

0.02

0.03

g/l

0.60

995

4658

Other nutritional deficiencies

1161

6762

1.64

52.74

1.9

2.3

0.01

0.03

g/l

2.71

1058

6210

Hyperparathyroidism

454

2091

2.21

52.06

2.6

2.2

0.03

g/l

0.01

411

1877

Other gastritis (incl. Duodenitis)

517

2533

2.09

51.88

2.2

2.3

0.01

0.05

g/l

1.78

463

2309

Immunodeficiencies

151

394

4.08

51.75

4.3

2.3

0.01

g/l

0.21

140

365

Diseases of the digestive system

955

5644

1.71

51.60

2.2

0.06

0.03

g/l

0.53

865

5115

Endocarditis

126

288

4.70

51.60

1.7

2.2

0.07

0.06

g/l

0.06

113

265

Mood disorders

1828

8024

1.49

51.39

2.0

2.3

0.02

g/l

0.23

1652

7351

Other coagulation defects

199

624

3.34

51.31

2.5

2.4

0.15

0.02

g/l

0.46

185

580

Mood [affective] disorders

1823

8016

1.49

51.24

2.0

2.3

0.02

g/l

0.21

1647

7344

Vocal cord dysfunction

237

724

3.00

51.08

2.7

2.5

0.03

0.02

g/l

0.24

214

686

Other anxiety disorders

715

3366

1.86

51.03

1.8

2.1

0.02

g/l

0.21

657

3099

Exposure to other specified factors

1323

7801

1.57

51.00

2.1

2.2

0.02

0.03

g/l

0.15

1210

7145

Obesity, other/unspecified

613

3199

1.95

50.99

1.7

2.2

0.00

0.03

g/l

2.85

565

2927

Benzodiazepine use

1840

8645

1.48

50.79

2.1

2.3

0.02

0.03

g/l

0.87

1641

7927

Hypo-osmolality and hyponatraemia

401

1784

2.30

50.77

2.6

2.0

0.05

0.04

g/l

0.13

372

1595

Other bacterial intestinal infections

498

2425

2.10

50.73

3.4

2.0

0.01

0.04

g/l

1.24

448

2199

Depression or dysthymia

1289

4453

1.62

50.63

2.2

2.3

0.02

0.03

g/l

0.09

1159

4120

Undetermined asthma, excluding more controls

257

933

2.83

50.61

2.1

1.5

0.04

0.01

g/l

0.60

234

848

Systemic lupus erythematosus, unspecified

112

238

5.11

50.31

1.9

0.00

0.02

g/l

0.50

106

223

Other diseases of hard tissues of teeth

1184

3748

1.65

50.23

2.2

2.1

0.04

0.03

g/l

0.38

1075

3405

Other diseases of liver

397

1778

2.30

50.19

2.0

2.2

0.00

0.02

g/l

1.56

354

1641

Symptoms and signs involving speech and voice

692

3781

1.87

50.17

2.5

2.2

0.01

0.04

g/l

2.03

619

3435

Factors influencing health status and contact with health services

535

1266

2.15

50.08

2.3

1.9

0.02

g/l

0.16

492

1151

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1716

6944

1.50

50.08

1.9

2.4

0.02

0.03

g/l

0.28

1556

6352

Anxiety disorders, excluding more controls

1436

6062

1.56

49.93

2.2

2.3

0.01

0.02

g/l

0.96

1311

5600

Cutaneous abscess, furuncle and carbuncle

511

2525

2.07

49.90

1.9

2.1

0.02

0.03

g/l

0.34

474

2313

Diseases of oral cavity, salivary glands and jaws

1198

3789

1.65

49.77

2.2

2.1

0.04

0.03

g/l

0.34

1082

3439

Implicit fungal Sepsis

195

619

3.31

49.43

2.8

2.2

0.03

0.02

g/l

0.52

180

573

Symptoms and signs involving the digestive system and abdomen

1810

6124

1.49

49.43

2.3

2.2

0.04

0.03

g/l

0.46

1665

5562

Other and unspecified coagulation defects

147

389

4.00

49.29

2.6

2.5

0.20

0.02

g/l

0.45

136

361

Polyuria

523

2626

2.04

49.15

2.0

2.3

0.03

0.04

g/l

0.18

483

2372

Secondary right heart disease

155

430

3.88

48.95

2.0

2.5

0.00

0.02

g/l

0.86

147

394

Episodal and paroxysmal disorders

1933

6749

1.47

48.89

2.0

2.3

0.01

0.04

g/l

2.16

1750

6177

Gastro-oesophageal reflux disease

1255

6933

1.58

48.74

1.9

2.3

0.04

0.03

g/l

0.13

1129

6357

Other respiratory diseases principally affecting the interstitium

460

2218

2.14

48.50

2.4

2.2

0.07

0.05

g/l

0.22

429

2004

Other cataract

941

4235

1.71

48.50

2.6

2.3

0.03

0.02

g/l

0.06

866

3866

Other functional intestinal disorders

844

4560

1.74

48.38

2.5

2.2

0.06

0.03

g/l

0.56

763

4144

Shoulder lesions

1384

5420

1.56

48.37

2.2

2.3

0.01

0.03

g/l

2.81

1267

4918

Cardiomyopathies, Primary/intrinsic

296

1185

2.58

48.33

1.9

2.2

0.01

0.06

g/l

1.93

271

1083

Gonarthrosis [arthrosis of knee](FG)

1315

4876

1.58

48.30

1.9

2.5

0.03

0.04

g/l

0.18

1213

4433

Cardiomyopathy (excluding other)

303

1230

2.55

48.02

1.9

2.2

0.01

0.04

g/l

1.39

277

1121

Diabetes, insulin treatment (Kela reimbursement)

1849

7687

1.47

47.81

1.9

2.3

0.02

0.03

g/l

0.38

1678

7022

Prurigo nodularis

103

214

5.29

47.72

1.7

3.4

0.00

0.02

g/l

0.50

198

Mycoses

1518

8848

1.51

47.70

2.2

0.03

g/l

0.07

1360

8124

Biological medication for rheuma

320

1334

2.46

47.57

1.5

2.2

0.01

g/l

0.12

302

1246

Chronic nephritic syndrome

134

343

4.19

47.33

2.6

2.7

0.22

0.02

g/l

0.47

126

317

Other diseases of intestine

343

1483

2.39

47.26

2.5

2.1

0.05

0.02

g/l

0.38

320

1344

Ischemic heart diseases

1551

6213

1.52

46.96

2.3

2.4

0.02

0.03

g/l

0.67

1426

5678

Other abnormal findings of blood chemistry

142

381

3.96

46.81

3.2

2.4

0.06

0.02

g/l

0.53

137

351

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

905

5275

1.69

46.75

1.9

2.1

0.01

0.03

g/l

1.56

814

4828

Arthrosis

1260

4388

1.59

46.68

2.1

2.3

0.03

0.04

g/l

0.37

1153

3990

Depression

1647

7576

1.49

46.62

2.0

2.3

0.02

g/l

0.13

1489

6952

Anxiety (asthma-related co-morbidities)

937

4345

1.69

46.61

1.8

2.2

0.02

0.03

g/l

0.83

860

4024

Insulin, intermediate and long-acting

1081

6600

1.61

46.53

1.9

2.3

0.01

0.03

g/l

3.56

981

6015

Injuries to the hip and thigh

988

5493

1.65

46.36

2.1

2.3

0.05

0.03

g/l

0.44

887

4980

Abnormal findings on examination of urine, without diagnosis

145

398

3.88

46.34

3.6

2.7

0.01

0.03

g/l

0.48

138

370

Soft tissue disorders related to use, overuse and pressure

543

2815

1.97

46.30

2.2

2.4

0.01

0.03

g/l

1.87

501

2557

Diffuse large B-cell lymphoma, including Hilmo

156

451

3.70

46.26

1.6

1.4

0.05

0.01

g/l

0.41

148

413

Diffuse large B-cell lymphoma, helper endpoint

156

451

3.70

46.26

1.6

1.4

0.05

0.01

g/l

0.41

148

413

Diffuse large B-cell lymphoma

156

451

3.70

46.26

1.6

1.4

0.05

0.01

g/l

0.41

148

413

Senile cataract

1264

4965

1.58

46.19

2.5

2.3

0.04

0.02

g/l

0.52

1145

4543

Allergic conjunctivitis

935

5528

1.67

46.16

1.9

2.1

0.01

0.02

g/l

1.52

840

5074

Hernia of abdominal wall, postoperative

345

1507

2.34

46.08

2.1

2.0

0.00

0.02

g/l

1.56

319

1390

Progressive vascular leukoencephalopathy

144

397

3.93

46.03

2.1

2.4

0.08

0.10

g/l

0.13

118

358

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

366

1650

2.29

45.84

1.5

2.2

0.03

0.04

g/l

0.38

328

1509

Asthma/COPD (KELA code 203)

1649

7707

1.48

45.79

2.1

2.3

0.03

0.02

g/l

0.22

1499

7024

Injuries to the thorax

911

5520

1.68

45.61

2.3

2.2

0.04

0.03

g/l

0.24

821

5021

Insulin, combination of fast acting with intermediate-acting or long-acting

1194

7032

1.57

45.59

2.1

2.3

0.01

0.04

g/l

3.21

1084

6400

Any mental disorder

1979

6922

1.44

45.48

2.0

2.3

0.02

0.03

g/l

0.25

1784

6379

All anxiety disorders

951

4571

1.66

44.91

1.8

2.2

0.01

0.03

g/l

0.76

874

4203

Obesity

1073

6541

1.60

44.91

1.8

2.2

0.00

0.03

g/l

4.83

981

6001

Obesity and other hyperalimentation

1077

6565

1.60

44.81

1.8

2.3

0.00

0.03

g/l

4.83

984

6023

Early onset COPD, excluding more controls

390

1813

2.20

44.73

2.1

1.8

0.10

0.01

g/l

0.61

364

1661

Agranulocytosis

274

1099

2.59

44.71

3.3

2.2

0.00

0.02

g/l

1.36

261

1016

Amputation

279

1130

2.57

44.67

2.0

2.2

0.01

0.07

g/l

2.28

265

1012

ILD, hospital admissions 3, with pneumonia sepsis

240

905

2.77

44.59

2.1

1.9

0.07

0.04

g/l

0.26

225

819

Conjunctivitis

1254

6834

1.55

44.46

2.1

2.2

0.01

0.03

g/l

0.93

1144

6250

Retention of urine

750

3539

1.77

44.44

1.9

2.4

0.02

0.04

g/l

0.87

678

3186

Any death

1292

6065

1.55

44.20

3.0

2.2

0.07

0.02

g/l

1.75

1149

5587

Seropositive rheumatoid arthritis, strict definition

350

1572

2.30

44.16

1.7

2.2

0.01

0.03

g/l

0.96

325

1435

Abdominal and pelvic pain

1772

6124

1.47

44.15

2.3

2.2

0.03

g/l

0.17

1624

5562

Other diseases of pericardium

136

369

3.90

44.09

1.7

2.3

0.00

0.05

g/l

1.13

120

339

Sleep disorders (combined)

2017

7480

1.43

44.00

2.0

2.3

0.02

0.03

g/l

0.83

1818

6849

Fibrosis and cirrhosis of liver

219

794

2.89

43.98

1.5

2.5

0.03

0.02

g/l

0.09

197

736

Chronic periodontitis, complicated

1065

6721

1.59

43.53

2.4

2.3

0.01

0.03

g/l

1.88

976

6151

Disorders of gallbladder, biliary tract and pancreas

1827

8068

1.44

43.49

2.2

2.3

0.02

0.03

g/l

0.72

1653

7369

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1111

7136

1.58

43.47

2.0

2.3

0.01

0.03

g/l

1.63

1017

6489

Other (seronegative) rheumatoid arthritis, wide

426

2080

2.10

43.34

2.0

2.2

0.00

0.04

g/l

2.06

395

1882

Voice disturbances

544

2890

1.92

43.23

2.7

2.2

0.01

0.03

g/l

1.04

489

2629

Coxarthrosis [arthrosis of hip](FG)

995

4334

1.64

43.18

2.1

2.6

0.03

0.04

g/l

0.29

917

3929

Later onset COPD, excluding more controls

471

1813

2.06

43.15

1.6

1.9

0.03

0.01

g/l

0.60

427

1615

Conduction disorders

600

2635

1.88

43.15

2.3

2.2

0.04

g/l

0.02

541

2398

Overexertion and strenuous or repetitive movements

231

867

2.76

43.08

2.4

2.3

0.00

0.02

g/l

1.50

205

813

Urticaria and erythema

629

3499

1.82

42.85

2.3

2.1

0.02

0.03

g/l

0.09

577

3193

Concussion

756

3581

1.74

42.78

2.1

2.2

0.01

0.04

g/l

1.57

678

3301

Other bacterial intestinal infections

398

1907

2.14

42.51

3.5

2.1

0.02

0.04

g/l

1.11

358

1729

COPD

949

4804

1.64

42.51

1.9

2.4

0.06

0.03

g/l

0.33

869

4342

Pleural effusion

392

1872

2.16

42.49

2.7

2.2

0.11

0.06

g/l

0.33

360

1689

Undetermined asthma

257

1021

2.58

42.40

2.1

1.6

0.04

0.01

g/l

0.58

234

924

Other pulmonary heart/vessel disease

158

487

3.46

42.39

2.0

2.5

0.00

0.02

g/l

0.96

148

445

Fracture of rib(s), sternum and thoracic spine

644

3631

1.81

42.24

2.6

2.2

0.05

0.03

g/l

0.39

586

3298

Special screening examination for infectious and parasitic diseases

344

1115

2.30

42.10

2.4

2.2

0.00

0.01

g/l

0.76

307

1047

Rash and other nonspecific skin eruption

237

913

2.69

42.05

2.0

2.3

0.00

0.01

g/l

0.55

221

839

Irritable bowel syndrome

483

2488

1.97

41.90

2.4

2.1

0.02

g/l

0.10

438

2282

Disorder of lipoprotein metabolism, unspecified

312

1366

2.36

41.85

1.7

2.1

0.01

0.05

g/l

1.71

286

1228

Visual disturbances

911

5648

1.64

41.74

2.2

0.02

0.03

g/l

0.27

840

5133

Convulsions, not elsewhere classified

372

1720

2.17

41.69

1.7

2.1

0.01

g/l

0.01

333

1576

Neurotic, stress-related and somatoform disorders

1475

7018

1.48

41.67

2.2

0.01

0.03

g/l

1.25

1350

6429

Methotrexate

285

1200

2.44

41.59

1.8

2.5

0.03

g/l

0.01

273

1092

ILD, hospital admissions

387

1856

2.15

41.57

2.3

0.06

0.05

g/l

0.06

361

1682

Zoster [herpes zoster]

979

6084

1.61

41.52

3.0

2.2

0.03

g/l

0.13

899

5506

Dysphagia

528

2815

1.91

41.52

2.2

2.3

0.01

0.03

g/l

0.84

478

2545

Abnormalities of heart beat

635

3503

1.80

41.50

2.1

2.2

0.01

0.03

g/l

1.15

574

3178

Osteonecrosis

176

586

3.16

41.29

6.5

2.0

0.04

0.02

g/l

0.54

160

552

Other interstitial pulmonary diseases

390

1885

2.14

41.03

2.3

0.06

0.05

g/l

0.04

364

1707

Other headache syndromes

720

4218

1.73

40.79

1.8

2.4

0.01

0.03

g/l

1.33

663

3861

Arthropathies in other diseases classified elsewhere

112

280

4.25

40.78

2.3

0.01

0.00

g/l

0.27

102

251

Nausea and vomiting

522

2727

1.91

40.71

2.8

2.2

0.03

g/l

0.07

486

2455

Stroke, excluding SAH

1243

6010

1.53

40.66

2.4

2.3

0.02

0.04

g/l

1.08

1120

5474

Volume depletion

226

864

2.70

40.64

2.0

2.2

0.01

0.05

g/l

1.14

195

772

Ischaemic Stroke, excluding all haemorrhages

1185

5791

1.54

40.52

2.4

2.3

0.02

0.04

g/l

0.92

1066

5262

Anxiety disorders

1488

7103

1.47

40.51

2.1

2.2

0.01

0.03

g/l

1.29

1361

6510

Interstitial lung disease

390

1897

2.12

40.36

2.3

2.2

0.06

0.05

g/l

0.05

364

1718

Interstitial lung disease endpoints

390

1897

2.12

40.36

2.3

2.2

0.06

0.05

g/l

0.05

364

1718

Stroke, including SAH

1285

6228

1.52

40.25

2.4

2.3

0.02

0.04

g/l

1.40

1158

5676

Selective serotonin reuptake inhibitors

1753

6408

1.44

40.21

2.2

2.3

0.04

0.03

g/l

0.39

1580

5881

External causes of morbidity and mortality

1115

3554

1.59

40.08

2.1

2.2

0.02

0.03

g/l

0.52

1022

3266

Visual disturbances and blindness

970

6161

1.59

40.07

2.3

2.2

0.02

0.03

g/l

0.31

892

5590

GI-bleeding

693

4060

1.74

39.70

2.2

0.08

0.03

g/l

0.83

624

3668

Emergency coronary revascularization (for ACS)

1607

6792

1.45

39.70

2.0

2.4

0.03

g/l

0.07

1473

6182

Peripheral artery operations in Hilmo

319

1443

2.28

39.59

2.1

2.2

0.01

0.07

g/l

2.59

303

1305

Diabetes medication

1799

7566

1.42

39.47

1.9

2.3

0.03

g/l

0.00

1630

6911

Disorders of conjunctiva

1386

7594

1.48

39.39

2.2

0.01

0.03

g/l

1.15

1268

6947

Other disorders of lacrimal gland

663

3854

1.75

39.02

2.9

2.2

0.01

0.04

g/l

1.85

600

3507

Percutaneous Coronary Intervention

1449

6077

1.48

38.99

2.0

2.4

0.03

g/l

0.09

1337

5553

Adverse effects, not elsewhere classified

361

1721

2.14

38.98

2.1

0.01

0.02

g/l

0.50

344

1594

Other diseases of the digestive system

687

4049

1.73

38.54

2.2

2.3

0.08

0.03

g/l

0.84

619

3656

Subjective visual disturbances

497

2664

1.90

38.46

2.2

0.01

0.04

g/l

0.79

456

2422

Secondary uncertain malignant neoplasm

301

1349

2.30

38.24

1.8

1.4

0.01

0.03

g/l

0.45

279

1209

Coronary revascularization (ANGIO or CABG)

1445

6078

1.47

38.08

2.0

2.4

0.03

g/l

0.04

1333

5554

Cardiodefibrillation

786

4811

1.66

37.94

2.2

2.3

0.01

0.04

g/l

2.02

715

4365

Viral infections characterized by skin and mucous membrane lesions

747

4511

1.68

37.90

3.4

2.1

0.07

0.03

g/l

0.51

699

4098

Other CVD

468

2477

1.94

37.88

2.6

2.2

0.02

0.05

g/l

1.48

411

2219

Abnormal involuntary movements

297

1340

2.28

37.12

2.1

2.3

0.01

0.03

g/l

0.85

275

1235

Hypotension

417

2140

2.00

37.08

2.7

2.2

0.02

0.05

g/l

1.34

363

1914

Benign neoplasm: Colon, unspecified

565

3192

1.81

37.06

2.3

2.2

0.03

0.04

g/l

0.61

497

2888

Diseases of pulp and periapical tissues and dental caries

1294

4446

1.51

37.03

2.2

2.3

0.04

0.03

g/l

0.14

1174

4037

Polyarthrosis

414

1957

2.01

36.96

2.4

2.5

0.01

0.05

g/l

2.00

375

1758

Cirrhosis of liver, NAS

161

545

3.12

36.87

1.6

2.6

0.03

g/l

0.12

147

502

Coxibs

524

1458

1.92

36.86

2.1

2.2

0.05

0.03

g/l

0.26

478

1319

Other noninfective gastroenteritis and colitis

469

2499

1.91

36.84

2.7

2.1

0.06

0.03

g/l

0.48

428

2264

Cardiomyopathy in other diseases

10.67

36.75

8.1

2.3

0.01

0.10

g/l

0.40

Rotator cuff syndrome

1100

5201

1.53

36.61

2.2

2.3

0.01

0.03

g/l

2.46

1006

4718

Noninfective enteritis and colitis

802

4970

1.63

36.60

2.4

2.2

0.04

0.03

g/l

0.23

737

4528

Lumbar disc prolapse

1084

5475

1.53

36.55

2.3

2.1

0.02

0.03

g/l

0.15

1003

4984

ILD, hospital admissions 1, main diag only

346

1672

2.14

36.54

2.4

2.3

0.06

0.04

g/l

0.33

322

1516

Type 2 diabetes, definitions combined

1655

6887

1.42

36.46

2.0

2.4

0.03

g/l

0.09

1496

6291

Pericarditis

106

277

4.05

36.31

1.8

2.2

0.09

0.02

g/l

0.33

258

Other chronic obstructive pulmonary disease

894

4683

1.60

36.07

1.9

2.4

0.06

0.03

g/l

0.34

819

4227

Major coronary heart disease event

1544

6547

1.44

36.04

2.1

2.4

0.03

g/l

0.08

1416

5980

Other symptoms and signs involving the urinary system

251

1069

2.43

36.03

2.4

2.3

0.07

0.03

g/l

0.49

243

964

Bacterial intestinal infections, IBD co-morbidities

399

2036

2.01

35.95

3.6

2.1

0.01

0.05

g/l

2.09

359

1846

Open wound of head

986

6204

1.55

35.92

2.2

0.02

0.04

g/l

0.59

890

5669

Type 2 diabetes, strict (exclude DM1)

1660

6937

1.42

35.74

2.0

2.4

0.03

g/l

0.09

1502

6336

Tumor necrosis factor alpha inhibitors

268

1177

2.33

35.52

1.4

2.3

0.01

g/l

0.03

253

1104

Other retinal disorders

1243

6612

1.48

35.41

2.3

0.08

0.03

g/l

1.05

1114

5997

Abnormal serum enzyme levels

628

3605

1.73

35.30

2.0

2.3

0.02

0.03

g/l

0.29

572

3294

Amputation of toe

201

783

2.69

35.19

2.1

2.4

0.01

0.03

g/l

0.94

193

714

Open wound of lower leg

314

1482

2.17

35.00

2.0

2.1

0.02

0.04

g/l

0.86

286

1357

Other reaction to severe stress, and adjustment disorders

534

3010

1.79

34.83

2.4

2.1

0.01

0.02

g/l

0.09

496

2769

Urticaria

481

2636

1.85

34.56

2.2

2.1

0.00

0.02

g/l

1.89

442

2414

Insulin, fast-acting

666

4005

1.69

34.50

1.9

2.2

0.01

0.04

g/l

2.25

609

3659

Acetic acid derivatives and related substances

519

1450

1.88

34.48

2.1

2.2

0.06

0.03

g/l

0.52

481

1311

Cellulitis

429

2275

1.92

34.39

2.7

2.2

0.01

0.04

g/l

1.61

400

2081

Isolated proteinuria with specified morphological lesion

7.04

34.34

4.6

2.9

0.03

0.06

g/l

0.17

Diseases of pulp and periapical tissues, including avohilmo

1839

6917

1.39

34.31

2.2

0.03

g/l

0.05

1664

6324

Other and unspecified effects of external causes

452

2437

1.88

34.25

2.0

2.1

0.01

0.03

g/l

1.13

424

2241

Superficial injury of head

458

2483

1.88

34.19

2.1

0.01

0.04

g/l

1.63

418

2242

Ischaemic heart disease, wide definition

1448

6299

1.44

34.15

2.4

0.03

g/l

0.00

1327

5743

Fracture of shoulder and upper arm

679

4116

1.67

34.04

2.5

2.3

0.01

0.03

g/l

1.13

598

3744

Type 1 diabetes

434

2312

1.90

34.00

1.8

2.2

0.01

0.04

g/l

1.38

399

2128

Dental caries, including avohilmo

1403

4987

1.45

33.62

2.1

2.3

0.04

0.03

g/l

0.22

1279

4538

Presence of cardiac and vascular implants and grafts

964

4693

1.55

33.53

1.7

2.3

0.02

0.03

g/l

0.21

861

4253

Other and unspecified types of non-Hodgkin lymphoma, hilmo

132

422

3.32

33.44

3.3

2.5

0.05

0.02

g/l

0.31

126

386

Malignant neoplasm of skin

951

4245

1.55

33.34

2.6

1.5

0.02

0.01

g/l

0.31

861

3844

Unspecified fall

910

5857

1.55

33.26

2.3

2.2

0.02

0.03

g/l

0.49

802

5352

Atopic dermatitis

837

4371

1.58

33.04

1.8

2.2

0.02

g/l

0.19

770

4012

Chronic sinusitis

737

4593

1.62

33.01

2.3

0.03

g/l

0.02

672

4194

Gonarthrosis

1110

4230

1.51

32.96

1.9

2.4

0.04

g/l

0.04

1027

3842

AV-block

381

1715

1.99

32.91

2.4

2.2

0.04

0.05

g/l

0.05

342

1549

Asthma and allergy, excluding more controls

173

631

2.75

32.88

1.9

1.4

0.01

0.00

g/l

0.35

156

586

Diabetic retinopathy, excluding more controls

474

1425

1.90

32.73

1.8

2.1

0.03

0.02

g/l

0.07

437

1285

Nonalcoholic fatty liver disease

212

876

2.50

32.55

2.1

2.4

0.00

0.01

g/l

1.22

190

818

Hypertrophic cardiomyopathy

126

399

3.34

32.39

2.7

0.03

0.02

g/l

0.11

115

369

Injuries to the shoulder and upper arm

1484

8575

1.41

32.35

2.4

2.2

0.02

0.03

g/l

0.44

1327

7848

Type 2 diabetes, definitions combined, including avohilmo

1633

6866

1.40

32.35

2.0

2.4

0.02

0.03

g/l

0.40

1479

6271

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

930

4118

1.55

32.25

2.7

1.5

0.02

0.01

g/l

0.43

849

3725

Acute upper respiratory infections of multiple and unspecified sites

1232

6321

1.46

32.25

3.4

2.0

0.03

0.02

g/l

0.06

1131

5769

Coxarthrosis

909

3892

1.56

32.22

2.1

2.5

0.03

0.04

g/l

0.30

837

3531

In situ neoplasms

731

4596

1.61

31.87

2.3

0.03

0.04

g/l

0.29

660

4129

Recurrent or chronic depression

620

2585

1.70

31.85

1.9

2.2

0.02

0.03

g/l

0.35

566

2419

Sleep apnoea

1654

7801

1.38

31.69

2.0

2.3

0.02

0.03

g/l

1.32

1516

7157

Other neurological diseases

1356

7553

1.42

31.66

2.2

2.3

0.02

0.03

g/l

1.11

1219

6871

Enterocolitis due to Clostridium difficile

256

1163

2.27

31.63

3.9

2.2

0.01

0.05

g/l

1.54

233

1058

Trochanteric bursitis

282

1330

2.17

31.55

2.3

2.2

0.01

0.03

g/l

0.66

263

1202

L01XX Other antineoplastic agents

172

658

2.75

31.41

3.4

2.4

0.00

0.02

g/l

1.06

157

606

Reactive arthropathies, FINNGEN

141

482

3.02

31.39

2.4

2.6

0.01

0.02

g/l

0.43

132

434

Sequelae of external causes of morbidity and mortality

510

2935

1.77

31.35

2.4

2.3

0.01

0.04

g/l

2.37

477

2672

Need for immunization against other single viral diseases

150

5.06

31.27

2.7

0.01

0.04

g/l

0.24

139

Decubitus ulcer and pressure area

164

614

2.79

31.08

1.7

2.5

0.07

0.06

g/l

0.06

141

554

Disorders of lacrimal system

766

4885

1.58

31.00

2.8

2.2

0.01

0.03

g/l

1.79

694

4437

Calcific aortic valvular stenosis

653

3901

1.65

30.96

2.3

2.2

0.04

0.05

g/l

0.07

590

3490

Calcific aortic valvular stenosis, operated

653

3901

1.65

30.96

2.3

2.2

0.04

0.05

g/l

0.07

590

3490

Calcific aortic valvular stenosis, including rheumatic fever

654

3905

1.65

30.94

2.3

2.2

0.04

0.05

g/l

0.07

591

3494

Migraine

706

3560

1.62

30.89

1.9

2.2

0.01

0.03

g/l

1.34

649

3287

Personality disorders, excluding more controls

357

1842

1.96

30.86

1.7

2.1

0.00

0.01

g/l

2.14

331

1721

Calcific aortic valvular stenosis, diagnosis (helper)

652

3897

1.65

30.85

2.3

2.2

0.04

0.05

g/l

0.07

589

3486

Operations 2 for CAVS

652

3897

1.65

30.85

2.3

2.2

0.04

0.05

g/l

0.07

589

3486

Eosinophilic disease (BM)

6.44

30.82

2.5

1.3

0.00

g/l

-0.00

Alcohol use disorder, Swedish definition

962

5913

1.51

30.78

1.7

2.3

0.04

0.03

g/l

0.43

854

5445

Injury, poisoning and certain other consequences of external causes

881

2837

1.57

30.56

2.1

2.3

0.01

0.02

g/l

0.54

814

2601

Lichen simplex chronicus and prurigo

159

591

2.80

30.52

1.9

2.7

0.01

0.02

g/l

0.28

145

546

Benign neoplasm of other and ill-defined parts of digestive system

387

2069

1.92

30.52

2.2

0.02

0.03

g/l

0.27

348

1886

Insulin, fast-acting or short human

669

4159

1.63

30.44

1.9

2.2

0.01

0.03

g/l

2.15

612

3789

Migraine with aura

352

1818

1.96

30.39

1.5

2.2

0.02

0.01

g/l

0.08

326

1678

Asthma and allergy

173

662

2.62

29.95

1.9

1.5

0.01

0.00

g/l

0.35

156

607

Caries of dentine, including avohilmo

1460

5337

1.41

29.83

2.2

2.3

0.03

g/l

0.03

1336

4862

Memory loss

235

1060

2.30

29.75

2.0

2.4

0.03

0.05

g/l

0.43

197

976

Solid cancers, helper endpoint

1357

5690

1.42

29.74

2.2

1.4

0.03

0.01

g/l

0.90

1237

5187

Substance abuse, excluding more controls

929

5297

1.51

29.73

1.6

2.3

0.03

g/l

0.06

824

4902

Primary hyperparathyroidism

261

1228

2.20

29.67

3.0

2.4

0.03

0.04

g/l

0.26

236

1114

Idiopathic thrombocytopenic purpura

252

3.88

29.63

2.5

2.6

0.07

0.02

g/l

0.32

229

Other inflammation of eyelid

284

1381

2.11

29.42

2.8

2.2

0.02

g/l

0.03

251

1274

Psychiatric diseases

1704

6273

1.37

29.39

2.1

2.3

0.02

g/l

0.18

1532

5792

Heart failure and hypertrophic cardiomyopathy

180

4.58

29.30

3.1

2.9

0.04

0.03

g/l

0.08

163

L04AC Interleukin inhibitors

125

416

3.11

29.28

1.7

2.3

0.01

g/l

0.18

119

390

Other diseases of upper respiratory tract

1922

7515

1.34

29.26

2.2

0.04

0.03

g/l

0.24

1765

6842

Sequelae of cerebrovascular disease

738

4076

1.59

29.21

2.1

2.3

0.02

0.05

g/l

0.84

642

3707

Cerebral palsy and other paralytic syndromes

234

1058

2.27

29.19

2.0

2.2

0.04

0.03

g/l

0.16

220

979

Spondyloarthritis

323

1647

2.00

29.12

2.1

2.2

0.00

0.04

g/l

2.26

302

1497

999

6171

1.48

28.97

1.7

2.3

0.04

0.03

g/l

0.37

891

5679

Other diseases of anus and rectum

546

3270

1.69

28.67

2.4

2.2

0.03

g/l

0.06

486

2977

1037

6300

1.46

28.57

1.7

2.3

0.04

0.03

g/l

0.35

925

5802

Nonorganic sleeping disorders, excluding more controls

299

1493

2.03

28.55

1.6

2.2

0.02

0.03

g/l

0.26

272

1397

Candidiasis

490

2861

1.74

28.54

2.4

2.2

0.02

0.03

g/l

0.36

443

2601

Zoster [herpes zoster]

386

2107

1.87

28.49

4.0

2.2

0.06

0.03

g/l

0.29

357

1902

Allergic asthma (mode), excluding more controls

300

1466

2.02

28.41

1.9

1.6

0.01

g/l

0.07

279

1346

Hypokalaemia

241

1115

2.22

28.40

2.8

2.1

0.03

0.04

g/l

0.16

219

1008

Coronary atherosclerosis

1208

5389

1.43

28.15

2.3

2.4

0.04

0.03

g/l

0.26

1111

4915

Other diseases of arteries and capillaries

202

875

2.38

28.01

2.1

2.3

0.00

0.03

g/l

1.29

177

803

Essential (haemorrhagic) thrombocythaemia

109

346

3.33

27.95

2.7

1.4

0.05

0.00

g/l

0.47

315

Diseases of spleen

144

4.89

27.94

1.7

2.3

0.01

0.04

g/l

0.32

131

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

193

820

2.42

27.93

3.2

2.2

0.01

0.02

g/l

0.87

180

758

Osteomyelitis

157

607

2.69

27.91

2.1

2.0

0.00

0.02

g/l

1.09

146

567

Other (not insulin) diabetes medications

1668

7353

1.36

27.83

2.0

2.3

0.03

g/l

0.02

1506

6710

Invasive ventilation

176

720

2.54

27.82

2.3

0.08

0.03

g/l

0.43

156

664

Other chronic obstructive pulmonary disease, including avohilmo

1048

6023

1.45

27.59

1.9

2.4

0.06

0.03

g/l

0.55

968

5461

Haemorrhage, not elsewhere classified

104

324

3.37

27.40

2.8

2.6

0.00

0.03

g/l

1.67

294

Disorders of muscles

196

846

2.37

27.28

1.7

2.0

0.03

g/l

0.01

182

773

Myeloproliferative diseases

203

896

2.35

27.08

3.0

2.3

0.03

0.02

g/l

0.06

180

823

Other degenerative diseases of the nervous system

503

2212

1.72

27.06

1.9

2.3

0.02

0.05

g/l

0.99

431

2017

Diseases of the myoneural junction and muscle

266

1306

2.09

26.96

1.7

2.2

0.01

0.02

g/l

0.73

243

1189

Other metabolic disorders

228

1054

2.21

26.85

3.1

2.1

0.02

0.03

g/l

0.16

219

969

Rheumatism, unspecified

256

1239

2.11

26.83

2.3

2.2

0.04

0.02

g/l

0.25

237

1121

Injuries to unspecified part of trunk, limb or body region

215

974

2.27

26.78

1.7

2.3

0.01

0.03

g/l

1.19

200

900

Acute sinusitis

785

4811

1.52

26.75

3.3

1.9

0.06

0.02

g/l

0.56

722

4407

Charcot foot

141

4.83

26.72

2.5

3.0

0.02

0.03

g/l

0.16

131

Somatoform disorder

285

1436

2.02

26.68

2.5

2.3

0.01

0.02

g/l

0.55

264

1327

Injuries to the knee and lower leg

1980

8406

1.31

26.67

2.1

2.3

0.01

0.03

g/l

1.86

1806

7681

Postmenopausal osteoporosis with pathological fracture

173

720

2.51

26.53

1.8

2.2

0.00

0.06

g/l

1.33

149

653

Viral pneumonia (unknown virus, not influenza)

148

569

2.69

26.53

2.4

2.5

0.05

0.01

g/l

0.44

139

527

Other viral diseases

526

3162

1.67

26.53

2.8

2.0

0.00

0.02

g/l

2.43

497

2903

Acute upper respiratory infections

1777

8277

1.33

26.53

3.1

2.0

0.05

0.02

g/l

0.84

1629

7537

Obesity due to excess calories

728

4766

1.54

26.51

1.9

2.3

0.00

0.03

g/l

3.27

667

4370

Other pleural conditions

247

1189

2.14

26.49

3.1

2.3

0.03

0.04

g/l

0.19

221

1069

Other malignant neoplasms of skin (=non-melanoma skin cancer)

857

3939

1.51

26.43

2.7

1.5

0.02

0.01

g/l

0.27

781

3558

Functional dyspepsia

460

2698

1.73

26.41

2.4

2.3

0.01

0.04

g/l

1.29

425

2476

Reactive arthropathies

165

669

2.53

26.39

2.3

2.5

0.01

0.02

g/l

0.60

153

608

Other specified and unspecified disorders of eye and adnexa

105

339

3.25

26.14

2.3

2.5

0.00

0.02

g/l

0.74

313

Abnormal findings on diagnostic imaging of other body structures

288

1471

2.01

26.12

2.5

2.3

0.02

0.04

g/l

0.39

268

1348

Spondylopathies (FG)

210

949

2.25

26.11

1.8

2.5

0.00

0.02

g/l

1.56

195

870

Migraine without aura

259

1268

2.07

26.10

2.1

0.01

g/l

0.11

239

1175

Myeloproliferative diseases (CML excluded)

187

814

2.38

25.82

3.1

2.4

0.03

0.02

g/l

0.08

165

748

Sleep apnoea, including avohilmo

1692

7902

1.34

25.82

2.0

2.3

0.02

0.03

g/l

1.36

1541

7244

Basal cell carcinoma, including avohilmo

851

3948

1.50

25.72

2.5

1.5

0.02

0.01

g/l

0.30

776

3563

Fracture of femur

557

3127

1.64

25.70

2.3

2.2

0.06

0.04

g/l

0.20

484

2801

Phobic anxiety disorders

171

714

2.43

25.40

2.0

0.00

0.01

g/l

1.03

161

669

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

259

3.55

25.36

1.5

2.1

0.00

0.02

g/l

0.50

245

Iron deficiency anaemia secondary to blood loss (chronic)

324

1739

1.90

25.28

2.1

2.3

0.07

0.05

g/l

0.28

284

1577

Deforming dorsopathies

454

2687

1.71

25.19

2.2

0.01

0.03

g/l

0.77

420

2424

Biguanides

1640

7529

1.34

25.17

2.0

2.3

0.03

g/l

0.03

1487

6874

Diabetic neuropathy

258

1281

2.07

25.14

2.1

2.0

0.01

0.03

g/l

0.76

235

1149

Phlebitis and thrombophlebitis (not including DVT)

421

2446

1.75

25.13

2.4

2.2

0.01

0.04

g/l

1.55

395

2221

Fungal Sepsis

109

369

3.10

25.03

2.9

2.2

0.04

0.02

g/l

0.39

103

342

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

563

3528

1.62

24.98

2.4

2.2

0.00

0.03

g/l

3.43

516

3225

Superficial injury of lower leg

413

2391

1.75

24.87

1.9

2.2

0.01

0.03

g/l

0.90

371

2183

Postprocedural endocrine and metabolic disorders, not elsewhere classified

213

990

2.20

24.81

3.0

2.1

0.02

0.03

g/l

0.16

204

915

Papulosquamous disorders

685

4496

1.54

24.80

2.1

2.3

0.02

0.03

g/l

0.46

636

4111

Type 1 diabetes, wide definition, subgroup 1

328

1772

1.88

24.80

1.8

2.2

0.01

0.05

g/l

2.31

300

1650

Other disorders of eye and adnexa

256

1278

2.04

24.70

2.0

2.2

0.01

0.02

g/l

0.74

238

1181

Other viral diseases

424

2468

1.73

24.68

2.9

2.1

0.00

0.02

g/l

2.05

403

2280

Major coronary heart disease event excluding revascularizations

1135

5411

1.41

24.67

2.3

2.5

0.05

0.03

g/l

0.45

1027

4932

Disorders of continuity of bone

182

801

2.33

24.29

3.4

2.0

0.00

0.01

g/l

1.17

168

746

Motor neuron disease

135

4.65

24.27

1.4

1.7

0.00

0.03

g/l

0.75

122

COPD, early/later onset

901

5267

1.46

24.26

1.8

2.4

0.06

0.04

g/l

0.29

825

4765

Valvular operations

275

1419

1.98

24.17

1.6

2.2

0.03

0.05

g/l

0.21

249

1287

Other general symptoms and signs

293

3.27

24.13

1.5

2.5

0.00

0.02

g/l

0.92

267

Drug-induced osteoporosis with pathological fracture

167

4.33

24.11

1.6

2.4

0.02

0.03

g/l

0.11

154

Basal cell carcinoma

816

3826

1.49

23.99

2.6

1.5

0.02

0.01

g/l

0.36

744

3456

Disorders of skin appendages

727

4859

1.51

23.91

2.2

0.04

0.02

g/l

0.39

675

4435

Allergic asthma (mode)

300

1558

1.90

23.90

1.9

1.6

0.01

g/l

0.05

279

1423

Psoriatic and enteropathic arthropathies

188

844

2.27

23.85

1.7

2.6

0.00

0.03

g/l

1.35

172

773

Motor neuron disease (with DMD)

137

4.57

23.81

1.4

1.7

0.00

0.03

g/l

0.75

124

Mixed and other personality disorders

134

517

2.65

23.78

1.7

2.1

0.00

0.01

g/l

0.65

126

489

Injuries to the ankle and foot

1039

6591

1.41

23.78

2.0

2.2

0.01

0.03

g/l

1.31

959

6066

Pyogenic arthritis

142

567

2.58

23.60

2.5

2.4

0.01

0.06

g/l

1.01

130

510

Other peripheral vascular diseases

172

750

2.36

23.56

1.6

2.3

0.01

0.02

g/l

0.51

158

696

Noninfectious colitis NAS

255

1295

2.01

23.48

2.6

2.2

0.02

0.03

g/l

0.41

234

1187

Dermatopolymyositis (FG)

103

5.25

23.45

3.3

3.1

0.00

0.05

g/l

0.50

Amiodarone users

237

1178

2.08

23.44

1.9

2.2

0.02

0.04

g/l

0.73

220

1075

Nonischemic cardiomyopathy

215

1028

2.15

23.42

2.2

0.01

0.04

g/l

1.13

196

936

Idiopathic urticaria

143

4.44

23.40

1.2

2.1

0.00

0.04

g/l

0.50

135

Myocardial infarction

922

4527

1.45

23.29

2.2

2.4

0.06

0.03

g/l

0.54

835

4114

Adalimumab

159

676

2.40

22.96

1.3

2.3

0.00

0.01

g/l

0.97

149

635

Implicit fungal Sepsis

100

339

3.09

22.96

3.0

2.1

0.04

0.02

g/l

0.39

312

Peripheral arterial reconstruction

375

2170

1.77

22.92

1.9

2.3

0.01

0.06

g/l

3.58

344

1947

Metatarsalgia

177

790

2.29

22.88

2.4

2.1

0.01

g/l

0.20

165

731

Polyarthritis, unspecified

287

3.27

22.86

2.9

2.2

0.03

g/l

0.09

257

Infection of intervertebral disc (pyogenic)

126

4.80

22.86

1.4

2.3

0.00

g/l

-0.00

114

Gastroduodenal ulcer

508

3170

1.62

22.80

1.9

2.3

0.02

0.05

g/l

0.84

460

2870

Psoriasis

491

3047

1.63

22.78

1.9

2.3

0.02

0.03

g/l

0.72

457

2784

DVT of lower extremities

372

2149

1.76

22.77

2.5

2.2

0.04

g/l

0.03

338

1955

Hypoparathyroidism

104

363

3.02

22.74

1.5

2.3

0.01

0.00

g/l

0.49

335

Generalized anxiety disorder

206

977

2.14

22.70

1.7

2.2

0.01

g/l

0.05

189

907

COPD related to multimorbidity

797

4624

1.47

22.67

1.8

2.3

0.02

0.04

g/l

0.85

721

4180

Injuries to the elbow and forearm

1131

7258

1.38

22.65

2.0

2.2

0.01

0.03

g/l

2.99

1019

6626

COPD, hospital admissions

884

5235

1.44

22.62

1.8

2.4

0.06

0.04

g/l

0.30

809

4735

Viral haemorrhagic fevers, not elsewhere classified/unspecified

293

1578

1.89

22.61

2.5

2.2

0.01

0.03

g/l

1.19

275

1452

Elevated blood glucose level

166

728

2.34

22.44

1.7

2.1

0.03

g/l

0.05

144

677

Dermatopolymyositis

107

5.04

22.42

3.3

2.7

0.00

0.05

g/l

0.50

101

Carcinoma in situ of skin of scalp and neck

283

3.34

22.39

1.8

2.6

0.03

g/l

0.01

259

Persistent mood disorders

325

1814

1.82

22.30

2.0

2.2

0.03

0.04

g/l

0.19

302

1667

Abnormal findings in nipple discharge synovial fluid wound secretions

108

4.98

22.16

3.5

2.2

0.02

0.05

g/l

0.21

102

Other enthesopathy of foot (+metatarsalgia)

182

834

2.23

22.06

2.4

2.1

0.01

g/l

0.19

170

770

Other encephalitis

209

3.67

22.06

1.9

2.8

0.05

0.03

g/l

0.18

196

Pain in thoracic spine

251

1299

1.96

21.84

2.9

2.1

0.00

0.02

g/l

0.71

237

1177

Neuromuscular dysfunction of bladder

186

866

2.21

21.77

2.1

2.6

0.03

0.04

g/l

0.08

168

796

Hypocalcemia

203

3.73

21.64

3.6

2.8

0.03

g/l

0.02

191

Bipolar affective disorders

261

1375

1.92

21.47

1.8

2.2

0.00

0.01

g/l

2.59

239

1286

Aortic aneurysm

463

2823

1.64

21.41

2.2

2.3

0.02

0.05

g/l

1.52

403

2568

Other and unspecified drugs and medicaments

175

801

2.25

21.40

3.1

2.2

0.01

0.02

g/l

0.46

162

735

Other viral hepatitis

108

395

2.81

21.36

1.9

2.0

0.00

0.02

g/l

0.63

100

371

Disorders of adult personality and behaviour

381

2250

1.71

21.36

1.7

2.0

0.00

0.01

g/l

2.47

353

2087

Gastric ulcer

354

2057

1.75

21.26

1.8

2.4

0.02

0.05

g/l

0.59

317

1858

Hypothyroidism, strict autoimmune

1081

5168

1.38

21.26

2.0

2.4

0.02

0.04

g/l

0.91

989

4674

Arthropod-borne viral fevers and viral haemorrhagic fevers

324

1836

1.80

21.19

2.5

2.2

0.01

0.02

g/l

1.35

306

1687

Thoracic aortic aneurysm

295

1630

1.85

21.18

2.3

0.02

0.05

g/l

0.89

257

1495

Type 1 diabetes, wide definition

339

1942

1.77

21.17

1.8

2.2

0.01

0.05

g/l

2.50

310

1800

Congenital malformations, deformations and chromosomal abnormalities

919

6046

1.41

21.17

1.9

2.2

0.01

0.03

g/l

2.61

845

5544

Spondylopathies in diseases classified elsewhere

113

4.86

21.15

20.3

1.5

0.03

0.00

g/l

0.49

100

Cramp and spasm

105

383

2.85

21.03

2.4

0.02

g/l

0.07

358

Other infectious diseases

190

906

2.15

20.95

2.5

2.2

0.09

0.03

g/l

0.38

172

831

Other enthesopathies

462

2885

1.62

20.87

1.9

2.2

0.00

0.03

g/l

2.02

427

2627

Complications of internal orthopaedic prosthetic devices, implants and grafts

441

2729

1.64

20.86

1.9

2.3

0.02

0.05

g/l

0.70

401

2455

Oxicams

413

1387

1.71

20.84

2.2

2.3

0.06

0.03

g/l

0.37

372

1251

Herpesviral [herpes simplex] infections

370

2187

1.71

20.75

2.8

2.2

0.04

0.01

g/l

0.43

348

2003

Artrosis, including avohilmo

1386

5726

1.33

20.68

2.0

2.3

0.03

g/l

0.19

1261

5226

Other embolism and thrombosis

252

1334

1.93

20.65

2.6

2.2

0.04

0.05

g/l

0.16

234

1207

Intracranial injury

941

6419

1.40

20.57

2.2

0.01

0.04

g/l

3.12

837

5855

Other extrapyramidal and movement disorders in other diseases

438

2715

1.64

20.56

2.2

0.01

0.04

g/l

1.80

399

2465

Anaemia in chronic diseases classified elsewhere

205

3.62

20.55

1.7

3.0

0.00

0.03

g/l

0.50

192

Alcoholic liver disease

209

1041

2.06

20.52

1.3

2.3

0.04

0.03

g/l

0.10

180

959

Budesonide

214

1073

2.03

20.43

2.0

2.3

0.01

g/l

0.01

198

987

Encephalitis

225

3.45

20.39

1.9

2.7

0.05

0.02

g/l

0.20

210

Chronic viral hepatitis

306

3.02

20.38

1.7

1.8

0.00

g/l

-0.00

295

Cervicalgia

343

1998

1.74

20.35

2.2

0.02

0.03

g/l

0.29

308

1805

Non-selective monoamine reuptake inhibitors

638

4144

1.50

20.33

2.3

2.4

0.03

g/l

0.12

585

3781

Chronic ulcer of skin, not elsewhere classified

155

693

2.31

20.15

2.4

2.3

0.00

0.04

g/l

1.74

144

632

Extrapyramidal and movement disorders

690

4740

1.47

20.14

2.1

2.3

0.02

0.03

g/l

0.69

624

4288

Other/unspecified reactive arthropathies

132

550

2.47

20.12

2.5

2.4

0.01

0.02

g/l

0.17

125

513

General examination and investigation of persons without complaint and reported diagnosis

896

3298

1.43

20.10

2.2

0.04

0.02

g/l

0.81

812

3012

Stomatitis and related lesions

327

1888

1.76

20.06

2.5

2.2

0.02

g/l

0.08

301

1735

Other diseases of lip and oral mucosa

657

4472

1.49

20.05

2.3

0.02

0.03

g/l

0.35

593

4082

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

286

1591

1.83

20.03

2.0

1.4

0.01

0.02

g/l

0.28

268

1436

Dental operations

1171

4443

1.36

20.01

2.2

2.1

0.03

g/l

0.05

1067

4020

Dermatophytosis

986

7204

1.38

19.97

2.1

2.2

0.03

g/l

0.00

876

6595

Viral hepatitis

126

515

2.51

19.95

1.9

2.1

0.00

0.01

g/l

0.76

114

482

All influenza (not pneumonia)

246

1305

1.92

19.93

4.6

1.8

0.01

0.03

g/l

0.79

222

1192

Substance abuse

929

6319

1.39

19.89

1.6

2.3

0.03

g/l

0.05

824

5813

Nonorganic sleeping disorders

299

1687

1.80

19.82

1.6

2.1

0.02

g/l

0.09

272

1571

Cholelithiasis, broad definition with cholecystitis

1470

7617

1.31

19.78

2.2

2.3

0.02

0.03

g/l

1.15

1326

6940

Superficial injury of hip and thigh

280

1553

1.84

19.75

1.9

2.2

0.04

g/l

0.04

257

1407

Radiculopathy

303

1721

1.79

19.74

2.3

2.2

0.02

0.04

g/l

0.42

279

1552

Mycoses

455

2875

1.60

19.68

2.7

2.2

0.02

0.03

g/l

0.56

422

2613

5-aminosalicylic acid

290

1624

1.81

19.68

1.8

2.2

0.04

0.02

g/l

0.30

267

1487

Oter anti-inflammatory and antirheumatic agents, non-steroids

407

1343

1.69

19.65

2.3

0.03

g/l

0.02

363

1208

KRA_PSY_EATING, excluding more controls

278

3.05

19.60

1.4

1.7

0.02

0.00

g/l

0.49

262

Other disorders of bone

307

1752

1.78

19.60

3.6

1.9

0.04

0.02

g/l

0.49

283

1628

Dilated cardiomyopathy

252

1363

1.90

19.45

1.8

2.3

0.00

0.04

g/l

2.52

230

1245

Disorders of sclera, cornea, iris and ciliary body

878

6338

1.40

19.33

2.2

0.03

g/l

0.03

810

5773

Pacemaker

658

4332

1.48

19.19

2.1

2.3

0.01

0.05

g/l

2.00

579

3888

Fracture of foot, except ankle

370

2235

1.68

19.17

2.2

2.1

0.02

g/l

0.11

340

2070

Benign neoplasm: Sigmoid colon

383

2341

1.67

19.15

2.4

2.3

0.03

0.04

g/l

0.23

352

2126

Mental and behavioural disorders due to psychoactive substance use

952

6452

1.38

19.10

1.6

2.3

0.03

g/l

0.03

846

5930

Fenamates

260

947

1.89

18.92

2.2

0.05

0.02

g/l

0.29

240

855

Panic disorder

188

925

2.06

18.89

1.4

2.3

0.00

0.01

g/l

1.03

175

859

Carcinoma in situ of skin of other and unspecified parts of face

206

1057

2.01

18.78

2.0

2.4

0.00

0.07

g/l

2.57

187

950

Other and unspecified acquired haemolytic anaemias

5.12

18.77

3.2

1.6

0.00

g/l

-0.00

Bronchiectasis

181

886

2.11

18.77

2.8

2.4

0.03

0.02

g/l

0.06

169

801

Benign neoplasm: Transverse colon

235

1259

1.92

18.75

2.8

2.3

0.08

0.03

g/l

0.55

206

1150

Myocardial infarction, strict

849

4335

1.41

18.61

2.1

2.4

0.05

0.04

g/l

0.36

773

3936

Injury of unspecified body region

157

732

2.20

18.41

1.6

2.4

0.00

0.02

g/l

1.34

144

677

Covid-19 suspected case

308

1793

1.74

18.32

2.7

2.1

0.11

0.02

g/l

0.51

286

1657

Collagenous colitis

182

901

2.07

18.23

3.1

2.3

0.09

0.02

g/l

0.80

166

834

Paracetamol or NSAID medication

234

602

1.97

18.20

2.6

1.9

0.02

g/l

0.04

213

552

Sequelae of injuries of lower limb

169

814

2.12

18.17

2.1

2.3

0.02

0.01

g/l

0.16

158

755

Benign neoplasm: Stomach

210

1097

1.97

18.10

2.3

0.01

0.02

g/l

0.20

184

1007

Personality disorders

357

2169

1.66

18.07

1.7

2.0

0.00

0.01

g/l

2.11

331

2012

Chronic pancreatitis

241

1316

1.87

18.03

1.9

2.3

0.02

0.03

g/l

0.40

223

1209

Migraine with aura and triptan purchases

195

991

1.99

17.93

1.4

1.9

0.02

0.01

g/l

0.36

183

911

Mucosal proctocolitis

201

1035

1.98

17.88

2.3

2.2

0.00

0.02

g/l

1.33

191

964

Other infectious diseases

163

781

2.14

17.86

2.7

2.2

0.10

0.02

g/l

0.43

149

716

Ptosis of eyelid

234

1273

1.88

17.79

2.5

2.3

0.03

g/l

0.01

217

1166

COPD, hospital admissions 3, with asthma pneumonia sepsis

548

3144

1.51

17.69

2.0

2.4

0.10

0.05

g/l

0.44

500

2813

Disorders of the thyroid gland

1525

7791

1.28

17.67

2.1

2.3

0.02

0.03

g/l

0.58

1399

7095

Eosinophilia

143

3.97

17.67

2.5

2.4

0.00

0.04

g/l

0.50

136

Faecal incontinence

190

967

2.01

17.63

1.6

2.4

0.03

0.01

g/l

0.25

176

877

Retinal detachments and breaks

653

4561

1.45

17.55

2.4

2.3

0.02

0.03

g/l

0.06

598

4142

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

339

2040

1.67

17.50

1.9

2.1

0.00

0.01

g/l

2.50

300

1907

Vasomotor and allergic rhinitis

511

3337

1.52

17.40

2.2

0.02

g/l

0.08

468

3057

Abnormal spermatozoa

1527

0.29

17.39

1.8

2.5

0.00

0.05

g/l

4.13

1386

COPD, hospital admission 2, with asthma infections

624

3705

1.46

17.21

1.9

2.3

0.09

0.04

g/l

0.45

570

3337

Disease of hard tissues of teeth, NOS

935

3579

1.38

17.13

2.2

2.1

0.03

g/l

0.07

859

3264

Psoriatic arthropathies

163

792

2.10

17.10

1.7

2.4

0.00

0.02

g/l

1.01

148

724

Congenital malformations, deformations and chromosomal abnormalities

799

5513

1.39

17.07

1.9

2.2

0.01

0.03

g/l

1.97

737

5046

Benign neoplasm: Ascending colon

287

1679

1.75

17.07

2.3

0.02

0.04

g/l

0.54

255

1526

Thyrotoxicosis

409

2611

1.59

17.01

1.8

2.2

0.01

0.03

g/l

1.09

373

2377

Sub-endpoint used in defining T1D endpoints

459

2955

1.54

16.97

1.8

2.1

0.01

0.04

g/l

2.64

420

2690

Oesophageal varices

387

2.63

16.93

1.5

2.5

0.00

0.03

g/l

1.20

356

Atopic dermatitis, strict definition with reimbursement

346

2046

1.65

16.87

1.8

2.0

0.03

0.02

g/l

0.23

324

1896

Open wound of ankle and foot

180

912

2.01

16.86

2.3

2.2

0.01

0.02

g/l

0.44

165

848

Paralytic ileus and intestinal obstruction

439

2853

1.56

16.82

2.5

2.2

0.05

0.03

g/l

0.29

403

2590

Migraine without aura and triptan purchases

192

993

1.96

16.80

1.6

1.9

0.01

g/l

0.00

178

917

Cholelithiasis

1395

7524

1.29

16.75

2.2

2.3

0.02

0.03

g/l

1.04

1256

6855

Other disorders of eyelid

805

5589

1.38

16.71

2.1

2.3

0.02

0.04

g/l

0.61

730

5068

Diseases of salivary glands

505

3399

1.50

16.43

2.0

2.2

0.01

0.03

g/l

0.89

452

3106

Other respiratory disorders and diseases

390

2488

1.59

16.37

2.0

2.2

0.04

0.05

g/l

0.19

352

2243

Other diseases of the respiratory system

390

2488

1.59

16.37

2.0

2.2

0.04

0.05

g/l

0.19

352

2243

Transient ischemic attack

954

5784

1.35

16.29

2.2

2.3

0.02

0.04

g/l

1.07

855

5250

Vitamin B12 deficiency anaemia

209

1128

1.89

16.27

1.8

2.3

0.02

0.06

g/l

1.02

188

1024

Enthesopathies of lower limb, excluding foot

333

2045

1.65

16.27

2.4

2.2

0.01

g/l

0.09

308

1857

Fissure and fistula of anal and rectal regions

380

2410

1.60

16.26

2.1

2.2

0.01

0.02

g/l

0.41

342

2207

Biomechanical lesions, not elsewhere classified

111

474

2.42

16.20

2.5

0.14

0.01

g/l

0.89

104

435

Congenital malformations of the urinary system

110

467

2.42

16.16

2.0

2.6

0.01

0.02

g/l

0.20

105

436

Raynaud syndrome

152

737

2.11

16.13

1.5

2.4

0.01

g/l

0.03

140

687

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

256

1427

1.76

16.01

1.7

2.2

0.00

0.03

g/l

1.52

232

1321

Sequelae with surgical and medical care as external cause

372

2366

1.60

15.85

2.1

2.2

0.01

0.04

g/l

1.62

343

2148

Other viral diseases, not elsewhere classified

352

2192

1.61

15.84

2.7

2.1

0.00

0.02

g/l

1.40

329

2018

Acute pancreatitis

348

2181

1.62

15.75

2.0

2.3

0.03

0.05

g/l

0.24

320

1980

Caries of enamel

1309

7398

1.28

15.67

2.5

2.2

0.02

g/l

0.07

1225

6792

Delirium, not induced by alcohol and other psychoactive substances

246

1410

1.78

15.63

1.8

2.3

0.04

0.06

g/l

0.16

211

1286

Lesion of lateral popliteal nerve

102

426

2.47

15.61

2.2

0.01

g/l

0.10

394

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

238

1310

1.78

15.48

1.7

2.2

0.00

0.03

g/l

1.47

216

1218

Thyroiditis, ILD-related definition

176

914

1.96

15.36

2.5

2.3

0.00

0.02

g/l

0.83

160

841

Thyrotoxicosis, other and/or unspecified

316

1946

1.65

15.34

1.9

2.2

0.01

0.02

g/l

1.07

290

1775

Other disorders of glucose regulation and pancreatic internal secretion

150

739

2.07

15.26

2.1

2.3

0.03

0.02

g/l

0.28

138

683

Fracture of lower leg, including ankle

867

6423

1.35

15.26

2.1

2.3

0.02

0.03

g/l

0.80

784

5865

Myocardial infarction, without ST-elevation

767

5136

1.37

15.20

2.1

2.3

0.02

0.04

g/l

0.73

696

4627

Ascites

155

776

2.05

15.17

1.5

2.3

0.01

g/l

0.05

141

708

Ankylosing spondylitis

146

715

2.08

15.08

1.6

2.0

0.00

0.01

g/l

0.87

134

658

Respiratory insufficiency

147

721

2.08

15.02

1.6

0.01

0.02

g/l

0.40

130

640

Other complications of surgical and medical care, not elsewhere classified

173

902

1.96

14.99

2.8

2.2

0.01

0.03

g/l

0.84

158

832

Unspecified acute lower respiratory infection

246

1429

1.75

14.94

2.7

2.2

0.01

0.03

g/l

0.66

226

1311

Scoliosis

131

618

2.16

14.91

1.8

2.2

0.00

0.01

g/l

0.23

121

563

Other viral diseases, not elsewhere classified

263

1552

1.71

14.87

2.9

2.2

0.00

0.02

g/l

1.20

248

1438

Pemphigoid

272

2.86

14.87

1.6

2.6

0.00

0.02

g/l

0.59

248

Fracture of skull and facial bones

336

2119

1.60

14.79

2.5

2.1

0.02

0.04

g/l

0.43

302

1957

Recurrent aphthous stomatitis , including avohilmo

236

1362

1.76

14.70

2.7

2.2

0.01

0.02

g/l

0.19

218

1256

Substance use, excluding alcohol

284

1721

1.67

14.69

1.5

2.2

0.00

0.02

g/l

3.23

249

1604

Pneumocystosis

188

3.29

14.65

5.5

2.6

0.04

0.03

g/l

0.16

176

Lung cancer and mesothelioma

322

1717

1.63

14.64

2.2

2.0

0.11

0.01

g/l

0.55

290

1548

Bullous disorders

129

613

2.17

14.60

1.9

2.4

0.02

g/l

0.04

119

566

Chronic tubulo-interstitial nephritis

314

2.67

14.53

2.3

2.0

0.00

g/l

-0.00

293

Other and unspecified visual disturbances

183

984

1.90

14.48

2.4

2.1

0.06

0.02

g/l

0.44

175

907

Meniscus derangement

832

4169

1.35

14.46

2.2

2.4

0.01

0.04

g/l

1.22

764

3800

Benign neoplasm of other and unspecified endocrine glands

238

1385

1.75

14.45

2.2

0.00

0.03

g/l

2.13

213

1286

Spirochaetal infections, other/unspecified

167

873

1.96

14.45

2.4

0.00

0.03

g/l

1.18

140

804

Vascular disorders of the intestines

143

708

2.07

14.44

2.3

2.0

0.12

0.01

g/l

0.76

130

634

Fracture of forearm

850

5855

1.34

14.37

2.0

2.3

0.01

0.03

g/l

2.12

759

5322

Fall on and from stairs and steps

421

2817

1.51

14.22

2.3

2.2

0.01

0.04

g/l

1.99

376

2573

Other and unspecified injuries of head

129

618

2.14

14.21

1.7

2.2

0.01

0.06

g/l

0.94

114

568

Other symptoms and signs involving the circulatory and respiratory systems

116

533

2.22

14.18

2.3

0.02

g/l

0.08

106

490

Exclusions for E4_PCOS_BROAD

255

1517

1.70

14.16

3.0

2.1

0.00

0.02

g/l

1.77

240

1405

Other and unspecified myopathies

172

915

1.92

14.12

1.7

2.3

0.01

0.03

g/l

1.18

154

834

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

195

1079

1.85

14.12

1.8

1.5

0.01

0.03

g/l

0.67

184

968

773

5279

1.36

14.09

2.7

2.3

0.06

0.04

g/l

0.27

689

4754

Herpesviral [herpes simplex] infections

191

1051

1.85

14.01

3.4

2.3

0.01

0.02

g/l

0.44

180

972

Use of pramipexole

399

2652

1.53

14.00

1.9

2.2

0.00

0.04

g/l

3.24

356

2401

Spondylolisthesis/Spondylolysis

290

1791

1.64

13.98

2.5

2.2

0.02

0.03

g/l

0.28

270

1618

Behavioural syndromes associated with physiological disturbances and physical factors

1375

7795

1.26

13.92

2.0

2.2

0.04

0.03

g/l

0.25

1240

7148

Other specified/unspecified hearing loss

175

941

1.90

13.92

2.2

0.04

0.03

g/l

0.17

163

857

Artificial opening status

121

573

2.18

13.85

3.3

2.1

0.05

0.03

g/l

0.13

108

528

Early onset COPD

390

2586

1.53

13.83

2.1

2.3

0.10

0.03

g/l

0.41

364

2345

Fibroblastic disorders

383

2534

1.53

13.67

2.5

2.3

0.03

0.05

g/l

0.31

349

2279

Allergic urticaria

130

634

2.09

13.63

1.8

2.3

0.00

0.01

g/l

0.41

116

593

Primary biliary cholangitis (PBC)

175

3.23

13.56

1.5

2.0

0.04

0.00

g/l

0.49

165

Other inflammatory liver diseases

126

610

2.12

13.55

1.7

2.6

0.01

0.02

g/l

0.53

112

565

Other and unspecified urticaria

280

1729

1.64

13.50

2.5

2.1

0.00

0.02

g/l

2.20

260

1597

Actinic keratosis

722

4968

1.36

13.43

2.8

2.3

0.07

0.04

g/l

0.30

645

4470

Other spirochaetal diseases

486

3384

1.45

13.42

2.8

2.3

0.02

0.03

g/l

0.53

430

3097

Cervical disc disorders

564

4032

1.41

13.39

2.3

2.2

0.03

g/l

0.00

520

3661

Pneumonia derived septicemia

298

2.64

13.39

5.2

2.6

0.16

0.00

g/l

0.58

272

Psoriasis vulgaris

303

1913

1.61

13.38

1.8

2.1

0.02

0.03

g/l

0.11

280

1769

Disorders of synovium and tendon

748

4887

1.35

13.31

1.9

2.2

0.02

0.03

g/l

0.53

685

4435

Allergic rhinitis

364

2365

1.53

13.30

2.3

2.0

0.01

g/l

0.26

334

2186

Poisoning by drugs, medicaments and biological substances

310

1969

1.59

13.26

2.0

2.1

0.00

0.02

g/l

1.68

277

1835

Mental and behavioural disorders due to alcohol

791

5734

1.33

13.25

1.6

2.3

0.03

g/l

0.16

704

5277

Atopic dermatitis, strict definition

328

2064

1.57

13.25

1.9

2.0

0.03

0.02

g/l

0.27

308

1917

Spirochaetal infections, other/unspecified

480

3343

1.45

13.25

2.8

2.3

0.02

0.03

g/l

0.53

425

3060

Special screening examination for neoplasms

107

491

2.23

13.18

3.3

2.1

0.27

0.01

g/l

0.47

454

Skin changes due to chronic exposure to nonionizing radiation

735

5066

1.35

13.17

2.7

2.3

0.06

0.04

g/l

0.30

656

4558

Mental and behavioural disorders due to alcohol, excluding acute intoxication

696

5138

1.36

13.13

1.6

2.3

0.04

0.02

g/l

0.38

614

4734

Other spirochaetal diseases

480

3350

1.45

13.10

2.8

2.3

0.02

0.03

g/l

0.53

425

3065

Personal history of malignant neoplasm

131

652

2.06

13.09

3.0

1.8

0.01

0.02

g/l

0.33

122

603

Malignant melanoma, including Hilmo

299

1893

1.60

13.09

2.3

1.4

0.02

g/l

0.04

260

1710

Lyme disease

476

3318

1.45

13.09

2.8

2.3

0.02

0.03

g/l

0.53

421

3037

Localized swelling, mass and lump of skin and subcutaneous tissue

486

3400

1.44

13.07

2.2

2.3

0.04

0.03

g/l

0.17

450

3087

Other hammer toe(s) (acquired)

286

1648

1.62

13.06

1.9

2.6

0.05

g/l

0.00

261

1472

Alcohol-induced chronic pancreatitis

123

599

2.11

13.06

2.0

2.5

0.01

0.02

g/l

0.19

108

561

Other specified/unspecified inflammatory spondylopathies

307

2.57

13.01

1.7

2.0

0.00

0.01

g/l

0.80

285

Malignant melanoma

253

1541

1.67

13.00

2.3

1.5

0.01

0.02

g/l

0.95

216

1388

Restless leg syndrome

234

1397

1.70

12.99

2.1

2.2

0.01

0.02

g/l

0.46

211

1287

Poisoning by medicine

281

1754

1.62

12.96

2.1

0.00

0.02

g/l

1.48

251

1638

Hydronephrosis

192

1085

1.80

12.95

1.8

2.0

0.04

0.02

g/l

0.35

178

988

Acute pancreatitis (for exclusion)

348

2287

1.54

12.90

2.0

2.2

0.03

g/l

0.06

320

2084

Cardiomyopathy, Hypertrophic obstructive

150

3.36

12.82

1.5

2.5

0.03

0.04

g/l

0.06

140

Persons encountering health services in other circumstances

545

3887

1.40

12.70

2.2

0.01

0.03

g/l

2.43

505

3514

Suppurative and necrotic conditions of lower respiratory tract

116

560

2.13

12.65

2.7

2.4

0.01

0.03

g/l

0.48

109

513

Degeneration of macula and posterior pole

879

5377

1.31

12.64

2.2

2.3

0.11

0.03

g/l

1.18

783

4843

Other and unspecified mood [affective] disorders

378

2.36

12.60

1.6

2.2

0.01

0.00

g/l

0.49

358

Exposure to other and unspecified inanimate mechanical forces

118

573

2.10

12.57

2.2

2.4

0.01

0.02

g/l

0.32

111

532

Hallux valgus (acquired)

486

2441

1.44

12.55

2.0

2.5

0.02

0.04

g/l

0.76

443

2202

Sarcoidosis

227

1357

1.70

12.55

2.0

2.2

0.03

0.02

g/l

0.20

207

1259

Vitreous haemorrhage

186

1053

1.80

12.54

1.9

2.3

0.07

0.03

g/l

0.30

174

972

Other congenital malformations

170

934

1.84

12.52

1.7

2.3

0.00

0.02

g/l

1.60

160

870

Sequelae of injuries, of poisoning and of other consequences of external causes

359

2390

1.52

12.49

2.6

2.2

0.02

g/l

0.09

330

2205

Diagnoses used for exclusion with ILD

442

3068

1.46

12.48

2.2

0.02

0.04

g/l

0.60

394

2777

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

775

5718

1.33

12.41

2.3

0.01

0.02

g/l

0.70

702

5236

Dementia in Alzheimer disease

131

2089

0.52

12.36

1.5

2.3

0.01

0.05

g/l

2.27

103

1882

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

231

1390

1.69

12.35

2.6

1.4

0.12

0.02

g/l

0.37

208

1234

Mental and behavioural disorders due to sedatives or hypnotics

105

491

2.18

12.34

1.4

2.2

0.00

0.01

g/l

0.50

463

Sleep disorders

1302

7587

1.25

12.31

1.9

2.2

0.04

0.02

g/l

0.26

1175

6959

Inflammatory diseases of the central nervous system

141

736

1.95

12.28

2.3

0.03

0.02

g/l

0.21

124

681

Diseases of external ear

531

3819

1.40

12.24

1.9

2.3

0.01

0.04

g/l

3.20

480

3475

Disorders of vitreous body and globe

865

6422

1.30

12.22

2.1

2.4

0.03

g/l

0.20

785

5841

Traumatic subdural haemorrhage

234

1361

1.67

12.19

2.4

2.3

0.01

0.05

g/l

1.59

206

1233

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

366

2.36

12.13

1.4

1.8

0.00

0.01

g/l

0.50

352

Gonarthrosis,primary

1532

7742

1.23

12.08

1.9

2.4

0.03

g/l

0.11

1399

7039

Attention to artificial openings

369

2.38

12.06

2.2

2.0

0.04

0.01

g/l

0.60

343

Missing teeth due to accident, extraction or parodontitis

997

7401

1.28

12.06

2.1

2.4

0.04

0.03

g/l

0.20

876

6786

Pneumococcal septicemia

290

2.57

12.05

5.5

2.7

0.16

0.02

g/l

0.49

267

Ankylosing spondylitis, ICD10

141

741

1.94

12.03

1.6

2.4

0.00

0.02

g/l

1.43

129

696

Demyelinating diseases of the central nervous system

124

623

2.02

12.03

1.6

2.1

0.00

0.01

g/l

0.65

115

581

COPD-related respiratory insufficiency

235

1436

1.67

12.02

2.1

2.3

0.03

0.05

g/l

0.29

209

1283

Asthma and opportunity respiratory infection

104

494

2.18

11.91

2.6

2.7

0.01

g/l

0.03

447

Insomnia

1256

7384

1.24

11.85

1.9

2.3

0.04

0.02

g/l

0.28

1135

6769

Hypoglycaemia, other or unspecified

117

581

2.06

11.78

1.7

2.3

0.04

0.02

g/l

0.43

108

539

Diabetic retinopathy

596

2714

1.38

11.75

1.8

2.1

0.02

0.03

g/l

0.10

547

2449

Inflammatory bowel disease

448

3156

1.43

11.64

2.2

0.04

0.03

g/l

0.14

413

2894

Cyst of kidney

145

781

1.90

11.60

2.5

0.01

0.02

g/l

0.20

139

719

Conjunctivitis (acute, non atopic)

378

2572

1.48

11.59

2.7

2.0

0.02

0.03

g/l

0.10

355

2364

Other or unspecified ileus, impaction or obstruction

305

1996

1.55

11.55

2.3

2.2

0.07

0.03

g/l

0.54

276

1799

Eating disorder

367

2.31

11.53

1.4

1.6

0.02

g/l

0.03

349

Diplopia

222

1351

1.67

11.51

2.1

0.05

0.03

g/l

0.27

204

1239

Other diseases of stomach and duodenum

126

649

1.99

11.50

2.2

2.5

0.02

g/l

0.05

112

597

Other lack of coordination

140

3.30

11.46

1.7

3.1

0.06

0.00

g/l

0.49

130

Cutaneous lupus erythematosus

210

2.83

11.45

2.4

2.1

0.00

0.03

g/l

0.50

195

Disorders of vitreous body

836

6271

1.30

11.45

2.1

2.4

0.03

g/l

0.19

758

5710

Pyothorax

417

2.25

11.40

3.0

2.5

0.01

0.03

g/l

0.36

383

Abnormal results of function studies

145

784

1.88

11.38

2.5

2.4

0.01

0.02

g/l

0.46

127

735

Benign neoplasm: Rectum, anus and anal canal

366

2499

1.48

11.37

2.4

2.3

0.02

0.04

g/l

0.88

342

2261

Benign neoplasm: Rectum

332

2225

1.51

11.34

2.4

2.3

0.02

0.03

g/l

0.42

311

2021

Problems related to lifestyle

141

755

1.89

11.34

1.4

2.3

0.05

0.01

g/l

0.51

126

696

Benign neoplasm: Caecum

210

1268

1.69

11.31

2.8

2.2

0.02

0.03

g/l

0.30

195

1160

Other shoulder lesions

138

736

1.90

11.26

1.7

1.9

0.00

0.01

g/l

1.53

131

682

Carcinoma in situ of other and unspecified digestive organs

338

2.40

11.21

2.2

2.8

0.01

0.03

g/l

0.56

308

Alcohol use disorder, ICD-based

633

4748

1.34

11.20

1.6

2.3

0.03

g/l

0.02

562

4374

Other and unspecified local infections of skin and subcutaneous tissue

159

889

1.82

11.20

3.0

2.3

0.00

0.03

g/l

2.00

149

829

Coronary artery bypass grafting

487

2597

1.41

11.19

1.6

2.5

0.02

0.05

g/l

1.28

447

2349

Systemic atrophies primarily affecting the central nervous system

414

2.24

11.18

1.5

2.6

0.00

0.02

g/l

0.72

381

Traumatic subarachnoid haemorrhage

270

2.55

11.18

2.5

1.9

0.00

0.09

g/l

0.82

251

Viral pneumonia (known virus, not influenza)

236

2.69

11.15

6.9

2.8

0.06

0.00

g/l

0.87

217

Squamous cell neoplasms and carcinomas of the skin

160

898

1.82

11.15

2.6

1.4

0.18

0.04

g/l

0.36

143

788

Acute posthaemorrhagic anaemia

301

2.47

11.14

3.2

2.7

0.43

0.03

g/l

0.45

275

Carbimazole or st.post thyroidectomy, condition for graves disease

307

2029

1.53

11.13

2.4

2.2

0.01

0.02

g/l

1.18

284

1863

Other/unspecified rheumatoid arthritis

225

1388

1.65

11.10

1.8

2.2

0.00

0.04

g/l

2.08

207

1251

Monoamine oxidase A inhibitors

189

1113

1.72

11.09

1.8

2.4

0.00

0.02

g/l

0.86

169

1029

Macular pucker

299

1973

1.54

11.06

1.7

2.5

0.04

g/l

0.00

270

1786

Other/unspecified enthesopathies of lower limb, excluding foot

110

547

2.05

11.04

1.8

2.2

0.01

g/l

0.06

101

502

Olecranon bursitis

110

548

2.05

11.03

2.2

2.0

0.00

0.03

g/l

1.21

102

500

Gingival hyperplasia

285

2.50

10.97

2.8

2.9

0.05

0.02

g/l

0.24

265

Emphysema

144

788

1.87

10.95

2.8

2.4

0.06

0.03

g/l

0.19

133

710

Alcohol-induced acute pancreatitis

310

2.43

10.93

2.6

2.8

0.05

0.03

g/l

0.19

292

Other abnormal immunological findings in serum

129

3.30

10.83

1.6

2.7

0.00

0.04

g/l

0.50

119

Diabetic maculopathy, excluding more controls

178

1039

1.74

10.81

1.3

2.3

0.00

0.06

g/l

2.30

166

962

Tubulo-interstitial nephritis, not specified as acute or chronic

116

593

1.99

10.80

2.4

2.0

0.00

0.04

g/l

0.74

104

545

Specific personality disorders

280

1825

1.55

10.79

1.7

2.0

0.00

0.01

g/l

1.56

259

1697

Other disorders of skin and subcutaneous tissue, not elsewhere classified

239

1508

1.61

10.72

2.3

2.1

0.01

0.05

g/l

1.77

220

1365

Transport accidents

589

3776

1.35

10.63

1.9

2.2

0.02

0.03

g/l

0.25

542

3492

Cervicobrachial syndrome

304

2025

1.52

10.62

2.1

0.00

0.02

g/l

1.30

289

1828

Erosion of teeth , including avohilmo

313

2101

1.50

10.52

2.2

2.0

0.07

0.02

g/l

0.67

284

1953

Emotionally unstable personality disorder

132

710

1.88

10.48

1.6

1.8

0.00

0.01

g/l

0.84

120

672

Cardiac arrest

403

2.11

10.45

2.2

0.00

0.07

g/l

0.89

373

Infections with a predominantly sexual mode of transmission

339

2311

1.47

10.44

1.9

0.00

0.01

g/l

1.03

308

2147

Infections with a predominantly sexual mode of transmission

416

2742

1.42

10.44

1.9

0.01

g/l

0.56

382

2541

Benign neoplasm: Adrenal gland

148

831

1.82

10.39

1.9

2.5

0.00

0.02

g/l

1.80

132

770

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

173

1015

1.74

10.38

3.1

2.3

0.17

0.02

g/l

0.44

161

940

Other local infections of skin and subcutaneous tissue

166

962

1.75

10.38

2.9

2.3

0.00

0.03

g/l

2.00

155

896

Carpal tunnel syndrome

943

6622

1.26

10.37

2.3

0.02

0.03

g/l

0.50

872

6029

Superficial injury of abdomen, lower back and pelvis

221

1381

1.62

10.31

2.1

0.05

0.04

g/l

0.07

204

1269

Dermatitis due to substances taken internally

441

2.13

10.25

3.1

2.7

0.00

0.02

g/l

1.09

410

Epilepsy

451

3245

1.40

10.25

1.9

2.4

0.03

0.04

g/l

0.20

389

2960

Secondary thrombocytopenia

104

3.56

10.22

3.9

1.6

0.00

g/l

-0.00

Thyrotoxicosis with toxic multinodular goitre

122

649

1.93

10.21

1.6

2.3

0.03

0.02

g/l

0.08

108

595

Adhesive capsulitis of shoulder

256

1660

1.56

10.20

1.9

2.1

0.01

0.04

g/l

1.53

233

1508

Ulcerative colitis

347

2394

1.46

10.19

2.4

2.1

0.03

0.02

g/l

0.02

321

2200

Mixed hyperlipidaemia

365

2.25

10.16

1.7

2.2

0.00

0.02

g/l

1.20

340

Insulin, fast-acting (human)

192

1163

1.67

10.13

1.7

2.0

0.01

0.02

g/l

0.52

176

1086

Lesion of ulnar nerve

223

1404

1.61

10.12

1.8

2.1

0.00

0.03

g/l

2.15

215

1295

Other and unspecified erythematous conditions

278

2.45

10.11

2.5

2.4

0.16

0.02

g/l

0.54

258

Nummular dermatitis

140

781

1.83

10.02

2.2

2.5

0.00

0.02

g/l

1.61

128

718

Suggestive for eosinophilic asthma

160

928

1.76

10.02

2.1

2.2

0.07

0.01

g/l

0.84

151

859

Bacterial, viral and other infectious agents

131

715

1.86

10.01

2.7

2.2

0.01

0.02

g/l

0.10

120

669

Algoneurodystrophy

213

2.65

9.99

1.3

1.9

0.00

0.02

g/l

0.50

202

Iridocyclitis

345

2389

1.46

9.98

2.5

2.1

0.05

0.03

g/l

0.35

318

2184

Intestinal stricture

516

3829

1.36

9.93

2.5

2.3

0.10

0.04

g/l

0.46

467

3455

Hemiplegia

461

2.09

9.89

1.6

2.4

0.06

0.01

g/l

0.34

421

Colonic or urogenital fistula

412

2950

1.41

9.89

2.3

2.2

0.01

0.03

g/l

1.01

371

2697

Parkinson's disease, excluding more controls

230

1381

1.59

9.84

2.0

2.3

0.04

0.05

g/l

0.18

205

1258

Carcinoma in situ of skin

172

1025

1.72

9.83

1.8

2.4

0.08

0.06

g/l

0.13

155

933

Hyperplasia of prostate

623

2669

1.34

9.81

2.3

2.5

0.03

g/l

0.20

574

2435

Hypothyroidism, other/unspecified

1345

7327

1.21

9.81

2.1

2.3

0.02

0.03

g/l

0.84

1233

6670

Other specified and unspecified personality disorders

118

627

1.91

9.80

1.7

2.2

0.00

0.01

g/l

0.97

110

590

Injuries to the neck

308

2093

1.48

9.80

2.7

2.1

0.01

0.02

g/l

1.03

277

1928

Symptoms and signs involving emotional state

192

2.73

9.80

1.4

2.0

0.00

g/l

-0.00

179

Carcinoma in situ of colon

200

2.73

9.73

2.5

3.0

0.00

0.02

g/l

0.80

183

Other and unspecified glaucoma

144

819

1.80

9.72

2.2

2.5

0.03

g/l

0.08

127

736

Keratitis

515

3832

1.35

9.71

2.1

2.2

0.02

0.03

g/l

0.18

476

3494

Other symptoms and signs involving the nervous and musculoskeletal systems

597

4539

1.32

9.67

2.0

2.3

0.02

0.04

g/l

0.86

549

4131

Ocular pain

127

695

1.86

9.66

1.7

2.3

0.01

g/l

0.13

118

644

Eating disorders

108

559

1.95

9.63

1.9

1.8

0.01

g/l

0.01

100

523

Carcinoma in situ of skin of trunk

362

2.24

9.61

2.5

2.3

0.04

0.03

g/l

0.11

328

Other bursopathies

208

1305

1.62

9.61

2.4

2.1

0.05

g/l

0.08

197

1186

Pollen allergy

185

1110

1.66

9.60

2.6

2.0

0.01

g/l

0.07

167

1047

Artificial joint re-operation

141

801

1.80

9.59

2.1

2.4

0.00

0.03

g/l

1.68

131

734

Other diseases of pancreas

151

875

1.76

9.54

2.1

2.4

0.01

0.04

g/l

0.84

140

803

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

428

3085

1.39

9.53

2.1

0.01

0.02

g/l

1.13

398

2857

Internal derangement of knee

497

3670

1.36

9.51

1.8

2.4

0.02

0.04

g/l

1.29

458

3345

Follicular lymphoma, hilmo

463

2.07

9.50

1.5

2.8

0.03

g/l

0.02

427

Diseases of male genital organs

778

3058

1.29

9.46

1.9

2.4

0.02

g/l

0.01

723

2803

Anti-inflammatory and antirheumatic products, non-steroids

413

1468

1.42

9.44

2.6

2.2

0.03

g/l

0.05

382

1329

Candidiasis

208

1311

1.61

9.43

3.2

2.2

0.04

0.02

g/l

0.46

192

1207

Other disorders of the musculoskeletal system and connective tissue

248

1629

1.54

9.40

2.3

0.06

0.02

g/l

0.61

230

1498

Calculus of kidney and ureter

493

3666

1.36

9.40

2.1

2.3

0.01

0.04

g/l

1.97

453

3349

Melanocytic naevi

408

2943

1.40

9.38

2.5

2.2

0.02

0.03

g/l

0.35

385

2684

Speech disturbances, not elsewhere classified

159

939

1.72

9.37

2.0

2.3

0.02

0.03

g/l

0.34

139

863

Crushed, pushed or stepped on by crowd or human stampede

463

2.04

9.35

2.5

2.2

0.02

0.01

g/l

0.22

435

Retinal vascular occlusion

225

1456

1.57

9.18

2.4

2.3

0.05

0.04

g/l

0.12

211

1310

Anogenital herpesviral [herpes simplex] infection

115

619

1.88

9.18

1.9

2.0

0.01

g/l

0.06

106

581

Speech and linguistic disorders, excluding more controls

330

2.19

9.18

2.5

2.3

0.01

0.00

g/l

0.49

302

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

355

2.21

9.17

2.9

2.6

0.02

0.01

g/l

0.09

329

Propionic acid derivatives

411

1468

1.42

9.16

2.5

2.2

0.04

0.03

g/l

0.16

378

1329

Other orthopaedic follow-up care

489

2.00

9.13

1.8

2.1

0.06

0.00

g/l

0.48

457

Idiopathic pulmonary fibrosis

153

903

1.73

9.10

2.1

2.4

0.01

0.02

g/l

0.47

140

814

Retinal vascular disorders

227

1475

1.56

9.09

2.4

2.3

0.05

0.04

g/l

0.13

213

1329

Parkinson's disease, strict definition, excluding more controls

215

1311

1.58

9.07

2.0

2.3

0.04

0.05

g/l

0.14

193

1198

Angina pectoris

939

5045

1.25

9.05

2.3

2.4

0.04

0.03

g/l

0.17

861

4597

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

197

1237

1.61

9.04

1.8

2.2

0.00

0.01

g/l

1.52

173

1167

Synovial cyst of popliteal space [Baker]

124

689

1.83

9.03

2.8

2.0

0.09

0.01

g/l

0.86

117

624

Other specified/unspecified soft tissue disorders

417

2.08

8.98

2.4

2.0

0.02

0.01

g/l

0.16

377

Arterial embolism and thrombosis

106

562

1.92

8.96

1.5

2.4

0.03

g/l

0.05

509

Lung transplant status

4.40

8.91

1.3

2.0

0.11

0.09

g/l

0.07

Lung transplantation

4.40

8.91

1.3

2.0

0.11

0.09

g/l

0.07

Colectomy operation

292

2007

1.47

8.90

2.6

2.2

0.13

0.04

g/l

0.39

267

1816

Dermatographic urticaria

501

1.97

8.84

1.8

2.3

0.01

g/l

0.04

474

Disorders of optic nerve and visual pathways

139

806

1.75

8.74

2.3

2.4

0.01

0.02

g/l

0.06

128

753

Other erythematous conditions

310

2.26

8.72

2.5

2.4

0.18

0.02

g/l

0.64

288

Hypothyreosis and Thyroxine purchase for inclusion criteria

1394

7695

1.19

8.63

2.1

2.3

0.02

0.03

g/l

0.91

1279

7003

Disorders of orbit

391

2.10

8.58

3.7

2.5

0.04

0.00

g/l

0.49

365

Vitamin deficiency, wide

411

2.06

8.57

2.6

2.4

0.07

0.02

g/l

0.51

378

Vitamin deficiency

411

2.06

8.57

2.6

2.4

0.07

0.02

g/l

0.51

378

Dermatopolymyositis, unspecified

5.04

8.56

6.5

3.0

0.00

g/l

-0.00

Other/unspecified disorders of vestibular function

406

2.08

8.53

1.7

2.6

0.06

0.02

g/l

0.25

373

Striking against or struck by other objects

431

3184

1.36

8.52

1.8

2.1

0.00

0.03

g/l

3.07

395

2933

Mental disorders, not otherwise specified

106

571

1.88

8.51

1.7

2.1

0.00

0.01

g/l

0.65

101

539

Cervicocranial syndrome

154

926

1.68

8.48

1.9

2.2

0.01

0.03

g/l

0.36

145

840

Abscess of anal and rectal regions

120

673

1.81

8.47

1.3

2.0

0.01

g/l

0.06

114

628

Pain and other conditions associated with female genital organs and menstrual cycle

223

1341

1.54

8.46

1.9

0.00

0.01

g/l

0.39

207

1226

Pneumothorax

121

682

1.81

8.45

2.2

0.06

0.02

g/l

0.40

109

627

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

339

2415

1.41

8.41

1.9

2.1

0.00

0.02

g/l

3.12

300

2247

Intestinal adhesions without obstruction

143

846

1.72

8.41

3.3

2.0

0.05

0.02

g/l

0.33

132

770

Bacterial, viral and other infectious agents

118

661

1.81

8.37

2.8

2.2

0.01

g/l

0.05

107

621

Hallux rigidus

209

1358

1.56

8.36

2.3

2.5

0.01

0.05

g/l

1.69

187

1224

Cryoglobulinemia

16.30

8.36

4.7

1.0

0.00

g/l

—

Other disorders of bladder

200

1289

1.57

8.33

2.3

2.4

0.00

0.05

g/l

3.05

177

1170

Neuralgia and neuritis, unspecified

402

2.05

8.31

2.6

2.0

0.03

0.01

g/l

0.19

371

Alcohol abuse, main dg, excluding more controls

200

1288

1.57

8.30

1.2

2.4

0.01

0.02

g/l

0.22

178

1205

Other sleep disorders

169

1048

1.63

8.26

1.5

2.3

0.01

0.04

g/l

1.25

144

966

Disorders of vestibular function (Vertigo)

745

5855

1.26

8.25

2.0

2.3

0.02

0.03

g/l

0.30

668

5305

Heartburn

164

1010

1.64

8.24

2.0

2.2

0.00

0.02

g/l

1.57

154

921

Malignant neoplasm of urinary organs

165

1023

1.64

8.13

1.6

1.4

0.01

0.03

g/l

0.57

154

922

Other and unspecified psoriasis

116

655

1.81

8.08

2.1

2.5

0.00

0.02

g/l

1.21

108

608

Other infective otitis externa

525

1.90

8.08

2.2

2.3

0.01

0.02

g/l

0.54

484

Malignant neoplasm of kidney, except renal pelvis

152

925

1.67

8.07

1.7

1.4

0.01

0.03

g/l

0.45

143

835

Left bundle-branch block

120

685

1.78

8.04

1.7

2.2

0.00

0.06

g/l

1.35

105

628

Portal vein thrombosis

132

2.92

8.00

1.7

2.8

0.00

0.04

g/l

0.50

126

Acute pharyngitis

167

1031

1.62

7.98

2.7

1.9

0.02

0.01

g/l

0.37

159

965

Temporomandibular joint disorders, including avohilmo

511

3855

1.31

7.97

2.1

0.01

0.02

g/l

0.67

472

3538

Dissociative [conversion] disorders

213

2.44

7.96

1.3

1.8

0.00

0.03

g/l

0.63

198

Other congenital malformations of skin

109

607

1.82

7.92

1.8

2.3

0.00

0.01

g/l

0.65

101

566

Congenital malformations and deformations of the musculoskeletal system

121

690

1.76

7.90

1.6

2.1

0.00

0.01

g/l

0.65

116

650

Acute generalized exanthematous pustulosis

390

2.05

7.89

3.3

2.6

0.11

0.02

g/l

0.36

360

Arthropathic psoriasis

173

1093

1.60

7.87

1.7

2.3

0.00

0.02

g/l

1.65

157

1014

Urolithiasis

522

4020

1.31

7.87

2.1

2.3

0.01

0.04

g/l

1.97

477

3665

Benign neoplasm: Rectosigmoid junction

433

2.00

7.85

2.0

2.7

0.00

0.03

g/l

1.19

398

Use of donepezil

187

2720

0.65

7.75

1.8

2.2

0.03

0.05

g/l

0.50

156

2415

Barrett oesophagus

491

1.92

7.73

2.1

2.8

0.00

0.02

g/l

1.03

455

Personal history of other diseases and conditions

122

704

1.74

7.69

3.3

2.0

0.13

0.01

g/l

0.52

114

656

Superficial injury of thorax

221

1482

1.51

7.67

1.4

2.3

0.06

0.03

g/l

0.29

193

1365

Coxarthrosis, primary

1014

7133

1.21

7.62

2.1

2.4

0.03

g/l

0.13

930

6452

Dislocation, sprain and strain of joint and ligaments of hip

362

2.07

7.60

1.8

2.4

0.01

g/l

0.23

337

Melanoma in situ

481

1.92

7.58

2.4

2.7

0.01

0.03

g/l

0.76

441

Other superficial mycoses

127

749

1.71

7.56

1.6

2.3

0.01

g/l

0.32

113

700

D07AA Corticosteroids, weak (group I)

185

1195

1.56

7.56

1.7

2.2

0.00

0.02

g/l

1.70

163

1111

Fall involving bed

324

2.13

7.49

2.8

2.5

0.00

0.03

g/l

0.95

292

Malignant melanoma of skin, including Hilmo

228

1550

1.49

7.43

2.1

1.5

0.02

g/l

0.04

199

1400

Viral and other specified intestinal infections

286

1952

1.42

7.39

1.7

1.9

0.04

0.03

g/l

0.18

269

1811

Trigger finger

197

1300

1.53

7.39

1.6

2.2

0.00

0.02

g/l

0.97

185

1195

COPD, hospital admissions 1, only main diagnosis

600

4054

1.28

7.36

2.0

2.3

0.08

0.04

g/l

0.33

546

3653

Anogenital herpesviral [herpes simplex] infection

352

2.04

7.32

1.7

1.9

0.01

0.02

g/l

0.07

330

Exclusions for E4_PCOS_CONSORTIUM

928

4790

1.22

7.24

2.3

2.1

0.00

0.02

g/l

3.07

845

4380

Follicular cysts of skin and subcutaneous tissue

266

1871

1.44

7.23

2.6

2.1

0.10

0.02

g/l

0.59

249

1718

Suicide or other Intentional self-harm

300

2155

1.40

7.19

1.9

2.1

0.00

0.02

g/l

3.12

267

2007

Bronchitis, not specified as acute or chronic

128

768

1.69

7.19

2.0

2.3

0.02

0.01

g/l

0.08

117

699

Disorders of oesophagus in diseases classified elsewhere

200

2.44

7.18

3.5

3.2

0.06

0.03

g/l

0.31

183

Psoriatic arthropathies, ICD10

159

1009

1.60

7.15

1.7

2.3

0.00

0.01

g/l

1.05

144

934

Sleep disorders, other/unspecified

218

2.34

7.14

1.2

1.8

0.00

0.03

g/l

0.63

207

Familial hypercholesterolemia

237

1638

1.46

7.11

2.5

2.2

0.06

0.04

g/l

0.13

216

1463

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

148

927

1.62

7.06

2.1

2.3

0.06

0.01

g/l

0.72

131

852

Retinal detachment with retinal break

219

1494

1.48

7.06

2.3

2.2

0.01

0.04

g/l

1.02

198

1367

Hernia of abdominal wall

697

5636

1.24

7.04

2.4

2.3

0.02

0.03

g/l

1.02

646

5134

Other/unspecified enthesopathies, not elsewhere classified

131

796

1.67

7.03

1.7

1.9

0.00

0.02

g/l

1.36

119

726

Deviated nasal septum

481

3718

1.30

7.03

2.8

2.3

0.02

g/l

0.01

442

3416

Glucagon-like peptide-1 (GLP-1) analogues

405

3062

1.33

7.03

1.5

2.5

0.00

0.02

g/l

3.15

376

2832

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

405

3062

1.33

7.03

1.5

2.5

0.00

0.02

g/l

3.15

376

2832

Procreative management

370

2291

1.35

7.03

1.8

2.0

0.01

0.02

g/l

0.37

349

2129

Polycythaemia vera

305

2.12

7.02

2.9

1.4

0.00

0.02

g/l

0.59

274

Cerebral cysts

449

1.90

7.02

1.4

2.2

0.00

0.02

g/l

0.72

416

Disorders of purine and pyrimidine metabolism

4.07

6.99

1.5

0.09

0.00

g/l

0.48

Diseases of inner ear

850

6786

1.22

6.98

2.0

2.3

0.03

g/l

0.17

767

6156

Congenital malformations of the circulatory system

180

1145

1.54

6.94

1.6

2.2

0.00

0.02

g/l

1.86

159

1065

Other and unspecified injuries of lower leg

103

589

1.77

6.90

2.3

0.00

0.01

g/l

1.10

548

Other disorders of optic [2nd] nerve and visual pathways

553

1.80

6.90

2.4

2.5

0.01

0.02

g/l

0.18

512

Other obstetric conditions, not elsewhere classified

239

1043

1.46

6.86

1.3

1.7

0.01

g/l

0.01

220

978

Childhood asthma (age<16), excluding more controls

329

1.92

6.80

1.5

1.4

0.00

0.01

g/l

0.50

314

Seborrhoeic keratosis

357

2668

1.35

6.76

2.2

2.3

0.01

0.05

g/l

3.17

323

2412

Fall on same level involving ice and snow

831

6871

1.22

6.75

2.0

2.3

0.02

0.03

g/l

0.14

747

6274

Alzheimer disease, excluding more controls

292

1379

1.41

6.75

1.9

2.4

0.02

0.05

g/l

1.16

243

1258

Other and/or unspecified nontoxic goitre

137

853

1.63

6.73

2.3

2.4

0.01

g/l

0.34

128

780

Other disorders of patella

188

1256

1.51

6.67

2.0

2.4

0.03

0.02

g/l

0.21

179

1162

Inguinal hernia

885

4902

1.21

6.67

2.8

2.2

0.03

g/l

0.16

812

4471

Viral agents as the cause of diseases classified to other chapters

188

2.40

6.64

2.7

2.0

0.01

0.03

g/l

0.31

175

Primary gonarthrosis, bilateral

853

6058

1.21

6.64

1.8

2.4

0.02

0.03

g/l

0.41

780

5487

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

229

997

1.46

6.61

1.3

1.7

0.01

g/l

0.01

211

937

Fracture of neck

106

621

1.74

6.60

3.4

2.2

0.00

0.03

g/l

1.60

571

Vascular diseases of the intestine

389

1.95

6.57

2.6

2.2

0.11

0.03

g/l

0.48

354

Rosacea

166

1086

1.55

6.56

1.9

2.3

0.02

g/l

0.09

155

1004

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

233

2.23

6.55

1.5

1.8

0.00

g/l

0.50

225

Hepatic failure, not elsewhere classified

341

2.01

6.54

2.0

2.8

0.00

0.03

g/l

0.86

313

Diseases of peritoneum

163

1064

1.55

6.53

2.0

2.3

0.00

0.03

g/l

2.00

156

972

Umbilical hernia

393

2994

1.32

6.51

2.1

2.2

0.02

0.03

g/l

0.21

366

2765

Superficial injury of wrist and hand

244

1724

1.43

6.49

1.8

2.1

0.03

0.02

g/l

0.09

226

1602

Other psoriatic arthropathies

152

978

1.57

6.49

1.8

2.3

0.00

0.01

g/l

1.05

138

905

Childhood asthma (age<16)

335

1.89

6.48

1.4

0.00

0.01

g/l

0.50

319

Thiazolidinediones

201

1374

1.48

6.47

1.6

2.3

0.00

0.05

g/l

2.58

181

1256

Maternal care for other conditions predominantly related to pregnancy

189

1247

1.49

6.46

1.8

1.9

0.00

0.01

g/l

1.31

172

1167

Melanocytic naevi of trunk

167

1099

1.54

6.43

2.1

2.3

0.04

0.02

g/l

0.61

158

1023

Alcohol dependence

398

3043

1.32

6.43

1.5

2.4

0.01

0.02

g/l

1.97

352

2803

Superficial injury of ankle and foot

135

846

1.61

6.41

1.7

2.2

0.01

0.02

g/l

0.03

121

790

Malignant neoplasm of other connective and soft tissue, including Hilmo

386

1.93

6.38

4.5

1.4

0.43

0.02

g/l

0.79

356

Other follicular disorders

545

1.77

6.33

1.9

2.4

0.00

0.02

g/l

1.03

509

Superficial injury of forearm

123

758

1.64

6.28

2.3

2.2

0.00

0.02

g/l

1.36

109

712

Speech and linguistic disorders

398

1.87

6.23

2.5

2.0

0.01

g/l

0.15

368

Acne

437

1.84

6.20

2.0

1.5

0.00

g/l

0.50

412

Drug-induced neutropenia

119

732

1.65

6.18

3.1

2.5

0.01

0.02

g/l

0.27

113

674

Arthropathy in hypersensitivity reactions classified elsewhere

17.92

6.17

1.8

1.3

0.00

g/l

—

Dermatophytosis

201

1387

1.47

6.16

2.5

2.2

0.01

0.03

g/l

1.42

185

1263

Other specified/unspecified bacterial intestinal infections

108

649

1.69

6.14

2.9

2.3

0.01

0.02

g/l

0.23

603

Unspecified lump in breast

219

1536

1.44

6.14

1.8

2.3

0.00

0.02

g/l

1.17

199

1396

Other/unspecified synovitis and tenosynovitis

153

999

1.55

6.12

1.9

2.0

0.06

0.01

g/l

0.41

141

917

Amenorrhoea

369

1.92

6.11

1.9

1.7

0.00

g/l

0.54

341

Benign neoplasm of mouth and pharynx

171

1145

1.51

6.11

2.9

2.3

0.07

0.02

g/l

0.69

154

1056

Haemorrhoids and perianal venous thrombosis

458

3585

1.28

6.08

2.2

2.3

0.05

0.03

g/l

0.30

415

3260

MS-disease / Multiple Sclerosis

500

1.78

6.08

1.7

2.1

0.00

0.01

g/l

0.65

469

Benign neoplasm: Other and unspecified parts of mouth

323

2.00

6.07

2.7

0.11

0.02

g/l

0.52

298

Acute and subacute iridocyclitis

268

1950

1.39

6.06

2.6

2.1

0.04

0.02

g/l

0.29

247

1794

Fracture at wrist and hand level

451

3525

1.28

6.06

2.1

2.2

0.01

0.03

g/l

2.40

399

3219

Fentanyl

149

969

1.55

6.04

6.0

1.7

0.01

g/l

0.03

127

862

Anterior Iridocyclitis

286

2105

1.37

6.03

2.6

2.1

0.04

0.02

g/l

0.29

264

1933

Hyposplenism

9.29

6.02

2.6

1.1

0.00

g/l

-0.00

Crohn's disease NAS

487

1.79

6.02

1.8

2.4

0.02

g/l

0.03

455

Alzheimer’s disease (Late onset), excluding more controls

253

1185

1.41

6.00

2.2

2.3

0.02

0.06

g/l

0.93

212

1079

Right bundle-branch block

317

2.00

5.99

2.9

2.3

0.00

0.05

g/l

1.13

290

Benign neoplasm: Pancreas

291

2.06

5.97

2.8

2.9

0.04

0.03

g/l

0.04

268

Plantar fascial fibromatosis

131

831

1.59

5.97

2.7

2.0

0.02

0.01

g/l

0.06

123

770

Chondrocostal junction syndrome [Tietze]

318

1.99

5.95

1.9

2.1

0.09

0.02

g/l

0.49

292

Otalgia

112

685

1.66

5.94

1.7

2.1

0.01

0.03

g/l

0.40

635

Inflammatory diseases of female pelvic organs

745

4523

1.22

5.94

1.6

2.3

0.02

g/l

0.13

688

4105

Unstable angina pectoris

616

3944

1.24

5.94

2.3

2.4

0.03

0.04

g/l

0.16

558

3560

Scabies

148

967

1.54

5.89

1.5

2.2

0.01

g/l

0.20

140

910

Other or ill-defined heart diseases

403

1.86

5.89

2.1

2.2

0.02

0.04

g/l

0.46

375

Somnolence, stupor and coma

376

1.90

5.85

1.2

2.8

0.00

0.01

g/l

0.74

340

Other and unspecified iridocyclitis

391

1.88

5.82

3.1

2.3

0.15

0.01

g/l

0.75

362

Disorders of psychological development

517

1.71

5.77

2.2

1.9

0.01

g/l

0.15

482

Sulfonylureas

609

3945

1.24

5.76

1.8

2.4

0.01

0.04

g/l

2.51

537

3549

Acute gastritis

119

746

1.62

5.74

1.9

2.5

0.03

0.02

g/l

0.25

108

689

Other Crohn's disease

487

1.77

5.73

1.3

2.2

0.01

0.02

g/l

0.18

456

Use of antiglaucoma preparations and miotics

143

938

1.55

5.69

2.4

0.05

g/l

0.08

122

840

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

137

2072

0.66

5.68

2.0

1.5

0.06

0.02

g/l

0.69

120

1871

Ectropion of eyelid

446

1.81

5.67

1.5

2.3

0.03

g/l

0.05

394

Viral agents as the cause of diseases classified to other chapters

164

2.38

5.66

2.6

2.0

0.01

0.03

g/l

0.31

154

Bicipital tendinitis

417

1.83

5.63

2.3

2.2

0.00

0.02

g/l

1.32

389

Nontoxic goitre/thyroid nodule

437

3446

1.28

5.63

2.2

2.3

0.04

0.03

g/l

0.25

397

3117

Hyperaldosteronism

256

2.09

5.63

2.3

2.8

0.00

g/l

0.50

238

Otitis externa

298

2234

1.34

5.59

2.0

2.1

0.00

0.03

g/l

2.33

273

2052

Other skin changes

280

2082

1.36

5.58

2.9

2.3

0.03

0.04

g/l

0.12

253

1893

Later onset COPD

514

3286

1.26

5.57

1.6

2.4

0.03

0.05

g/l

0.85

463

2939

Generalized skin eruption due to drugs and medicaments

347

1.91

5.57

3.3

2.7

0.00

0.03

g/l

0.86

320

Pediculosis, acariasis and other infestations

183

1265

1.46

5.56

1.5

2.2

0.01

0.02

g/l

0.59

173

1185

Blepharochalasis

458

3639

1.27

5.56

1.9

2.3

0.02

0.04

g/l

0.64

415

3289

Atypical facial pain

456

1.78

5.54

2.1

2.5

0.09

0.01

g/l

0.50

422

Periapical abscess

613

5028

1.23

5.52

1.8

2.3

0.01

0.03

g/l

0.84

557

4617

Viral warts

253

1855

1.37

5.49

2.3

2.2

0.13

0.02

g/l

0.46

232

1720

Palmar fascial fibromatosis [Dupuytren]

240

1747

1.39

5.48

2.5

2.2

0.05

0.04

g/l

0.11

216

1573

severe traumatic brain injury, does not include concussion

351

2702

1.31

5.48

2.3

2.2

0.01

0.05

g/l

3.77

310

2435

Hypothyroidism, strict autoimmune, 3 medication purchases required

1216

7117

1.16

5.45

1.9

2.3

0.02

0.03

g/l

0.50

1114

6468

Crohn disease

159

1075

1.49

5.44

1.5

2.2

0.01

0.02

g/l

0.19

146

996

Ulcerative colitis, NAS

178

1232

1.46

5.40

2.2

0.03

0.02

g/l

0.22

166

1142

Contact with and exposure to communicable diseases

283

2105

1.34

5.40

2.1

2.0

0.02

0.01

g/l

0.38

266

1963

Ankylosing spondylitis, strict definition

287

1.98

5.39

1.5

2.5

0.00

0.02

g/l

0.50

276

Congenital malformations of cardiac septa

444

1.77

5.38

1.4

2.3

0.00

0.01

g/l

0.50

415

Entropion and trichiasis of eyelid

151

1015

1.51

5.38

2.3

2.4

0.03

0.06

g/l

0.41

135

916

Chronic hepatitis, not elsewhere classified

288

1.99

5.37

1.6

2.8

0.00

0.02

g/l

0.50

270

Hyperkinetic disorders, excluding more controls

327

1.88

5.36

1.3

1.6

0.00

0.01

g/l

0.50

312

Other diseases of oesophagus

149

999

1.51

5.35

2.0

2.4

0.03

0.06

g/l

0.50

138

916

Hepatocellular carcinoma, including Hilmo

269

2.02

5.30

2.7

1.4

0.12

0.02

g/l

0.56

245

Malignant melanoma of skin

166

1140

1.47

5.29

2.2

1.4

0.01

0.03

g/l

1.11

143

1031

Other and unspecified rosacea

126

817

1.56

5.29

1.9

2.4

0.00

0.02

g/l

1.54

118

761

Other hearing loss

487

3837

1.25

5.27

2.4

2.2

0.02

0.04

g/l

0.98

433

3459

Ulcerative enterocolitis

222

2.11

5.24

1.9

2.4

0.00

0.02

g/l

0.50

205

Disorders of optic nerve, not elsewhere classified

203

2.19

5.24

2.5

3.2

0.00

0.03

g/l

0.50

187

Cholecystectomy

1072

7996

1.16

5.16

2.3

0.02

0.03

g/l

0.20

978

7266

Coeliac disease

160

1097

1.47

5.14

2.6

2.1

0.05

0.02

g/l

0.27

144

1014

Ventral hernia

355

2763

1.29

5.13

2.7

2.2

0.01

0.04

g/l

1.93

328

2511

Nail disorders

111

706

1.59

5.08

1.6

2.3

0.01

0.02

g/l

0.09

100

658

Bell's palsy

164

1133

1.46

5.07

2.3

2.1

0.05

0.03

g/l

0.32

148

1039

Other and unspecified vascular occlusions

161

1110

1.47

5.07

2.3

2.4

0.07

0.04

g/l

0.22

152

1005

Adenomyosis (Endometriosis of uterus)

191

1358

1.42

5.05

2.4

2.1

0.02

0.03

g/l

0.09

181

1217

Assault

133

882

1.52

5.01

1.7

2.1

0.00

0.02

g/l

1.43

120

838

N06DA Anticholinesterases

413

4078

0.79

5.00

2.0

2.3

0.02

0.05

g/l

0.87

352

3641

Use of anticholinesterases

413

4078

0.79

5.00

2.0

2.3

0.02

0.05

g/l

0.87

352

3641

Event of undetermined intent

478

1.72

4.98

1.9

2.4

0.00

0.02

g/l

0.86

448

Injuries to the wrist and hand

1432

8754

1.14

4.98

2.0

2.3

0.01

0.03

g/l

2.05

1318

7998

Extreme obesity with alveolar hypoventilation

369

1.82

4.93

1.7

2.6

0.00

0.03

g/l

1.09

339

Liver disorders in diseases classified elsewhere

6.29

4.92

2.2

1.2

0.00

g/l

-0.00

Benign paroxysmal vertigo

434

3481

1.25

4.91

2.1

2.3

0.01

0.04

g/l

1.21

388

3160

Scleritis and episcleritis

511

1.69

4.90

1.7

2.1

0.01

g/l

0.11

482

Inflammatory disease of uterus

151

1034

1.47

4.88

1.8

2.1

0.08

0.02

g/l

0.44

138

954

Obsessive-compulsive disorder

290

1.91

4.87

1.9

2.1

0.00

0.02

g/l

0.63

277

Benign neoplasm of major salivary glands

151

1037

1.47

4.86

2.0

2.3

0.11

0.02

g/l

0.37

139

952

Disorders of ocular muscles, binocular movement, accommodation and refraction

578

4736

1.21

4.85

2.2

0.02

0.03

g/l

0.46

534

4318

Cardiac murmurs and other cardiac sounds

105

659

1.59

4.83

2.0

2.2

0.01

g/l

0.10

608

Other and unspecified disorders of vitreous body

640

5274

1.20

4.83

2.1

2.4

0.01

0.03

g/l

1.54

577

4810

Drug-induced Cushing's syndrome

9.83

4.81

2.4

1.0

0.00

g/l

—

Thyrotoxicosis with diffuse goitre

177

1254

1.42

4.79

2.0

2.3

0.00

0.02

g/l

0.56

167

1160

Benign neoplasm: Duodenum

266

1.97

4.77

3.3

2.8

0.02

0.03

g/l

0.06

247

Alcohol abuse, main dg

200

1448

1.39

4.77

1.2

2.2

0.01

0.02

g/l

0.55

178

1352

Tinnitus

346

2712

1.28

4.77

2.3

0.01

0.03

g/l

1.63

317

2480

Postmenopausal bleeding

412

1741

1.27

4.75

2.2

0.02

0.03

g/l

0.05

365

1564

Selective deficiency of immunoglobulin A [IgA]y

5.34

4.75

2.4

4.5

0.00

g/l

-0.00

Triptan medication for migraine, min. 3 purchases

597

3774

1.21

4.74

2.2

2.0

0.01

g/l

0.32

554

3490

Spontaneous abortion

339

2918

0.78

4.74

2.0

2.3

0.01

0.02

g/l

0.61

310

2667

Superficial injury of shoulder and upper arm

150

1034

1.46

4.72

2.2

0.02

g/l

0.12

135

963

IBD patients in KELA-register

271

2060

1.32

4.69

2.3

2.1

0.04

0.02

g/l

0.32

252

1911

Other specified and unspecified retinal disorders

339

1.84

4.68

2.9

2.7

0.02

g/l

0.00

313

Artificial joint operation, meniscal resection

1426

8204

1.13

4.65

2.1

2.3

0.02

0.03

g/l

0.29

1307

7480

Open wound of hip and thigh

240

1.99

4.63

1.3

2.8

0.00

0.02

g/l

0.50

223

Presence of other devices

241

3176

0.75

4.63

2.6

2.3

0.03

0.04

g/l

0.29

224

2860

Benign neoplasm: salivary glands, exclude unknown (D119)

135

918

1.49

4.60

2.0

2.3

0.13

0.02

g/l

0.38

124

851

Acute myeloid leukaemia, including Hilmo

2.82

4.60

1.4

1.2

0.00

0.07

g/l

0.49

Acute myeloid leukaemia

2.82

4.60

1.4

1.2

0.00

0.07

g/l

0.49

Acute myeloid leukaemia, helper endpoint

2.82

4.60

1.4

1.2

0.00

0.07

g/l

0.49

Viral conjunctivitis

141

2.32

4.60

2.3

1.7

0.00

0.04

g/l

0.50

133

Benign neoplasm: Parotid gland

122

813

1.52

4.59

2.0

2.4

0.14

0.03

g/l

0.38

112

754

Haemophagocytic lymphohistiocytosis

8.89

4.58

3.2

1.0

0.10

0.00

g/l

—

Acute laryngitis and tracheitis

103

649

1.57

4.56

1.6

1.8

0.00

0.01

g/l

0.65

608

Misadventures to patients during surgical and medical care

203

1487

1.38

4.55

1.9

2.1

0.01

0.04

g/l

1.49

186

1353

Psychotic depression

461

1.69

4.52

1.6

2.5

0.01

g/l

0.02

424

Benign neoplasm: Pituitary gland, craniopharyngeal duct

439

1.71

4.52

2.9

2.5

0.00

0.02

g/l

0.95

406

Diseases of tongue

554

1.63

4.51

2.5

2.1

0.00

0.02

g/l

0.65

499

Parapsoriasis

162

2.22

4.50

1.8

2.8

0.00

g/l

-0.00

153

Focal brain injury

523

1.64

4.50

1.7

2.1

0.00

0.10

g/l

1.68

481

Dissection of aorta

308

1.86

4.46

1.7

2.8

0.00

0.04

g/l

1.36

285

Other noninflammatory disorders of vulva and perineum

115

761

1.53

4.45

1.4

1.9

0.00

0.03

g/l

0.80

101

685

All dysplastic lesions of the cervix uteri, vagina or vulva

272

2053

1.31

4.44

1.9

0.00

0.01

g/l

1.70

250

1892

Urethral stricture

588

1.61

4.44

2.3

2.6

0.00

0.06

g/l

1.60

530

Benign neoplasm: Small intestine

435

1.71

4.43

2.8

2.6

0.02

g/l

0.10

403

Atopic conjunctivitis

287

1.87

4.40

1.5

1.8

0.00

0.02

g/l

0.50

269

Viral conjunctivitis

259

1.92

4.39

2.0

2.2

0.00

0.02

g/l

0.50

243

Benign neoplasm: Descending colon

118

790

1.52

4.38

2.1

2.4

0.02

g/l

0.10

103

735

Allergic bronchopulmonary aspergillosis (ABPA)

5.84

4.38

2.8

2.6

0.09

0.00

g/l

0.47

Cholecystitis

217

1622

1.35

4.29

2.2

2.3

0.04

0.06

g/l

0.27

194

1458

Hordeolum and other deep inflammation of eyelid

484

1.65

4.29

2.5

0.00

0.01

g/l

1.23

457

Duodenal ulcer

171

1232

1.40

4.27

1.9

2.4

0.01

0.05

g/l

1.15

158

1118

Viral infections of the central nervous system

602

1.58

4.25

2.4

2.3

0.00

0.01

g/l

0.74

556

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

382

3075

1.25

4.24

2.5

2.2

0.02

0.03

g/l

0.44

351

2828

Other and unspecified nonorganic psychotic disorders

203

1504

1.36

4.23

1.5

2.2

0.00

0.02

g/l

1.89

182

1405

Vascular dementia (subcortical)

366

1.76

4.21

2.3

2.2

0.22

0.10

g/l

0.31

326

Diphtheria

9.08

4.21

3.9

4.0

0.00

g/l

—

Aortic valve malfunction, age under 60 years

120

812

1.49

4.21

1.8

2.2

0.02

g/l

0.15

110

761

Specific development disorders of speech and language

294

1.82

4.19

2.0

2.3

0.01

0.02

g/l

0.15

272

Diabetic retinopathy, strict definition

254

1718

1.32

4.19

1.6

2.0

0.00

0.02

g/l

2.47

234

1543

Aortic arch syndrome [Takayasu]

8.85

4.18

1.8

1.1

0.00

g/l

—

Ovarian cyst

427

1992

1.24

4.18

1.8

2.0

0.02

g/l

0.03

397

1806

Postprocedural disorders of nervous system

449

1.66

4.16

2.1

2.0

0.02

0.01

g/l

0.06

426

Glucosamine medication

791

5434

1.17

4.15

2.4

2.3

0.05

0.03

g/l

0.28

720

4903

Hereditary hypogammaglobulinemia

4.53

4.14

2.1

1.1

0.00

g/l

-0.00

Other disorders of penis

130

897

1.46

4.13

1.7

2.4

0.00

0.04

g/l

2.65

122

813

Viral infections of the central nervous system

646

1.55

4.13

2.3

0.00

0.02

g/l

0.99

595

Clear cell adenocarcinoma of kidney

436

1.68

4.13

1.5

1.4

0.00

0.01

g/l

0.59

402

Organic, including symptomatic, mental disorders

856

5274

1.16

4.11

2.1

2.4

0.04

g/l

0.14

740

4795

Viral and other specified intestinal infections

191

1377

1.36

4.05

1.5

1.9

0.06

0.03

g/l

0.21

178

1275

Left ventricular outflow tract obstruction (LVOTO), broad definition

125

860

1.47

4.04

1.7

2.3

0.02

g/l

0.15

115

805

Other disorders of pigmentation

408

1.69

4.04

2.4

2.3

0.03

0.02

g/l

0.07

379

Other keratitis

140

984

1.43

4.04

2.2

2.1

0.01

0.02

g/l

0.77

131

914

Astigmatism

446

1.65

4.00

2.3

2.4

0.02

g/l

0.08

410

Premature rupture of membranes

961

0.64

3.99

2.0

1.8

0.01

g/l

0.15

900

Diphtheria

8.09

3.98

3.9

3.7

0.00

g/l

—

Other obstructive and reflux uropathy

297

1.81

3.98

1.5

2.2

0.00

g/l

-0.00

279

Special screening examination for other diseases and disorders

126

870

1.46

3.98

2.9

2.3

0.01

0.02

g/l

0.40

119

799

Thyroiditis

629

1.54

3.96

2.3

0.00

0.02

g/l

0.89

584

Injury of eye and orbit

168

1223

1.38

3.95

1.4

2.0

0.00

0.02

g/l

1.98

152

1138

Disorders of speech understanding and production

242

1.89

3.95

2.0

2.5

0.01

0.00

g/l

0.49

222

Use of memantine

323

3342

0.80

3.94

1.8

2.3

0.02

0.05

g/l

1.23

265

2977

Use of other anti-dementia drugs

323

3342

0.80

3.94

1.8

2.3

0.02

0.05

g/l

1.23

265

2977

Other neurotic disorders

426

1.67

3.94

1.5

2.7

0.00

0.02

g/l

0.62

390

Chondropathies

187

1387

1.36

3.92

1.9

2.1

0.06

0.02

g/l

0.62

169

1289

Gonarthrosis, primary, with knee surgery

930

6479

1.15

3.91

2.0

2.4

0.02

0.03

g/l

0.35

854

5868

Other arterial embolism and thrombosis

271

1.84

3.88

1.4

2.7

0.00

0.03

g/l

0.82

250

Other disorders of nervous system

101

673

1.52

3.87

2.3

0.00

0.02

g/l

1.09

620

Follow-up examination after treatment for malignant neoplasms

141

1001

1.42

3.87

2.5

2.2

0.14

0.03

g/l

0.39

130

903

Other, unspecified and serous retinal detachments

301

1.80

3.85

2.0

2.9

0.00

0.02

g/l

0.62

278

Disorders of refraction and accommodation

296

2333

1.27

3.84

2.1

0.02

g/l

0.09

269

2142

Other and unspecified tonsillitis

318

2129

1.26

3.81

1.6

1.9

0.02

0.01

g/l

0.22

303

1990

Diseases of the ear and mastoid process

1680

7622

1.11

3.79

2.2

0.02

0.03

g/l

0.48

1528

6989

Disorders of phosphorus metabolism and phosphatases

4.04

3.78

1.6

1.4

0.00

g/l

-0.00

Orchitis and epididymitis

128

900

1.44

3.72

1.6

2.3

0.03

0.04

g/l

0.24

116

814

Other deformities of toe(s)

297

1.78

3.71

1.8

2.0

0.00

0.03

g/l

0.50

264

Alzheimer’s disease (undefined)

0.00

3.70

0.0

2.2

—

0.01

—

Ingrowing nail

403

1.66

3.68

1.9

2.5

0.02

0.01

g/l

0.10

373

Inflammatory bowel disease, strict (require KELA)

271

2135

1.28

3.68

2.3

2.1

0.04

0.02

g/l

0.27

252

1983

Complications of labour and delivery

543

3577

0.84

3.67

2.4

2.1

0.01

0.02

g/l

0.64

508

3269

Senility

2.66

3.66

1.8

1.5

0.00

g/l

-0.00

Necrosis of pulp, including avohilmo

714

6158

1.16

3.65

1.9

2.2

0.02

g/l

0.03

656

5673

Maternal care for known or suspected fetal abnormality and damage

124

745

1.44

3.64

1.8

1.7

0.00

g/l

0.75

118

696

Postprocedural disorders of digestive system, not elsewhere classified

299

1.77

3.64

1.8

2.8

0.00

0.02

g/l

0.50

278

Pneumonia due to Streptococcus pneumoniae

321

1.74

3.63

5.9

1.8

0.05

0.01

g/l

0.39

289

Medical abortion

788

3702

1.16

3.63

1.8

2.3

0.02

g/l

0.09

717

3351

Dislocation, sprain and strain of joints and ligaments at neck level

160

1174

1.37

3.62

2.4

2.2

0.02

0.01

g/l

0.06

148

1098

Other salmonella infections

307

1.75

3.61

2.7

2.1

0.00

0.02

g/l

0.50

281

Injury of other and unspecified intrathoracic organs

611

1.52

3.61

1.6

2.3

0.02

0.03

g/l

0.11

565

Presence of other functional implants

931

5678

1.14

3.60

2.4

2.3

0.06

0.03

g/l

0.71

840

5158

Nasal polyp

270

2135

1.27

3.58

2.8

2.3

0.08

0.03

g/l

0.74

249

1940

Sequelae of injuries of neck and trunk

242

1.85

3.56

3.6

2.9

0.00

0.02

g/l

0.50

228

Type 1 diabetes, definitions combined

538

1.55

3.55

2.1

2.0

0.00

0.02

g/l

1.04

511

Disorders of tooth development and eruption

169

1011

1.36

3.55

1.9

2.0

0.00

0.02

g/l

1.49

151

929

Malignant neoplasm, without specification of site, including Hilmo

454

1.61

3.55

2.7

1.4

0.00

0.04

g/l

0.69

410

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

258

2005

1.28

3.54

2.0

0.01

g/l

0.38

238

1848

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

326

2636

1.24

3.54

1.6

2.1

0.00

0.02

g/l

3.71

305

2431

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

183

1377

1.34

3.52

2.6

2.2

0.02

g/l

0.08

171

1284

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

486

1.58

3.51

1.7

2.3

0.00

0.01

g/l

0.78

448

Visual field defects

124

879

1.43

3.49

2.0

2.1

0.03

0.02

g/l

0.15

113

806

Atrial septal defect

249

1.82

3.49

1.5

2.1

0.00

0.02

g/l

0.50

234

Atrophic disorders of skin

188

1426

1.33

3.45

1.8

2.2

0.01

0.04

g/l

1.09

180

1299

Hepatocellular carcinoma

195

1.94

3.44

2.1

1.4

0.18

0.00

g/l

0.76

175

Tonsillectomy and adenotomy

401

3367

0.83

3.44

1.8

2.0

0.03

0.01

g/l

0.42

373

3133

Ulcerative colitis (strict definition, all Crohn cases excluded)

164

1221

1.35

3.41

2.9

2.2

0.02

g/l

0.07

153

1138

Abdominal aortic aneurysm (AAA)

158

1162

1.36

3.39

1.9

2.3

0.02

0.08

g/l

1.82

137

1035

Malignant neoplasm of thymus

4.21

3.38

3.9

1.1

0.07

0.00

g/l

0.47

Type 1 diabetes, strict (exclude DM2)

537

1.53

3.37

2.1

2.0

0.00

0.02

g/l

1.04

510

Ganglion

232

1815

1.28

3.37

2.1

0.02

g/l

0.06

207

1654

Migraine, single triptan purchase ok & required. ICD-code if available is included

916

5473

1.14

3.36

2.1

2.2

0.01

0.02

g/l

0.34

851

5036

Triptan medication for migraine, single purchase ok

916

5473

1.14

3.36

2.1

2.2

0.01

0.02

g/l

0.34

851

5036

Other salmonella infections

352

1.67

3.35

2.6

2.3

0.00

0.02

g/l

0.62

326

Single spontaneous delivery

397

2537

0.83

3.34

2.2

2.1

0.02

g/l

0.15

371

2300

Ventricular septal defect, a heart condition

108

2.25

3.32

1.3

1.7

0.00

0.05

g/l

0.50

103

Atlantoaxial subluxation

2.89

3.32

1.3

1.9

0.00

g/l

-0.00

Disorders of breast

587

4575

1.17

3.31

2.0

2.2

0.01

0.02

g/l

0.30

532

4159

Open wound of abdomen, lower back and pelvis

212

1.87

3.29

1.6

2.2

0.00

0.02

g/l

0.50

199

Ulcerative colitis (strict definition, require KELA)

187

1428

1.32

3.28

2.6

2.2

0.02

g/l

0.05

175

1334

Congenital malformations of heart and great arteries

139

985

1.38

3.25

1.9

2.2

0.00

0.02

g/l

1.67

120

927

Other disorders of cornea

133

968

1.39

3.24

1.8

2.1

0.03

0.02

g/l

0.10

124

895

Undefined dementia

100

1313

0.70

3.21

1.6

2.3

0.05

0.07

g/l

0.24

1146

Salpingitis and oophoritis

214

1672

1.29

3.18

1.6

2.4

0.00

0.02

g/l

1.92

198

1531

Septal defects

418

1.58

3.17

1.4

2.4

0.00

0.01

g/l

0.50

392

Diseases of appendix

986

7931

1.12

3.14

2.5

2.2

0.04

0.03

g/l

0.12

908

7266

Mental and behavioural disorders due to cannabinoids

111

2.18

3.14

1.8

1.5

0.00

g/l

-0.00

106

Recurrent dislocation and subluxation of joint

405

1.59

3.13

1.8

2.3

0.00

g/l

0.50

378

Lichen ruber planus, wide definition including periferal and oral lichen planus

302

2462

1.23

3.12

2.2

2.3

0.02

g/l

0.15

283

2243

Lumbosacral root disorders, not elsewhere classified

2.29

3.11

2.8

2.2

0.00

g/l

-0.00

Other condition

174

1327

1.32

3.11

2.1

0.00

0.02

g/l

1.82

162

1230

Post-traumatic wound infection, not elsewhere classified

210

1.84

3.08

1.8

2.9

0.00

0.02

g/l

0.50

197

Delivery

403

2540

0.83

3.07

2.1

0.02

g/l

0.16

377

2303

Hyperfunction of pituitary gland

322

1.66

3.07

3.0

2.0

0.00

g/l

0.50

306

Malignant neoplasm of bronchus and lung, including Hilmo

317

2173

1.23

3.07

2.2

1.5

0.11

0.02

g/l

0.49

284

1959

Secondary polycythaemia

196

1.87

3.06

3.0

0.02

0.03

g/l

0.09

181

Focal epilepsy, strict definition

259

2082

1.25

3.04

1.9

2.2

0.03

0.04

g/l

0.19

224

1906

Schizophrenia or delusion, excluding more controls

323

2633

1.22

3.00

1.9

2.3

0.01

0.03

g/l

1.29

282

2437

Otitis externa, unspecified

129

947

1.37

2.99

1.8

2.2

0.01

0.02

g/l

0.97

119

878

Acute suppurative otitis media

217

1595

1.27

2.99

2.9

1.9

0.02

0.01

g/l

0.17

200

1490

Arterial embolism and thrombosis of lower extremity artery

364

1.62

2.98

1.6

2.7

0.06

0.03

g/l

0.21

333

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

202

1581

1.28

2.98

2.6

2.1

0.05

0.02

g/l

0.35

190

1470

Acute appendicitis

903

7526

1.12

2.96

2.5

2.2

0.04

0.03

g/l

0.16

833

6902

Achilles tendinitis

126

924

1.37

2.95

2.9

2.1

0.02

g/l

0.09

119

854

Subacute thyroiditis

311

1.66

2.94

3.1

2.2

0.00

g/l

0.50

289

Malignant neoplasm of bladder, including Hilmo

172

1313

1.31

2.94

2.3

1.4

0.08

0.03

g/l

0.47

156

1175

Postinflammatory hyperpigmentation

7.29

2.94

2.3

4.2

0.00

g/l

—

Ulcer of oesophagus

103

732

1.42

2.93

2.0

2.6

0.02

0.05

g/l

0.41

673

Nontoxic multinodular goitre

274

2228

1.24

2.93

1.8

2.3

0.05

0.03

g/l

0.41

245

2017

Early complications of trauma

374

1.60

2.92

2.5

2.6

0.00

0.02

g/l

0.62

351

!Aliquae complicationes praecoces traumatis

374

1.60

2.92

2.5

2.6

0.00

0.02

g/l

0.62

351

Diabetic maculopathy

177

1288

1.31

2.90

1.3

2.0

0.00

0.02

g/l

2.31

165

1158

Myocardial infarction, with ST-elevation

271

2204

1.24

2.90

2.0

2.2

0.02

0.06

g/l

1.61

246

1978

Unspecified dementia

1235

0.71

2.90

1.6

2.4

0.03

0.06

g/l

0.50

1106

Lichen simplex chronicus

282

1.69

2.89

2.5

2.9

0.04

0.03

g/l

0.08

261

Delivery, wide proxy

332

2129

0.82

2.88

2.1

0.02

0.03

g/l

0.09

307

1903

Chronic laryngitis and laryngotracheitis

186

1449

1.29

2.88

1.7

2.1

0.04

0.02

g/l

0.29

166

1315

Prepatellar bursitis

368

1.59

2.86

2.4

2.1

0.00

0.03

g/l

1.52

336

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

0.00

g/l

—

Postpartum haemorrhage

124

1409

0.74

2.86

1.9

0.04

0.01

g/l

0.62

114

1307

Other epidermal thickening

392

1.58

2.85

2.2

2.7

0.00

0.03

g/l

1.26

362

Type 1 diabetes, strict definition

335

1.62

2.85

1.3

1.4

0.00

0.01

g/l

0.78

322

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

121

786

1.37

2.85

1.3

1.6

0.00

0.01

g/l

0.83

110

744

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.47

2.85

1.5

0.00

g/l

-0.00

Degenerative macular diseases

187

1462

1.29

2.83

2.3

0.07

0.03

g/l

0.29

169

1325

Mucinosis of skin

9.34

2.83

3.6

1.0

0.00

g/l

—

Appendectomy

809

6877

1.13

2.81

2.2

0.03

g/l

0.04

749

6322

Alzheimer’s disease (undefined), excluding more controls

0.00

2.81

0.0

1.7

—

0.30

—

Complications of other internal prosthetic devices, implants and grafts

394

1.57

2.80

2.4

2.3

0.04

0.03

g/l

0.13

360

Appendicitis, broad definition

969

7874

1.12

2.79

2.5

2.2

0.04

0.03

g/l

0.12

892

7212

Injury of muscle and tendon at lower leg level

195

1537

1.28

2.76

2.9

2.2

0.02

0.03

g/l

0.48

186

1432

All dysplastic lesions of the cervix uteri

217

1717

1.26

2.74

1.9

2.0

0.00

0.01

g/l

1.44

200

1580

Benign neoplasm: Spinal meninges

105

2.16

2.74

1.3

2.0

0.00

0.05

g/l

0.50

Vascular dementia

148

1086

1.32

2.74

2.0

2.2

0.18

0.06

g/l

0.54

118

972

Behçet disease

4.45

2.73

2.1

4.1

0.00

g/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

161

1240

1.30

2.72

1.7

2.1

0.01

0.02

g/l

0.39

153

1138

Corneal ulcer

221

1771

1.25

2.72

2.3

2.1

0.03

g/l

0.08

203

1638

Wet age-related macular degeneration

290

2323

1.22

2.70

2.6

2.2

0.21

0.03

g/l

0.87

262

2061

Use of disulfiram, acamprosate or naltrexone

101

727

1.40

2.69

1.4

2.2

0.00

0.02

g/l

1.27

683

Excessive attrition of teeth

675

5961

1.14

2.67

2.2

0.03

0.02

g/l

0.18

613

5485

Impingement syndrome of shoulder

302

2507

1.21

2.66

2.7

2.3

0.00

0.02

g/l

1.81

272

2289

Other specified/unspecified dorsopathies

289

1.65

2.66

4.8

2.2

0.01

0.00

g/l

0.25

265

Drug-induced thyroiditis

4.97

2.65

1.3

1.4

0.00

g/l

—

Impacted cerumen

146

1117

1.32

2.63

2.1

2.4

0.02

0.04

g/l

0.59

123

1019

Abnormal findings in secretions and smears from cervix uteri vagina vulva

500

3264

1.16

2.63

2.1

0.03

0.02

g/l

0.12

450

2990

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

655

1.42

2.63

2.1

1.4

0.07

0.04

g/l

0.23

590

Autonomic disorders

192

1.80

2.62

2.3

0.00

0.03

g/l

0.50

178

Crohn's disease of large intestine

385

1.55

2.60

1.4

2.4

0.01

0.02

g/l

0.06

359

Acute appendicitis, no complications

671

5908

1.13

2.59

2.5

2.2

0.05

0.02

g/l

0.23

620

5439

Lichen planus, including avohilmo

254

2081

1.23

2.58

2.3

2.2

0.02

g/l

0.02

239

1896

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

715

1.40

2.58

2.3

2.4

0.00

0.06

g/l

1.38

652

Gluteal tendinitis

323

1.60

2.57

1.9

2.2

0.00

g/l

-0.00

296

Allergic contact dermatitis

144

1103

1.31

2.56

1.4

2.3

0.01

0.02

g/l

0.20

134

1020

Sequelae of injuries of head

427

1.51

2.56

3.1

2.6

0.00

0.02

g/l

0.85

395

Other benign neoplasms of skin

518

4512

1.15

2.56

3.2

2.3

0.04

0.03

g/l

0.03

470

4089

Hydrocele

165

1290

1.29

2.53

2.5

0.03

0.04

g/l

0.10

156

1162

Lesion of medial popliteal nerve

3.62

2.53

1.6

1.3

0.00

g/l

—

Unspecified/other endometriosis

584

1.43

2.52

2.0

1.8

0.00

g/l

0.54

530

Irregular menses

480

3280

1.16

2.51

2.0

2.1

0.01

0.02

g/l

0.38

443

3010

Cholangitis (primary sclerosing, PSC)

586

1.43

2.50

1.8

2.4

0.05

0.03

g/l

0.30

534

Pain associated with micturition

147

1135

1.30

2.49

2.9

2.3

0.10

0.03

g/l

0.49

134

1034

Visual impairment including blindness (binocular or monocular)

680

1.40

2.47

2.5

2.1

0.00

0.04

g/l

1.57

617

Other and unspecified disorders of adult personality and behaviour

3.22

2.47

1.4

1.1

0.00

g/l

—

Non-small cell lung cancer, including Hilmo

219

1672

1.24

2.46

2.2

1.4

0.15

0.02

g/l

0.48

197

1496

Nocardiosis

7.05

2.45

2.6

1.5

0.00

g/l

—

Drug-induced hypoglycaemia without coma

138

1.92

2.44

1.1

2.6

0.00

g/l

-0.00

127

malignant neoplasm of male genital organs

412

2148

1.17

2.43

2.2

1.5

0.06

0.02

g/l

0.88

378

1955

Secondary parkinsonism, excluding more controls

182

1.78

2.42

2.8

1.6

0.05

0.09

g/l

0.22

165

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

466

1.48

2.41

1.7

1.5

0.09

0.03

g/l

0.38

421

Malignant neoplasm of prostate, including Hilmo

420

2142

1.17

2.40

2.2

1.5

0.06

0.02

g/l

0.81

387

1948

Contusion of other and unspecified parts of foot

305

1.59

2.39

2.3

0.04

0.02

g/l

0.23

289

Combinations of oral blood glucose lowering drugs

407

3504

1.17

2.39

1.6

2.5

0.01

0.04

g/l

2.03

371

3214

Retrobulbar neuritis in diseases classified elsewhere

4.28

2.39

5.4

1.1

0.09

0.00

g/l

—

Tracheo-bronchomalasia

4.23

2.38

1.7

3.5

0.00

g/l

—

Parkinson's disease, including avohilmo

244

2012

1.22

2.37

2.0

2.2

0.03

0.05

g/l

0.21

216

1807

Benign neoplasm: Skin of eyelid, including canthus

219

1787

1.23

2.35

3.2

2.2

0.08

0.03

g/l

0.32

198

1628

Coxarthrosis, primary, with hip surgery

738

6187

1.12

2.35

2.2

2.4

0.04

0.03

g/l

0.04

675

5593

Glaucoma-related operations

645

1.40

2.35

2.8

2.5

0.03

0.04

g/l

0.03

590

Crohn's disease of small intestine

518

1.44

2.35

1.7

2.3

0.01

0.02

g/l

0.25

485

Sensorineural hearing loss

992

7405

0.91

2.34

2.4

2.3

0.03

g/l

0.10

897

6757

Burns and corrosions

152

1190

1.28

2.33

2.0

2.1

0.06

0.02

g/l

0.32

142

1114

Trigeminal neuralgia

536

1.43

2.33

2.5

2.3

0.08

0.00

g/l

0.57

498

Polypectomy (DHB20)

654

1.39

2.32

2.4

2.3

0.04

0.02

g/l

0.32

606

Mouth breathing

516

4523

1.14

2.32

2.5

2.3

0.03

0.02

g/l

0.18

472

4172

Endocrine disorders, other/unspecified

154

0.32

2.30

1.8

2.1

0.00

g/l

—

146

Deep endometriosis

838

0.68

2.30

1.3

2.1

0.00

0.02

g/l

1.03

772

Varicose veins

895

6117

1.11

2.28

2.3

0.04

g/l

0.12

807

5539

Focal epilepsy

268

2236

1.20

2.28

1.9

2.2

0.03

0.04

g/l

0.17

232

2049

Malignant neoplasm, without specification of site

286

1.59

2.27

2.4

1.5

0.00

0.02

g/l

0.67

255

Malignant neoplasm of liver and intrahepatic bile ducts

271

1.61

2.26

1.7

1.4

0.06

0.01

g/l

0.44

244

Benign neoplasm of breast

152

1197

1.28

2.25

2.2

2.1

0.01

0.03

g/l

0.76

138

1087

Malignant neoplasm of respiratory system and intrathoracic organs

298

2091

1.19

2.23

2.2

1.5

0.15

0.02

g/l

0.69

265

1882

Other disorders of the genitourinary system

179

1439

1.25

2.23

2.3

0.05

0.03

g/l

0.13

169

1304

Burns and corrosions of external body surface, specified by site

119

908

1.32

2.23

2.1

2.2

0.08

0.02

g/l

0.36

109

851

Acute alcohol intoxication, ICD10

239

1979

1.21

2.23

1.3

2.3

0.01

0.02

g/l

0.79

217

1835

therapeutic use

312

1.56

2.22

1.8

2.4

0.00

0.03

g/l

0.74

285

Redundant prepuce, phimosis and paraphimosis

237

1943

1.21

2.20

2.0

2.4

0.06

0.03

g/l

0.26

225

1773

Degeneration of the brain due to alcohol

211

1.69

2.20

1.3

3.0

0.00

0.02

g/l

0.74

196

Focal epilepsy, mode (most common among epilepsy diagnosis)

234

1937

1.21

2.19

2.0

2.2

0.04

g/l

0.08

202

1768

Graves disease, strict definition

110

833

1.33

2.18

2.3

2.1

0.01

g/l

0.19

104

776

Glaucoma suspect

412

4731

0.87

2.17

2.0

2.4

0.05

0.03

g/l

0.22

367

4289

Pyogenic granuloma

130

1.88

2.15

1.1

2.6

0.06

0.00

g/l

0.48

121

Retinal breaks without detachment

221

1825

1.22

2.15

2.4

2.3

0.01

0.03

g/l

1.87

198

1671

Degeneration of nervous system due to alcohol

213

1.67

2.13

1.3

3.0

0.00

0.02

g/l

0.74

196

Malignant neoplasm of breast, HER2-negative, including Hilmo

502

2856

1.14

2.12

2.1

1.4

0.01

g/l

0.38

448

2595

Malignant neoplasm of breast, including Hilmo

502

2856

1.14

2.12

2.1

1.4

0.01

g/l

0.38

448

2595

Pilonidal cyst

554

1.40

2.12

1.9

2.2

0.03

g/l

0.06

527

Strabismus

300

2542

1.18

2.12

2.2

2.1

0.01

0.03

g/l

2.20

278

2330

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

496

1.42

2.11

1.8

2.3

0.00

0.01

g/l

0.50

462

Seborrhoeic dermatitis

118

908

1.31

2.11

2.1

2.4

0.01

0.02

g/l

0.27

108

837

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

325

2748

1.17

2.10

2.7

1.5

0.06

0.02

g/l

0.44

289

2494

Retinal haemorrhage

261

1.60

2.09

5.1

2.8

0.00

0.05

g/l

0.79

240

Inguinal hernia, bilateral

152

1210

1.27

2.09

3.0

2.2

0.04

g/l

0.04

136

1104

Other blood glucose lowering drugs, excl. Insulins

239

1997

1.20

2.07

1.8

2.3

0.01

0.05

g/l

1.49

218

1805

Oesophageal obstruction

342

1.51

2.06

3.3

2.8

0.03

g/l

0.00

316

Other strabismus

225

1861

1.21

2.06

2.2

0.01

0.02

g/l

0.61

209

1725

Other acute skin changes due to ultraviolet radiation

326

1.52

2.06

1.9

2.4

0.00

0.02

g/l

0.50

299

Pneumonitis due to solids and liquids

114

877

1.31

2.06

1.4

2.1

0.00

0.03

g/l

1.62

794

Hypertrophy of tongue papillae

104

1.96

2.03

2.3

2.4

0.00

0.05

g/l

0.50

Parkinson's disease

230

1919

1.21

2.03

2.0

2.2

0.04

0.05

g/l

0.19

205

1729

Tongue abnormality

628

1.37

2.03

2.5

0.01

0.02

g/l

0.56

577

Endometriosis

388

1969

1.16

2.02

1.9

2.0

0.02

g/l

0.07

358

1782

HSIL lesion of the cervix uteri, vagina or vulva

167

1348

1.24

2.02

1.9

1.8

0.00

0.01

g/l

1.44

153

1236

Other and unspecified disorders of skin and subcutaneous tissue

612

0.65

2.01

1.7

2.5

0.00

0.03

g/l

1.42

565

Inguinal or femoral hernia, bilateral

154

1234

1.26

2.01

3.0

2.2

0.04

g/l

0.04

138

1124

Other and unspecified acute skin changes due to ultraviolet radiation

240

1.61

2.01

2.1

2.6

0.00

0.02

g/l

0.50

220

Viral warts

105

801

1.32

2.01

2.2

2.4

0.29

0.02

g/l

0.51

744

Supplementary factors related to causes of morbidity and mortality classified elsewhere

383

3332

1.15

2.01

1.9

2.2

0.01

0.03

g/l

1.82

337

3042

Primary coxarthrosis, bilateral

435

3820

1.14

2.01

2.2

2.3

0.03

0.04

g/l

0.19

399

3429

Other disorders of ear

1351

8203

1.08

2.00

2.2

0.02

0.03

g/l

0.56

1218

7499

Polyp of the female genital tract

380

1889

1.16

1.99

1.9

2.1

0.00

0.02

g/l

1.71

338

1703

Other facial nerve disorders

217

1.63

1.99

2.3

0.00

g/l

-0.00

196

Alport

4.90

1.99

1.4

3.5

0.00

g/l

—

Malignant neoplasm of prostate

403

2099

1.15

1.97

2.2

1.5

0.06

0.02

g/l

0.88

370

1908

Status epilepticus

305

1.52

1.97

1.5

2.8

0.07

0.04

g/l

0.19

277

Crohn disease (strict definition, require KELA)

445

1.43

1.96

1.8

2.2

0.01

g/l

0.04

419

Crohn disease (strict definition, require KELA, min 2 HDR)

437

1.43

1.95

1.8

2.1

0.01

g/l

0.04

412

Malignant neoplasm of ureter, including Hilmo

2.11

1.95

2.5

1.4

0.00

0.01

g/l

0.49

Other puerperal infections

354

1.48

1.95

1.3

1.6

0.02

0.01

g/l

0.13

339

Parkinson's disease, strict definition

215

1792

1.21

1.94

2.0

2.3

0.04

0.05

g/l

0.19

193

1614

HSIL lesion of the cervix uteri

146

1167

1.26

1.94

1.8

1.9

0.00

0.01

g/l

1.29

135

1072

Lichen planus

172

1402

1.23

1.94

2.5

2.3

0.03

0.02

g/l

0.43

160

1288

Other diseases of gallbladder

455

1.42

1.94

2.6

2.5

0.00

0.03

g/l

0.97

414

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

203

1.64

1.94

2.4

0.00

0.03

g/l

0.50

192

Malignant neoplasm of breast

491

2831

1.13

1.93

2.0

1.4

0.01

g/l

0.39

438

2570

Disturbance of activity and attention

420

1.43

1.93

1.2

1.5

0.00

g/l

0.50

399

Contact with heat and hot substances

405

1.44

1.92

1.6

2.5

0.00

0.01

g/l

0.50

381

Alzheimer’s disease (Atypical or mixed)

1255

0.76

1.92

1.4

2.3

0.01

0.07

g/l

1.60

1121

Malignant neoplasm of bladder

711

1.33

1.92

1.8

1.4

0.01

0.05

g/l

1.15

631

Suppurative and unspecified otitis media

338

2588

1.16

1.92

2.6

2.0

0.02

g/l

0.12

310

2389

Other bursitis of knee

1.99

1.92

2.2

2.7

0.07

0.00

g/l

0.48

LSIL lesion of the cervix uteri, vagina or vulva

126

992

1.28

1.91

2.1

2.0

0.00

0.01

g/l

0.93

115

918

Type 1 diabetes, strict definition, subgroup 1

306

1.51

1.90

1.3

1.4

0.00

0.01

g/l

0.78

294

Excessive, frequent and irregular menstruation

422

2023

1.15

1.89

1.9

2.0

0.04

0.02

g/l

0.26

382

1831

Any dementia, excluding more controls

576

3547

1.12

1.88

1.9

2.4

0.06

0.05

g/l

0.13

490

3209

Lung diseases due to external agents

197

1633

1.21

1.88

2.5

2.2

0.01

0.04

g/l

1.17

169

1478

Maternal care for other known or suspected fetal problems

103

847

0.77

1.88

1.6

1.8

0.03

0.00

g/l

0.43

793

Outcome of delivery

123

593

1.29

1.88

1.8

0.01

0.00

g/l

0.23

116

560

Malignant neoplasm of breast, ER-positive, including Hilmo

388

2615

1.15

1.87

2.0

1.4

0.01

g/l

0.35

344

2366

Mental and behavioural disorders due to tobacco

104

802

1.31

1.87

1.8

2.4

0.00

0.02

g/l

1.51

753

Other maternal disorders predominantly related to pregnancy

471

3334

0.88

1.87

2.1

2.2

0.02

0.01

g/l

0.18

431

3070

Maternal care related to the fetus and amniotic cavity and possible delivery problems

314

2139

0.86

1.86

2.6

1.9

0.01

g/l

0.16

297

1971

Flat foot [pes planus] (acquired)

102

785

1.31

1.86

1.6

2.7

0.00

0.05

g/l

1.17

711

Spontaneous rupture of synovium and tendon

100

768

1.31

1.85

2.1

2.0

0.00

0.01

g/l

0.57

701

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

484

1.39

1.85

1.7

2.3

0.01

0.02

g/l

0.09

451

Traction detachment of retina

2.17

1.85

1.1

2.4

0.00

g/l

-0.00

Malignant neoplasm of breast, HER2-negative

485

2814

1.13

1.83

2.0

1.4

0.01

g/l

0.40

431

2553

Macular cyst

311

1.50

1.83

2.3

2.9

0.22

0.06

g/l

0.37

289

Benign neoplasm of meninges

142

1143

1.25

1.82

1.9

2.3

0.00

0.02

g/l

1.46

128

1042

Hyperkinetic disorders

450

1.40

1.81

1.3

1.5

0.00

g/l

0.50

429

Acquired coagulation factor deficiency

3.58

1.79

2.7

1.0

0.00

g/l

—

Other and unspecified acne

2.19

1.79

1.3

1.8

0.00

g/l

-0.00

Schizophrenia

114

1442

0.79

1.78

2.6

2.1

0.01

0.02

g/l

0.08

1347

Myopia

113

887

1.28

1.78

2.1

2.3

0.01

0.02

g/l

0.11

107

826

Injury of nerves and spinal cord at neck level

201

1.62

1.76

3.2

3.1

0.00

0.03

g/l

0.50

187

Unspecific neurodegenerative disorder

580

4399

0.90

1.76

1.9

2.3

0.02

0.05

g/l

1.11

484

3980

Cytomegaloviral hepatitis

3.06

1.76

1.7

2.3

0.00

g/l

—

Other and unspecified mononeuropathies, also in other diseases

257

1.54

1.75

2.1

2.5

0.00

g/l

0.50

235

Dementia in other diseases classified elsewhere

499

1.38

1.74

1.7

2.5

0.00

0.06

g/l

1.05

451

Smoking dependency

104

811

1.29

1.74

1.8

2.4

0.00

0.02

g/l

1.51

762

Other diseases of biliary tract

120

953

1.27

1.74

2.4

0.00

0.04

g/l

1.33

105

864

Aortic stenosis

4.03

1.74

1.4

4.4

0.00

g/l

—

Non-small cell lung cancer, adenocarcinoma

655

1.32

1.73

1.9

1.5

0.04

g/l

0.07

592

Colorectal neuroendocrine tumor and carcinoma

1.91

1.73

3.8

1.4

0.00

0.05

g/l

0.49

Acute alcohol intoxication

323

2815

1.15

1.71

1.4

2.4

0.01

0.03

g/l

1.97

294

2583

Gonococcal infection

267

1.51

1.70

2.3

1.8

0.00

0.02

g/l

0.50

252

Hereditary lymphedema

3.34

1.70

1.0

1.2

0.00

g/l

—

Contact with machinery

1105

0.76

1.69

2.0

2.2

0.00

0.04

g/l

2.83

1021

Dronedarone medication

276

1.50

1.68

1.7

2.5

0.01

0.06

g/l

0.68

256

Postpartum hemorraghe, all women as controls

124

1518

0.80

1.68

1.9

1.8

0.04

0.01

g/l

0.65

114

1412

Unspecified jaundice

485

1.37

1.68

1.9

2.4

0.03

0.01

g/l

0.24

443

All dysplastic lesions of the vulva

360

1.43

1.65

1.3

2.2

0.00

0.02

g/l

0.63

338

Gonococcal infection

261

1.51

1.64

2.3

1.8

0.00

0.02

g/l

0.50

247

Type of accident

353

3108

1.14

1.63

1.9

2.2

0.01

0.04

g/l

1.62

309

2846

Other predominantly sexually transmitted diseases, not elsewhere classified

160

1322

1.21

1.62

1.8

2.0

0.00

0.01

g/l

0.65

147

1236

Contraceptive management

325

2602

0.87

1.61

2.2

2.0

0.02

0.01

g/l

0.15

300

2425

Alkalosis

3.13

1.61

2.0

2.7

0.00

g/l

—

Malignant neoplasm of colon, including Hilmo

246

2112

1.17

1.60

2.6

1.4

0.13

0.02

g/l

0.46

218

1897

Malignant neoplasm of breast, HER-positive

377

2596

1.14

1.60

2.1

1.4

0.01

g/l

0.36

333

2348

Other intracranial haemorrhages

304

1.46

1.60

1.8

2.4

0.00

0.05

g/l

1.35

277

Laparoscopic right hemicolectomy

655

1.31

1.60

2.3

2.5

0.35

0.03

g/l

0.44

606

Paralytic strabismus

716

1.29

1.60

2.1

2.4

0.00

0.02

g/l

1.79

662

483

3777

1.12

1.59

2.4

2.2

0.17

0.03

g/l

1.06

431

3375

Malignant neoplasm of pancreas

696

0.71

1.59

2.1

1.4

0.13

0.04

g/l

0.61

628

Disturbances of smell and taste

397

1.40

1.58

3.0

0.05

0.00

g/l

0.49

367

Bitten or struck by other mammals

112

894

1.26

1.58

2.3

2.4

0.02

g/l

0.20

105

837

Contact with blunt object, undetermined intent

2.33

1.57

1.5

3.1

0.00

g/l

—

Use of levodopa decarboxylase inhibitor

204

1732

1.18

1.56

2.2

2.3

0.08

0.05

g/l

0.27

182

1561

Pre-eclampsia or poor fetal growth

254

2184

1.16

1.56

2.1

2.0

0.00

0.01

g/l

1.84

237

2003

Other and unspecified myoneural disorders

2.51

1.56

1.6

1.4

0.00

g/l

—

Other changes in lacrimal passages

3.57

1.56

2.8

1.9

0.00

g/l

—

Congenital malformations of the respiratory system

122

1.74

1.56

2.8

2.2

0.00

0.04

g/l

0.50

114

Other symptoms and signs involving the digestive system and abdomen

194

1641

1.19

1.54

1.9

2.3

0.12

0.01

g/l

1.19

183

1491

Right hemicolectomy

641

1.31

1.54

2.9

2.4

0.02

g/l

0.09

588

Vascular dementia (sudden onset)

0.00

1.53

0.0

2.7

—

0.00

—

Single delivery by caesarean section

106

764

0.79

1.53

2.1

1.6

0.00

g/l

0.82

712

Unspecified mental disorder

456

4094

1.12

1.53

2.0

2.2

0.00

0.03

g/l

3.56

402

3756

Pre-eclampsia or eclampsia

200

1699

1.18

1.51

2.1

0.00

0.01

g/l

1.70

188

1549

Brain meningioma

452

1.36

1.51

2.5

1.4

0.00

0.01

g/l

0.50

412

Meningitis

409

1.38

1.51

2.4

0.02

0.01

g/l

0.16

382

Vascular dementia (mixed)

194

1.57

1.51

1.9

2.0

0.02

0.00

g/l

0.46

172

Macular hole

671

1.29

1.49

2.0

2.5

0.11

0.03

g/l

0.34

618

Other otitis externa (chronic)

592

1.31

1.48

2.4

0.01

0.02

g/l

0.14

545

Erectile dysfunction

117

949

1.24

1.47

2.2

2.3

0.01

0.05

g/l

1.99

110

857

Congenital malformations of genital organs

554

1.32

1.47

1.6

1.9

0.00

0.01

g/l

0.65

523

Noninflammatory disorders of female genital tract

452

2031

1.12

1.47

2.1

2.0

0.04

0.02

g/l

0.29

413

1839

Other disorders of skin and subcutaneous tissue related to radiation

3.31

1.47

1.2

1.1

0.00

g/l

—

Congenital stenosis of pulmonary valve

2.54

1.46

1.0

1.1

0.00

g/l

—

Corns and callosities

629

1.30

1.46

1.7

2.4

0.03

g/l

0.01

584

Reduction defects of upper limb

3.24

1.45

1.2

1.0

0.00

g/l

—

Status post-ami

391

2659

1.12

1.45

1.7

2.4

0.07

0.05

g/l

0.18

355

2400

Anankastic personality disorder

236

1.49

1.45

1.8

2.6

0.01

0.02

g/l

0.17

229

Benign neoplasm of middle ear and respiratory system

102

817

1.26

1.43

2.6

2.3

0.09

0.02

g/l

0.58

751

Acute nasopharyngitis (common cold)

120

971

1.23

1.43

1.8

1.9

0.02

0.01

g/l

0.17

111

905

Antepartum haemorrhage, not elsewhere classified

473

1.34

1.43

2.2

1.7

0.00

0.02

g/l

0.78

443

Malignant neoplasm of digestive organs

510

3648

1.11

1.43

2.2

1.5

0.08

0.01

g/l

0.59

454

3289

Other infiltrative disorders of skin and subcutaneous tissue

2.25

1.43

2.7

0.00

0.11

g/l

—

Congenital malformations of trachea and bronchus

1.89

1.42

3.5

2.1

0.00

g/l

-0.00

Peritonsillar abscess

208

1784

1.17

1.42

2.5

2.1

0.03

0.02

g/l

0.23

193

1638

Viral haemorrhagic fevers, not elsewhere classified/unspecified

749

0.74

1.41

2.5

2.3

0.00

0.02

g/l

1.79

699

Open wound of wrist and hand

525

4668

1.10

1.39

2.4

2.1

0.02

g/l

0.17

492

4296

Other predominantly sexually transmitted diseases, not elsewhere classified

138

1145

1.21

1.38

1.9

0.00

0.01

g/l

0.59

127

1069

Neuralgic amyotrophy

3.08

1.38

7.8

3.6

0.00

g/l

—

Cyclic neutropenia

3.08

1.38

1.4

3.7

0.00

g/l

—

Pedal cyclist injured in noncollision transport accidents

122

1001

1.22

1.38

1.8

2.2

0.02

g/l

0.03

113

936

Malignant neoplasm of bronchus and lung

252

1824

1.15

1.37

2.0

1.4

0.14

0.02

g/l

0.48

222

1632

Malignant neoplasm of oral cavity, including Hilmo

408

1.36

1.37

2.5

1.4

0.05

0.02

g/l

0.37

373

Cerebral aneurysm, nonruptured

105

849

1.24

1.37

1.5

2.3

0.00

0.03

g/l

1.56

784

Chronic iridocyclitis

435

1.34

1.35

2.4

0.00

0.02

g/l

0.72

402

Familial hypercholesterolemia, with ischemic heart disease

137

1142

1.21

1.34

2.1

2.3

0.09

0.06

g/l

0.11

127

1023

Injuries involving multiple body regions

291

1.42

1.33

2.6

2.5

0.00

0.02

g/l

0.50

269

Ménière disease

122

1007

1.22

1.32

1.6

2.4

0.03

g/l

0.02

109

923

FESS (DNB20)

1165

0.80

1.32

2.0

2.3

0.02

g/l

0.09

1085

Foreign body entering into or through eye or natural orifice

683

1.27

1.32

2.9

2.3

0.00

0.02

g/l

1.38

639

Non-small cell lung cancer, squamous, helper endpoint

521

0.70

1.31

1.9

2.4

0.02

0.03

g/l

0.40

467

Alcohol withdrawal state with delirium

676

1.27

1.30

1.2

2.3

0.03

0.02

g/l

0.08

629

Postpartum hemorraghe, parous women as controls

124

1272

0.83

1.30

1.9

2.0

0.04

0.00

g/l

0.66

114

1186

Nontoxic single thyroid nodule

712

1.26

1.29

2.7

2.3

0.03

0.00

g/l

0.39

655

Polycystic ovarian syndrome, consortium definition

812

4467

1.08

1.27

2.0

2.1

0.04

0.02

g/l

0.58

736

4065

Abrasion of teeth

399

3602

1.11

1.27

2.6

2.3

0.02

g/l

0.40

362

3295

Schizoaffective disorder

562

1.29

1.27

1.7

2.3

0.00

0.01

g/l

0.83

530

Ulcerative rectosigmoiditis

669

1.26

1.27

1.9

2.3

0.04

0.02

g/l

0.19

627

Tibial collateral bursitis [Pellegrini-Stieda]

1.85

1.27

3.3

1.7

0.00

g/l

-0.00

Menorrhagia

391

1949

1.12

1.27

1.9

2.1

0.06

0.02

g/l

0.65

347

1760

Impotence

529

1.29

1.25

2.0

2.3

0.03

0.04

g/l

0.06

479

Fitting and adjustment of other devices

404

4028

0.90

1.25

2.7

2.1

0.04

0.03

g/l

0.01

373

3609

Use of rotigotine

108

1.70

1.24

2.1

1.6

0.00

0.05

g/l

0.50

101

Nonspecific lymphadenitis

460

1.31

1.22

1.8

2.2

0.00

0.01

g/l

0.65

432

Aneurysms, operations, SAH

208

1811

1.15

1.22

1.9

2.1

0.01

0.04

g/l

1.79

184

1654

Erythema intertrigo

205

1.48

1.21

1.8

3.3

0.04

0.03

g/l

0.09

189

Haemangioma, any site

792

1.23

1.19

3.1

2.3

0.17

0.02

g/l

0.43

736

Respiratory tuberculosis, confirmed

173

1.52

1.19

1.3

2.8

0.00

0.03

g/l

0.50

155

Conductive and sensorineural hearing loss

1060

7595

0.94

1.19

2.4

2.3

0.03

g/l

0.24

957

6931

Infective bursitis

239

1.44

1.19

1.8

2.2

0.00

0.03

g/l

1.06

220

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1049

0.81

1.19

3.2

1.5

0.01

0.03

g/l

1.06

954

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

452

0.70

1.18

1.9

2.1

0.00

0.01

g/l

0.60

421

Traumatic secondary and recurrent haemorrhage

2.64

1.17

1.6

4.1

0.00

g/l

—

Other congenital malformations of respiratory system

2.62

1.17

1.0

1.1

0.00

g/l

—

Other haemoglobinopathies

2.61

1.17

1.8

1.0

0.00

g/l

—

Nonsuppurative otitis media

194

1457

1.15

1.17

2.0

1.9

0.02

g/l

0.12

181

1347

Reduction defects of upper limb

2.57

1.16

1.2

1.0

0.00

g/l

—

Pedestrian injured in transport accident

606

1.26

1.16

1.5

2.3

0.00

0.03

g/l

1.03

563

Scarlet fever

2.08

1.16

1.0

2.0

0.00

g/l

—

Haemangioma and lymphangioma, any site

102

841

1.22

1.15

3.0

2.3

0.16

0.02

g/l

0.42

779

Recurrent dislocation of patella

207

1.45

1.15

1.2

1.8

0.00

g/l

-0.00

196

Benign neoplasm: Cerebral meninges

124

1043

1.20

1.14

2.0

2.4

0.00

0.02

g/l

1.36

114

955

Diseases of middle ear and mastoid

624

4725

1.08

1.14

2.4

2.1

0.02

0.03

g/l

0.95

575

4322

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

770

1.23

1.14

2.1

2.4

0.01

0.03

g/l

0.32

713

Brain meningioma, including Hilmo

475

1.29

1.13

2.5

1.4

0.00

0.01

g/l

0.50

431

Other and unspecified abdominal hernia

405

1.32

1.13

1.3

1.9

0.00

0.02

g/l

0.59

371

Presbyopia

546

1.27

1.13

1.5

2.2

0.05

0.02

g/l

0.27

512

Pregnancy, childbirth and the puerperium

309

1802

0.89

1.13

1.7

2.1

0.05

0.03

g/l

0.19

285

1597

Lateral epicondylitis

132

1117

1.19

1.13

1.7

2.0

0.01

g/l

0.30

125

1032

Other problems related to primary support group, including family circumstances

645

1.24

1.11

2.0

2.1

0.00

0.01

g/l

0.73

605

Noise effects on inner ear

364

0.68

1.10

2.0

2.7

0.18

0.02

g/l

0.89

339

Other mycoses, not elsewhere classified/unspecified

2.25

1.10

6.3

3.8

0.00

g/l

—

Use of peginterferon beta-1a

2.43

1.10

1.0

0.00

g/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

765

1.22

1.09

2.4

0.00

0.01

g/l

1.17

709

Adenocarcinoma and papilloma adenocarcinoma of rectum

1005

0.81

1.09

3.3

1.5

0.01

0.03

g/l

1.06

914

Other meningitis

128

1.58

1.09

1.6

2.8

0.01

0.04

g/l

0.33

119

Arthropod-borne viral fevers and viral haemorrhagic fevers

939

0.81

1.09

2.9

2.3

0.00

0.02

g/l

1.80

874

Benign neoplasm of eye and adnexa

129

1096

1.18

1.07

1.7

2.3

0.01

0.02

g/l

1.02

116

1010

Embolic stroke

479

1.28

1.07

1.8

2.5

0.00

0.05

g/l

1.89

434

Chalazion

125

1060

1.18

1.06

3.3

2.3

0.01

g/l

0.68

111

986

Primary open-angle glaucoma, strict

327

3601

0.90

1.06

2.2

2.3

0.05

0.04

g/l

0.04

287

3223

Malignant neoplasm of thyroid gland, including Hilmo

641

1.24

1.06

2.7

1.4

0.04

0.01

g/l

0.35

587

L01XE Protein kinase inhibitors

579

1.25

1.05

3.0

2.6

0.39

0.02

g/l

0.46

540

Tick-borne viral encephalitis

2.01

1.05

1.1

2.0

0.00

g/l

—

Lichen sclerosus et atrophicus

121

1025

1.19

1.05

1.7

2.1

0.01

0.04

g/l

0.79

115

924

Benign neoplasm of brain and other parts of central nervous system

616

1.24

1.04

2.2

2.4

0.07

0.01

g/l

0.58

572

Obstructed labour due to malposition and malpresentation of fetus

126

1378

0.85

1.03

1.6

1.9

0.01

g/l

0.03

119

1284

Malignant neoplasm of stomach, including Hilmo

581

1.25

1.02

1.2

1.4

0.00

0.04

g/l

1.13

520

Pleural plaque without asbestos

439

1.29

1.02

1.7

2.4

0.02

0.03

g/l

0.22

398

Crohn disease (strict definition, all UC cases excluded)

360

1.31

1.01

1.4

2.4

0.02

g/l

0.01

339

Crowding of teeth, including avohilmo

315

0.71

1.00

3.6

1.7

0.10

0.02

g/l

0.38

304

Dysplasia of cervi uteri

224

1438

1.13

1.00

1.9

0.00

0.02

g/l

1.06

206

1304

Secondary malignant neoplasm of other and unspecified sites

159

0.56

0.99

1.3

1.4

0.00

g/l

—

148

Respiratory tuberculosis, bacteriologically and histologically confirmed

181

1.45

0.99

1.3

2.7

0.00

0.03

g/l

0.50

162

Aggressive periodontitis

181

1.45

0.99

1.3

3.0

0.00

0.03

g/l

0.50

169

Frostbite with tissue necrosis

0.00

0.99

0.0

2.3

—

0.00

—

Conductive hearing loss, unspecified

802

1.20

0.98

2.1

2.2

0.02

0.03

g/l

0.10

743

Personal history of certain other diseases

1.68

0.98

1.1

1.6

0.00

0.06

g/l

0.49

Lesion of radial nerve

301

1.34

0.98

2.0

2.4

0.15

0.00

g/l

0.47

280

L02BA Anti-estrogens

190

1676

1.14

0.97

2.0

2.2

0.01

0.02

g/l

0.70

167

1524

Polyhydramnios

223

0.63

0.96

1.5

1.8

0.00

g/l

0.50

211

Dementia due to Parkinsons disease, excluding more controls

191

1.43

0.95

1.3

2.1

0.00

0.17

g/l

1.03

173

Epidural haemorrhage

1.78

0.95

1.9

1.7

0.00

0.05

g/l

—

Pleural plaque with presence of asbestos

931

0.82

0.94

2.6

2.3

0.01

0.05

g/l

1.04

832

942

0.82

0.93

1.3

2.3

0.03

0.04

g/l

0.13

860

Other abnormal uterine and vaginal bleeding

270

1743

1.11

0.93

2.3

2.1

0.04

0.03

g/l

0.18

234

1561

Oral lichen planus, including avohilmo , including avohilmo

662

1.22

0.92

2.0

2.5

0.03

0.01

g/l

0.49

608

Malignant neoplasm of rectum

1015

0.83

0.91

2.8

1.4

0.01

0.03

g/l

1.09

920

Infective dermatitis

127

1096

1.16

0.91

1.7

2.4

0.05

0.03

g/l

0.24

114

1004

Changes in corneal membranes

2.13

0.91

1.5

2.6

0.00

g/l

—

Primary open-angle glaucoma

414

4331

0.92

0.91

2.2

2.3

0.04

g/l

0.05

364

3879

Benign neoplasm: Lower jaw bone

1.95

0.90

1.6

2.9

0.00

g/l

—

Leiomyoma of uterus

746

3977

1.06

0.89

2.2

0.02

g/l

0.03

667

3622

Excessive earwax

762

7015

1.06

0.89

2.5

2.3

0.03

g/l

0.23

690

6387

Other disorders of breast

132

1145

1.16

0.89

2.4

2.2

0.01

g/l

0.03

118

1050

Non-small cell lung cancer

129

1110

1.16

0.87

1.8

1.5

0.03

g/l

0.00

113

984

Lack of expected normal physiological development

2.02

0.87

1.0

1.1

0.00

g/l

—

Tick-borne viral encephalitis

1.86

0.87

1.1

2.0

0.00

g/l

—

Pre-eclampsia

173

1531

1.13

0.87

2.2

2.1

0.00

0.02

g/l

1.70

162

1401

Non-invasive ventilation

163

1648

0.88

0.86

2.3

2.4

0.06

0.03

g/l

0.44

144

1534

Non-allergic asthma

786

1.19

0.86

2.1

2.4

0.13

0.02

g/l

0.54

724

Ethmoidectomy

104

1213

0.85

2.6

2.2

0.02

0.01

g/l

0.07

1126

Female genital prolapse

297

1841

0.91

0.85

2.6

2.1

0.00

0.02

g/l

1.35

272

1659

LSIL lesion of the cervix uteri

706

1.19

0.84

2.5

2.0

0.00

0.01

g/l

0.93

665

Abnormalities of forces of labour

679

1.20

0.83

1.4

2.0

0.00

0.01

g/l

0.78

641

Car occupant injured in other and unspecified transport accidents

181

1612

1.13

0.83

2.0

2.2

0.06

0.02

g/l

0.38

164

1495

Other specified and unspecified disorders of choroid

1.91

0.83

1.2

2.5

0.00

g/l

—

Whooping cough

1.90

0.82

1.0

3.5

0.00

g/l

—

Other fall from one level to another

240

2174

1.11

0.81

2.1

2.2

0.01

0.03

g/l

1.82

215

1998

Dislocation, sprain and strain of joints and ligaments of elbow

445

1.24

0.81

1.8

2.0

0.01

g/l

0.18

419

Congenital deformities of feet

241

1.33

0.81

1.6

2.0

0.00

0.02

g/l

0.50

227

Inflammatory disease of cervix uteri

642

0.81

1.4

2.2

0.00

0.05

g/l

1.00

589

Foreign body on external eye

119

1362

0.87

0.78

2.2

0.05

0.02

g/l

0.39

107

1276

Labour and delivery complicated by umbilical cord complications

349

0.74

0.77

4.0

2.1

0.00

0.02

g/l

0.59

334

Malignant neoplasm of colon

182

1632

1.12

0.77

2.6

1.5

0.17

0.02

g/l

0.44

164

1462

Brain astrocytoma, including Hilmo

0.00

0.77

0.0

1.1

—

0.00

—

Brain astrocytoma

0.00

0.77

0.0

1.1

—

0.00

—

Malignant neoplasm of hypopharynx, including Hilmo

1.72

0.76

1.4

1.2

0.00

g/l

—

Malignant neoplasm of head and neck

816

1.17

0.76

2.4

1.4

0.04

g/l

0.02

741

Congenital malformations of aortic and mitral valves

306

1.28

0.75

1.9

2.5

0.00

0.02

g/l

0.50

290

Congenital malformations of cardiac chambers and connections

2.11

0.75

1.6

2.2

0.00

g/l

—

Other noninflammatory disorders of vagina

688

1.18

0.75

2.8

1.9

0.00

0.03

g/l

0.74

614

Residual foreign body in soft tissue

360

1.26

0.74

2.3

2.2

0.02

g/l

0.01

333

Oesophagitis, drug-induced

2.06

0.74

1.0

0.00

g/l

—

Injury of nerves and spinal cord at thorax level

1.82

0.73

5.0

1.9

0.00

g/l

—

Endometriosis ASRM stages 3,4

193

2135

0.90

0.73

1.7

2.1

0.02

0.03

g/l

0.19

175

1933

Palindromic rheumatism

1.60

0.72

1.5

0.00

g/l

-0.00

Other abnormal products of conception

231

1391

1.10

0.71

1.7

2.0

0.00

0.01

g/l

1.18

218

1292

Bacterial meningitis

291

1.28

0.71

2.9

2.8

0.01

0.02

g/l

0.27

271

Internuclear ophthalmoplegia

1.96

0.71

1.2

2.7

0.00

g/l

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

739

1.17

0.71

1.9

2.5

0.04

0.02

g/l

0.36

680

Dislocation of lens

143

1.41

0.71

3.6

2.5

0.00

0.01

g/l

0.50

131

Other rupture of muscle

1.73

0.70

1.0

1.9

0.00

g/l

—

Gender identity disorders

1.72

0.70

1.0

1.8

0.00

g/l

—

Labour and delivery complicated by fetal stress [distress]

118

879

0.88

0.70

1.7

0.00

g/l

0.75

113

817

Inflammation of lacrimal passages (chronic)

157

0.63

0.70

1.2

2.0

0.00

g/l

—

142

Other peripheral vertigo

112

983

1.14

0.69

2.0

2.5

0.03

0.02

g/l

0.29

906

Recurrent and persistent haematuria

1.58

0.69

1.6

2.4

0.18

0.00

g/l

0.71

Otorrhoea

1.90

0.69

1.4

1.1

0.00

g/l

—

Specific developmental disorder of motor function

1.89

0.69

1.0

2.2

0.00

g/l

—

Circumscribed brain atrophy

222

1.32

0.69

1.7

3.0

0.00

0.02

g/l

0.50

203

Vasomotor rhinitis (mode)

676

1.17

0.69

2.3

2.6

0.02

g/l

0.05

627

Medical treatment for female infertility

104

1181

0.87

0.68

1.6

1.8

0.01

g/l

0.06

1095

Other factor of the environment

102

1.49

0.68

3.3

1.7

0.00

g/l

-0.00

Divergent concomitant strabismus

603

1.18

0.67

2.0

2.2

0.00

0.02

g/l

0.89

558

Obstructed labour due to maternal pelvic abnormality

122

1376

0.88

0.67

2.6

2.2

0.00

0.02

g/l

1.78

109

1260

Anomalies of dental arch relationship, including avohilmo

129

1308

0.89

0.67

2.0

2.2

0.02

0.01

g/l

0.17

114

1224

Severe combined immunodeficiency [SCID] with reticular dysgenesis

1.82

0.67

1.0

2.7

0.00

g/l

—

Schistosomiasis [bilharziasis]

1.82

0.67

1.2

2.0

0.00

g/l

—

Transient global amnesia

1098

0.87

0.66

2.8

2.3

0.03

0.04

g/l

0.09

1010

Benign neoplasm: Skin of other and unspecified parts of face

104

1183

0.88

0.66

4.1

2.4

0.00

0.02

g/l

2.03

1083

Benign mammary dysplasia

165

1489

1.11

0.66

2.8

2.2

0.01

0.03

g/l

0.76

153

1349

Contact with other hot metals

103

1.47

0.65

1.1

2.8

0.00

g/l

-0.00

Burn and corrosion confined to eye and adnexa

154

1.37

0.65

1.8

2.5

0.00

g/l

-0.00

149

Use of galantamine

947

0.86

0.65

1.3

2.3

0.00

0.07

g/l

2.05

846

Other bursal cyst

120

1.43

0.65

2.4

1.9

0.00

g/l

-0.00

108

Acute appendicitis, with complications

232

2130

1.09

0.65

2.6

2.1

0.02

0.03

g/l

0.73

213

1960

Congenital deformities of feet

146

1.38

0.64

1.7

1.9

0.00

0.03

g/l

0.50

140

Motor disorders

1.72

0.63

1.0

2.1

0.00

g/l

—

Other vitreous opacities

369

1.23

0.63

2.2

2.7

0.01

0.03

g/l

0.26

344

Presbycusis

214

1943

1.09

0.63

2.6

2.2

0.02

0.05

g/l

1.40

182

1731

Pregnancy with abortive outcome

752

3740

1.05

0.63

1.8

2.3

0.02

g/l

0.15

695

3381

Optic atrophy

138

1.39

0.63

4.1

1.6

0.06

0.04

g/l

0.13

128

Helminthiases

261

1.27

0.62

2.7

2.4

0.00

0.02

g/l

0.50

244

Other complications of labour and delivery, not elsewhere classified

480

0.82

0.61

1.3

1.5

0.03

0.00

g/l

0.39

447

Other drug-induced secondary parkinsonism

1.50

0.61

1.3

2.4

0.00

0.06

g/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

154

1392

1.11

0.61

2.5

2.4

0.02

0.05

g/l

0.93

132

1280

Congenital malformations of lung

0.00

0.61

0.0

2.4

—

0.00

—

Congenital hydrocephalus

0.00

0.61

0.0

4.6

—

0.00

—

Syndactyly

0.00

0.60

0.0

2.9

—

0.00

—

Maternal care for known or suspected abnormality of pelvic organs

154

1160

0.90

0.60

2.7

1.9

0.00

0.01

g/l

0.78

141

1079

Familial benign pemphigus (Hailey-Hailey disease)

0.00

0.60

0.0

1.3

—

0.00

—

Discharge from other and unspecified firearms

0.00

0.60

0.0

2.5

—

0.00

—

Car occupant injured in noncollision transport accident

245

1.27

0.60

3.4

2.6

0.00

0.02

g/l

0.50

228

Sequelae of other and unspecified infectious and parasitic diseases

408

1.21

0.60

2.8

2.1

0.03

0.02

g/l

0.15

381

ILD medications: pirfenidone

1.46

0.60

2.1

1.6

0.07

0.01

g/l

0.41

Other helminthiases

0.00

0.59

0.0

2.9

—

0.00

—

Long labour

152

1436

0.90

0.59

2.4

2.0

0.03

0.01

g/l

0.49

144

1333

Enterobiasis

0.00

0.59

0.0

1.0

—

0.00

—

Pectus excavatum

0.00

0.58

0.0

2.3

—

0.00

—

Bicuspidal aortic valve syndrome

282

1.25

0.58

1.9

2.6

0.00

0.02

g/l

0.50

267

Ovarian dysfunction, other/unspecified

1.73

0.58

2.7

2.4

0.00

g/l

—

Intermittent heterotropia

345

1.22

0.58

2.3

2.1

0.02

g/l

0.05

320

Left ventricular outflow tract obstruction, narrow definition

355

1.22

0.57

1.8

2.5

0.00

0.01

g/l

0.50

333

Examination and encounter for administrative purposes

374

1.21

0.57

3.3

2.8

0.00

0.02

g/l

0.95

344

Optic atrophy

141

1.36

0.57

4.1

2.1

0.06

0.04

g/l

0.14

131

Other specified transport accidents

1.64

0.56

1.0

1.9

0.00

g/l

—

Acute and transient psychotic disorders

110

983

1.12

0.55

2.3

2.2

0.01

g/l

0.01

921

Other disorders of conjunctiva

175

1604

1.09

0.54

2.6

2.2

0.02

0.05

g/l

0.60

164

1458

Alzheimer disease, including avohilmo

525

3882

0.95

0.53

1.8

2.3

0.02

0.06

g/l

1.86

439

3477

Retained placenta and membranes, without haemorrhage

1004

0.88

0.53

2.1

2.0

0.03

0.01

g/l

0.34

925

Injury of nerves at hip and thigh level

1.52

0.52

5.8

1.9

0.73

0.00

g/l

—

Acute inflammation of orbit

1.51

0.52

11.0

1.3

0.00

g/l

—

Tooth eruption problems

668

1.14

0.52

2.3

1.8

0.00

0.01

g/l

0.63

629

Exposure to other specified electric current

136

0.66

0.51

2.2

2.1

0.00

0.04

g/l

—

131

Other and unspecified nerve root and plexus disorders, also in other diseases

216

2005

1.08

0.51

2.6

2.1

0.03

0.02

g/l

0.14

194

1847

Mumps

202

0.74

0.50

1.5

2.5

0.00

0.03

g/l

0.50

188

Other appendicitis

763

1.13

0.50

2.9

2.3

0.00

0.02

g/l

1.50

715

Complications following infusion, transfusion and therapeutic injection

136

1.33

0.49

1.6

2.4

0.00

0.04

g/l

0.50

124

Schizophrenia or delusion

323

3044

1.06

0.49

1.9

2.1

0.01

0.03

g/l

1.31

282

2811

Communicating hydrocephalus

208

1.26

0.48

1.6

3.1

0.00

0.03

g/l

0.50

191

Papillary adenocarcinoma of thyroid gland

428

1.17

0.48

1.4

1.3

0.07

0.01

g/l

0.37

394

Serous carcinoma of ovary, including Hilmo

333

0.81

0.48

2.5

1.4

0.00

0.02

g/l

0.50

303

Contact with other hot fluids

208

1.26

0.48

1.1

2.3

0.00

0.03

g/l

0.50

196

Sudden idiopathic hearing loss

125

1138

1.10

0.47

2.4

2.2

0.01

0.03

g/l

0.73

110

1043

Any dementia

610

4062

1.04

0.47

1.9

2.3

0.06

0.05

g/l

0.10

516

3660

Non-small cell lung cancer, squamous

441

0.84

0.47

1.9

1.4

0.02

0.06

g/l

0.60

392

Family history of malignant neoplasm

920

0.89

0.47

3.3

2.0

0.03

0.02

g/l

0.11

855

Leiomyosarcoma, including Hilmo

0.60

0.46

4.0

1.3

0.24

0.06

g/l

—

Acute poliomyelitis

121

0.66

0.46

1.4

2.3

0.00

0.04

g/l

—

112

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

600

4945

0.96

0.45

2.2

0.03

g/l

0.03

543

4515

Burns and corrosions confined to eye and internal organs

183

1.26

0.45

1.7

2.3

0.00

g/l

-0.00

175

Malignant neoplasm of other and ill-defined digestive organs

1.46

0.44

1.4

1.3

0.00

g/l

—

Malignant neoplasm of eye, brain and central nervous system

348

1.18

0.44

1.5

1.4

0.09

0.02

g/l

0.37

321

Lifestyle-related condition

1.38

0.44

3.6

1.7

0.00

g/l

-0.00

Pedal cyclist injured in transport accident

230

2157

1.07

0.43

2.1

0.01

0.02

g/l

0.30

215

1993

Congenital malformations of spine and bony thorax

1.63

0.43

1.0

2.3

0.00

g/l

—

Scarlet fever

1.62

0.43

1.0

2.2

0.00

g/l

—

Benign neoplasm: Ill-defined sites within the digestive system

1.42

0.42

1.3

2.6

0.00

g/l

—

Lesion of plantar nerve

606

0.87

0.42

2.9

2.3

0.00

0.01

g/l

0.60

550

Vascular dementia (undefined)

439

1.15

0.42

1.6

2.2

0.24

0.09

g/l

0.27

386

Obstetric embolism

0.00

0.42

0.0

1.1

—

0.00

—

Torsion of ovary, ovarian pedicle and fallopian tube

149

1.28

0.42

1.4

2.2

0.00

g/l

0.50

140

Carcinoma in situ of oral cavity and pharynx

0.00

0.42

0.0

1.1

—

0.00

—

Urticaria due to cold and heat

1.39

0.42

1.6

1.7

0.00

0.08

g/l

—

Cyst of spleen

0.00

0.41

0.0

3.8

—

0.00

—

Toxic effects of substances chiefly nonmedicinal as to source

974

0.90

0.41

1.8

2.2

0.00

0.02

g/l

1.97

908

Family history of mental and behavioural disorders

0.00

0.41

0.0

1.2

—

0.00

—

Secondary parkinsonism+Parkinsonism in other disease

277

1.20

0.41

2.8

0.05

0.00

g/l

0.45

253

Other helminthiases

0.00

0.41

0.0

2.8

—

0.00

—

Unequal limb length (acquired)

1.52

0.41

1.0

2.3

0.00

g/l

—

Hypospadias

0.00

0.41

0.0

2.9

—

0.00

—

Pectus excavatum

0.00

0.41

0.0

2.8

—

0.00

—

Secondary parkinsonism

268

1.20

0.41

2.8

2.6

0.05

0.00

g/l

0.48

245

Congenital malformations of lung

0.00

0.41

0.0

2.6

—

0.00

—

Supervision of normal pregnancy

127

790

0.92

0.41

2.1

1.8

0.01

0.00

g/l

0.28

122

740

Vestibular neuronitis

101

920

1.10

0.40

2.2

2.4

0.01

0.02

g/l

0.22

850

Schizophrenia, schizotypal and delusional disorders

323

3070

1.05

0.40

1.9

2.1

0.01

0.03

g/l

1.30

283

2832

Early lumbar disc prolapse operation

624

0.88

0.39

2.1

1.7

0.00

g/l

0.83

600

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

749

1.11

0.39

1.9

2.1

0.05

0.01

g/l

0.52

687

Congenital malformations of spine and bony thorax

1.44

0.39

1.0

2.2

0.00

g/l

—

Perforation of tympanic membrane

104

950

1.10

0.39

2.2

0.01

0.02

g/l

0.66

876

Alzheimer disease

454

3464

0.96

0.39

1.8

2.2

0.02

0.05

g/l

2.00

373

3096

Malignant neoplasm of eye and adnexa

1.37

0.38

1.1

0.00

0.08

g/l

—

493

1.13

0.38

1.8

2.3

0.01

0.07

g/l

0.73

423

Injury of muscle and tendon at wrist and hand level

144

1337

1.08

0.38

1.8

2.3

0.02

g/l

0.02

136

1240

Glaucoma, exfoliation

128

1383

0.92

0.38

2.5

2.4

0.02

0.04

g/l

0.40

115

1234

Tuberculosis, IBD comorbidity

771

1.11

0.38

2.1

2.3

0.00

0.03

g/l

1.94

694

Colorectal adenocarcinoma

212

2244

0.94

0.38

2.7

1.5

0.15

0.02

g/l

0.45

183

2022

Other noninflammatory disorders of uterus, except cervix

267

1703

1.06

0.38

2.6

2.2

0.04

0.03

g/l

0.20

244

1526

Benign lipomatous neoplasm of other sites/unspecified

104

953

1.09

0.37

3.3

2.3

0.00

0.02

g/l

1.30

876

Use of levodopa decarbox-comt-inhibitor

355

1.16

0.37

1.1

2.9

0.00

0.03

g/l

1.19

328

Other menopausal disorders

314

1683

1.05

0.37

2.1

0.01

0.02

g/l

0.91

293

1525

Other and unspecified injuries of shoulder and upper arm

244

1.19

0.36

1.2

2.8

0.11

0.00

g/l

0.48

226

Calculus of lower urinary tract

592

1.12

0.36

2.2

2.5

0.01

0.03

g/l

0.73

541

Nontraumatic intracranial haemmorrhage

255

2418

1.06

0.36

2.4

2.2

0.01

0.04

g/l

2.48

229

2186

Dentofacial anomalies [including malocclusion]

752

5855

1.03

0.36

2.2

2.1

0.01

0.02

g/l

0.98

691

5384

Dementia

633

4501

0.97

0.36

2.0

2.4

0.06

0.04

g/l

0.32

538

4084

Use of rivastigmine

188

1992

0.94

0.36

2.2

2.3

0.03

0.05

g/l

0.54

163

1765

Medicines for HER+ breast cancer

405

3998

0.96

0.36

2.1

2.3

0.01

0.03

g/l

0.93

361

3619

Malignant neoplasm of penis, including Hilmo

1.44

0.36

4.0

1.4

0.00

g/l

—

Abnormal findings on diagnostic imaging of breast

123

0.73

0.35

1.3

2.2

0.00

0.04

g/l

—

113

Dislocation, sprain and strain of joints and ligaments of knee

651

5807

1.03

0.35

1.8

2.2

0.00

0.03

g/l

4.76

599

5358

Carcinoma in situ of cervix uteri

555

1.12

0.35

1.8

2.0

0.00

0.01

g/l

0.65

521

Chondrosarcoma, including Hilmo

1.38

0.35

2.5

1.1

0.00

g/l

—

Discontinuity and dislocation of ear ossicles

1.37

0.34

2.0

2.4

0.00

0.11

g/l

—

Fall on and from ladder

786

1.10

0.34

4.2

2.4

0.02

0.04

g/l

0.26

728

Inguinal hernia, unilateral

275

0.83

0.33

2.8

2.0

0.00

0.02

g/l

0.50

255

Inguinal of femoral hernia, unilateral

275

0.83

0.33

2.8

2.0

0.00

0.02

g/l

0.50

255

Femoral hernia, unilateral

275

0.83

0.33

2.8

2.0

0.00

0.02

g/l

0.50

255

Malignant neoplasm of endocrine gland

606

1.11

0.33

1.9

1.4

0.05

0.01

g/l

0.35

553

Sequelae of injuries of upper limb

885

1.09

0.32

2.5

2.4

0.04

0.02

g/l

0.36

821

Motorcycle rider injured in noncollision transport accidents

183

1.21

0.32

2.0

1.8

0.00

g/l

-0.00

175

Malignant neoplasm of brain, including Hilmo

408

1.13

0.31

2.7

1.4

0.08

0.02

g/l

0.36

374

Hypothermia

165

1.22

0.31

1.3

3.4

0.00

g/l

-0.00

151

Dental pulpitis, including avohilmo

1077

6829

1.02

0.31

1.9

2.2

0.03

0.02

g/l

0.35

1002

6293

Hydatidiform mole

100

0.70

0.31

1.0

2.0

0.20

0.05

g/l

—

Other specified/unspecified diseases of inner ear

1.31

0.31

1.9

2.1

0.00

g/l

—

Benign neoplasm of ovary

189

1790

1.06

0.30

2.2

0.00

0.03

g/l

1.80

175

1618

Tuberculosis, wide

811

1.09

0.30

2.0

2.4

0.00

0.03

g/l

1.93

733

Endometriosis diagnosis and infertility diagnosis occurring together

686

1.09

0.30

1.4

2.0

0.02

0.01

g/l

0.11

645

Injury of nerves at forearm level

1.30

0.30

1.3

2.5

0.00

g/l

-0.00

Endometriosis ASRM stages 1,2

129

1375

0.94

0.29

1.5

1.9

0.01

g/l

0.11

120

1269

Diabetes mellitus in pregnancy

187

1262

0.95

0.28

1.5

1.8

0.00

0.01

g/l

1.15

171

1181

Benign neoplasm: Choroid

651

1.09

0.28

1.4

2.5

0.00

0.02

g/l

1.51

601

Varus deformity, not elsewhere classified

1.30

0.28

1.5

2.1

0.00

g/l

-0.00

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

148

1397

1.06

0.28

2.8

2.2

0.12

0.02

g/l

0.41

137

1295

Postmenopausal atrophic vaginitis

326

1729

1.04

0.28

2.4

2.2

0.01

0.02

g/l

0.33

299

1559

Pregnancy hypertension

354

3057

1.04

0.27

2.1

0.00

0.01

g/l

1.92

336

2803

Mental retardation, excluding more controls

190

1.18

0.27

1.7

2.6

0.00

g/l

-0.00

174

Other noninflammatory disorders of cervix uteri

511

0.90

0.27

2.7

1.9

0.00

0.04

g/l

0.68

449

Other benign neoplasms of uterus

604

0.91

0.26

3.1

2.2

0.00

0.05

g/l

1.01

541

Other benign neoplasms of connective and other soft tissue

102

953

1.07

0.26

2.5

2.3

0.03

0.02

g/l

0.24

881

Poor fetal growth

586

1.09

0.26

1.9

1.7

0.00

0.01

g/l

1.02

549

L02BX Other hormone antagonists and related agents

654

1.09

0.26

1.3

2.4

0.03

0.05

g/l

0.21

595

Myocardial infarction, unclassifiable

290

2689

0.96

0.26

1.7

2.2

0.03

0.06

g/l

0.89

261

2388

Melanocytic naevi, other sites/unspecified

707

0.92

0.26

2.2

2.4

0.02

g/l

0.11

665

Malignant neoplasm of corpus uteri, including Hilmo

101

945

1.07

0.25

1.5

1.4

0.01

g/l

0.03

847

Injury of muscle and tendon at shoulder and upper arm level

454

4408

1.03

0.25

2.4

2.3

0.04

0.02

g/l

0.37

414

4056

Intracerebral haemorrhage

160

1520

1.05

0.25

2.5

2.2

0.00

0.06

g/l

3.04

146

1362

Embedded and impacted teeth

143

1246

0.95

0.25

1.9

0.00

0.01

g/l

1.63

137

1169

Benign neoplasm: Other/unspecified site

148

0.81

0.24

1.7

2.0

0.00

0.04

g/l

0.50

138

Haemorrhage in early pregnancy

213

2164

0.96

0.24

2.2

2.1

0.02

0.01

g/l

0.16

200

1994

Sequelae of infectious and parasitic diseases

667

1.08

0.24

3.0

2.2

0.02

g/l

0.05

610

Torticollis

0.72

0.24

1.0

1.9

0.00

g/l

—

False labour

181

1183

0.95

0.24

1.6

1.8

0.02

0.01

g/l

0.44

170

1104

Use of ropinirole

379

1.11

0.24

2.5

2.9

0.00

0.03

g/l

1.09

351

malignant neoplasm of female genital organs

145

1517

0.95

0.24

1.8

1.4

0.01

g/l

0.16

129

1365

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

152

1.19

0.24

1.9

1.4

1.03

0.04

g/l

0.57

137

Other female pelvic inflammatory diseases

143

1505

0.95

0.23

1.6

2.3

0.00

0.02

g/l

1.96

131

1371

Malignant neoplasm of thyroid gland

562

1.09

0.23

2.0

1.4

0.05

0.01

g/l

0.36

515

Kela-code for severe mental illness

377

3657

1.03

0.23

2.0

2.2

0.00

0.03

g/l

2.81

327

3351

Effects of foreign body entering through natural orifice

256

2469

1.04

0.22

2.1

2.2

0.02

0.03

g/l

0.14

232

2276

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.23

0.22

1.4

2.3

0.00

g/l

—

Malignant neoplasm of meninges

0.00

0.22

0.0

1.1

—

0.00

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

0.22

0.0

1.0

—

0.00

—

Toxic effect of pesticides

0.00

0.22

0.0

1.0

—

0.00

—

Hydroxyapatite deposition disease

0.00

0.22

0.0

5.2

—

0.00

—

Myiasis

0.00

0.22

0.0

5.6

—

0.00

—

Benign neoplasm: Mediastinum

1.20

0.21

1.8

2.5

0.00

g/l

—

L02BG Aromatase inhibitors

339

3488

0.97

0.21

2.2

2.4

0.01

0.03

g/l

1.26

303

3158

Ovarian dysfunction: androgen excess

0.00

0.21

0.0

5.0

—

0.00

—

Need for immunization against certain single viral diseases

0.00

0.21

0.0

1.3

—

0.00

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

0.00

—

Syndactyly

0.00

0.21

0.0

3.8

—

0.00

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.5

—

0.00

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

0.00

—

Other congenital malformations of spinal cord

0.00

0.21

0.0

1.2

—

0.00

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.21

0.0

3.3

—

0.00

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.0

—

0.00

—

Unicornuate uterus

0.00

0.21

0.0

1.0

—

0.00

—

Ectopic testis

0.00

0.21

0.0

1.2

—

0.00

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

0.00

—

Burn and corrosion of respiratory tract

0.00

0.21

0.0

3.2

—

0.00

—

Congenital malformations of nose

0.00

0.21

0.0

1.0

—

0.00

—

Hydrocephalus

832

0.94

0.21

2.3

2.4

0.06

0.05

g/l

0.07

753

Benign neoplasm: Pineal gland

0.00

0.21

0.0

1.2

—

0.00

—

Bullous keratopathy

1.26

0.20

1.0

2.4

0.00

g/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.20

0.0

3.1

—

0.00

—

Drug-induced gout

1.23

0.20

2.5

1.7

1.37

0.00

g/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

127

1.19

0.19

1.2

1.3

0.00

0.04

g/l

0.51

114

Alzheimer’s disease (Late onset)

340

2781

1.03

0.19

2.0

2.2

0.02

0.06

g/l

1.89

280

2488

Benign neoplasm: Bladder

1.23

0.19

2.3

3.3

0.00

g/l

-0.00

Valgus deformity, not elsewhere classified

1.13

0.19

1.2

1.5

0.00

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.19

0.18

2.1

1.6

0.00

g/l

—

Female infertility

255

1500

1.03

0.18

2.0

0.00

0.01

g/l

1.49

234

1370

Subarachnoid haemorrhage

116

1108

1.05

0.17

2.1

2.2

0.01

0.05

g/l

0.93

101

1000

Puerperal sepsis

110

1152

0.95

0.17

2.2

0.00

0.01

g/l

0.91

103

1063

Degenerative diseases of the nervous system

534

3844

1.02

0.17

1.8

2.3

0.02

0.05

g/l

1.16

444

3442

Unspecified urinary incontinence

933

1.05

0.17

1.4

2.2

0.00

0.04

g/l

1.20

842

Glaucoma

807

6832

1.02

0.17

2.2

2.3

0.03

g/l

0.08

716

6208

Other benign neoplasm of uterus: Corpus uteri

0.71

0.17

1.4

2.3

0.00

0.08

g/l

—

Pathological resorption of teeth

292

1.10

0.16

1.1

2.7

0.07

0.02

g/l

0.31

276

Colorectal cancer

276

2627

1.03

0.16

2.6

1.5

0.11

0.02

g/l

0.44

246

2367

Injury of urinary and pelvic organs

162

0.86

0.16

7.2

2.7

0.00

g/l

-0.00

149

Mixed conductive and sensorineural hearing loss

144

1495

0.96

0.16

2.4

2.2

0.03

0.04

g/l

0.32

129

1349

Tuberculosis

689

0.94

0.16

2.0

2.4

0.00

0.02

g/l

1.70

616

Malignant neoplasm of other and unspecified female genital organs

151

0.86

0.16

1.8

1.5

0.00

0.04

g/l

0.50

136

Exposure to excessive heat of man-made origin

0.77

0.16

5.5

3.3

0.00

g/l

—

Complications predominantly related to the puerperium

203

1969

1.03

0.15

1.8

2.0

0.01

g/l

0.40

190

1809

Malignant neoplasm of corpus uteri

820

1.05

0.15

1.6

1.4

0.01

g/l

0.03

734

Female infertility, cervical, vaginal, other or unspecified origin

232

1467

1.03

0.14

2.1

2.0

0.00

0.01

g/l

1.22

213

1339

Chronic suppurative otitis media, including avohilmo

704

1.05

0.14

1.4

2.4

0.01

0.03

g/l

0.49

652

Inflammatory diseases of prostate (prostatitis)

143

1382

1.04

0.14

1.7

2.6

0.02

0.04

g/l

0.45

132

1248

Carcinoma in situ of breast, other/unspecified

141

1.14

0.14

2.2

0.00

0.04

g/l

0.50

129

Other contact dermatitis

685

1.05

0.14

1.8

2.4

0.00

0.02

g/l

1.24

634

Malignant neoplasm of rectum, including Hilmo

128

1324

0.97

0.13

3.1

1.4

0.01

0.03

g/l

0.55

113

1190

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

410

3501

1.02

0.13

2.0

2.1

0.01

g/l

0.05

386

3201

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

142

1.13

0.12

1.4

0.13

0.04

g/l

0.27

130

Endovascular or surgical operations to intracerebral aneurysms

590

0.95

0.12

2.1

2.4

0.03

0.02

g/l

0.15

549

Pedal cyclist injured in other and unspecified transport accidents

1007

0.96

0.12

2.3

2.2

0.00

0.02

g/l

1.59

940

Gestational diabetes (for exclusion)

224

1595

0.98

0.12

1.8

0.00

0.01

g/l

1.19

202

1495

Hypertrophy of breast in women and men

178

1736

1.03

0.11

2.1

2.2

0.04

0.01

g/l

0.36

162

1599

Deep bite

667

0.96

0.11

2.3

0.00

0.02

g/l

1.22

631

Colon adenocarcinoma

133

1292

1.03

0.11

2.6

1.5

0.23

0.03

g/l

0.44

116

1154

Malignant neoplasm of brain

260

1.08

0.11

1.5

1.4

0.15

0.02

g/l

0.38

239

Simple and mucopurulent chronic bronchitis

403

0.94

0.10

1.8

2.4

0.00

0.01

g/l

0.70

360

Supervision of high-risk pregnancy

133

777

1.03

0.10

1.6

1.8

0.02

0.00

g/l

0.40

123

726

Use of biperiden

446

1.05

0.10

1.4

2.5

0.00

0.02

g/l

0.86

412

Alzheimer’s disease (Atypical or mixed), excluding more controls

750

0.96

0.10

1.4

2.2

0.02

0.07

g/l

1.00

678

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.14

0.10

1.2

1.7

0.00

g/l

—

Acute otitis externa, noninfective

135

0.89

0.10

1.1

2.3

0.00

0.04

g/l

0.50

126

Other congenital malformations, not elsewhere classified

1.11

0.10

1.4

2.2

0.00

g/l

—

Postpartum haemorrhage due to retained placenta

626

0.96

0.10

2.1

1.7

0.07

0.01

g/l

0.59

584

Onycholysis

1.09

0.09

1.2

2.1

0.00

g/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

226

2112

1.02

0.09

2.0

1.4

0.01

g/l

0.33

201

1905

Blepharospasm

1.14

0.09

1.1

2.0

0.00

0.06

g/l

0.49

Follicular adenocarcinoma of thyroid gland

1.09

0.09

7.2

1.3

0.00

g/l

—

Ill-defined and unknown causes of mortality

968

0.97

0.08

1.9

2.3

0.07

0.04

g/l

0.34

871

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

216

0.92

0.08

1.8

2.0

0.00

0.01

g/l

0.54

200

Pleural plaque

123

1200

1.03

0.08

2.2

0.01

0.05

g/l

1.86

113

1075

Ectopic pregnancy

136

1392

0.98

0.08

1.5

2.3

0.01

0.02

g/l

0.40

128

1282

Ulcer of oesophagus, drug-induced

0.80

0.08

1.0

2.2

0.00

g/l

—

Chronic diseases of tonsils and adenoids

878

5594

0.99

0.08

1.8

2.2

0.01

0.02

g/l

0.88

827

5143

Carcinoma in situ of breast, intraductal

874

1.03

0.08

1.7

2.1

0.01

0.02

g/l

0.34

801

L02BB Anti-androgens

119

1161

1.03

0.08

1.7

2.3

0.01

0.05

g/l

1.53

104

1034

Persons encountering health services in circumstances related to reproduction

562

3824

0.99

0.08

2.1

2.2

0.01

g/l

0.04

528

3551

Preterm labour and delivery

214

2177

0.98

0.08

2.2

2.1

0.03

0.02

g/l

0.31

199

1998

Other nonscarring hair loss

1.10

0.08

1.3

2.4

0.00

0.08

g/l

—

Osteitis due to dental implant

0.85

0.07

6.2

2.0

0.00

g/l

—

Leisure time condition

189

1857

1.02

0.07

1.7

2.2

0.02

0.03

g/l

0.50

158

1701

Follicular adenocarcinoma of thyroid gland, including Hilmo

0.86

0.07

6.3

1.3

0.00

g/l

—

Stenosis and insufficiency of lacrimal passages

994

0.98

0.07

1.5

2.4

0.01

0.02

g/l

0.14

905

Struck by thrown, projected or falling objec

383

1.05

0.07

1.1

2.5

0.00

0.02

g/l

0.62

360

Other conjunctival vascular disorders and cysts

216

1.07

0.07

3.5

1.7

0.00

0.02

g/l

0.50

203

Primary angle-closure glaucoma

478

0.96

0.07

2.7

2.6

0.01

0.04

g/l

0.61

438

Early lumbar disc prolapse, operated

522

1.03

0.06

2.1

1.8

0.00

0.01

g/l

1.32

498

Follow-up care involving plastic surgery

315

0.95

0.06

1.7

1.9

0.00

g/l

-0.00

295

Anomalies of pupillary function

158

1.08

0.06

3.2

2.2

0.04

0.03

g/l

0.02

149

Uterine polyps

929

1.02

0.06

1.7

2.0

0.00

0.03

g/l

0.94

836

Chronic suppurative otitis media

592

1.03

0.06

1.3

2.4

0.00

0.02

g/l

1.09

543

Traumatic ischaemia of muscle

100

1.10

0.05

1.4

2.1

0.00

g/l

-0.00

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

818

0.98

0.05

2.0

2.4

0.00

0.01

g/l

1.02

755

Mental retardation

217

1.05

0.04

1.7

2.2

0.00

0.02

g/l

0.50

203

Hypertrophy of breast

147

1452

1.01

0.04

1.5

2.1

0.04

0.01

g/l

0.29

132

1338

Respiratory tuberculosis, confirmed and not-confirmed

573

0.98

0.03

2.0

2.4

0.00

0.03

g/l

1.70

517

Respiratory tuberculosis

573

0.98

0.03

2.0

2.4

0.00

0.03

g/l

1.70

517

Dementia, including avohilmo

689

4757

1.00

0.03

2.1

2.4

0.06

0.04

g/l

0.24

590

4312

Benign lipomatous neoplasm

342

3399

1.01

0.03

2.8

2.3

0.05

0.03

g/l

0.23

319

3083

Endometriosis of pelvic peritoneum

126

1215

0.99

0.03

1.6

2.0

0.01

g/l

0.01

118

1103

Oral lichen planus and hypothyroidism or thyroxine medication

179

0.95

0.03

1.5

1.8

0.00

0.03

g/l

0.50

168

Endometriosis of ovary

155

1497

1.01

0.03

1.7

2.1

0.02

0.03

g/l

0.11

142

1358

Congenital malformations of eye, ear, face and neck

420

0.98

0.02

3.2

2.2

0.01

0.02

g/l

0.26

393

Alzheimer’s disease, strict definition

358

2963

0.99

0.02

2.0

2.2

0.02

0.05

g/l

1.94

298

2656

Gestational [pregnancy-induced] hypertension

185

1833

1.01

0.02

2.2

2.0

0.00

0.01

g/l

1.70

177

1669

Malignant neoplasm of breast, HER-negative

201

1960

1.01

0.02

1.9

1.4

0.02

0.01

g/l

0.35

178

1765

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

1.08

0.02

1.1

2.2

0.00

g/l

—

Guttate psoriasis

117

0.94

0.01

1.4

1.9

0.05

0.04

g/l

0.01

112

Benign neoplasm: Bronchus and lung

127

0.94

0.01

1.5

2.1

0.00

g/l

-0.00

118

Malignant neoplasm of pancreas, including Hilmo

889

0.99

0.01

2.3

1.5

0.08

0.03

g/l

0.42

803

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

217

0.97

0.01

4.3

2.7

0.00

0.02

g/l

0.50

202

Exposure to smoke, fire and flames

196

0.97

0.00

1.1

2.8

0.00

0.03

g/l

0.50

179

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

324

1.02

0.00

1.1

2.1

0.00

0.01

g/l

0.50

303

Normotensive glaucoma

107

1069

1.00

0.00

2.3

2.4

0.12

0.04

g/l

0.40

973

Periodontal disease, other/unspecified

214

0.98

0.00

4.1

2.4

0.06

0.02

g/l

0.22

199

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

276

1.01

0.00

1.9

1.4

0.00

0.02

g/l

0.50

252

Bruxism

122

0.98

0.00

1.2

2.2

0.00

g/l

-0.00

116

Other osteochondropathies

546

1.01

0.00

2.6

2.2

0.09

0.02

g/l

0.55

507

Tularaemia

152

0.99

0.00

1.1

3.2

0.00

0.03

g/l

0.50

142

Otosclerosis

792

1.00

0.00

1.4

2.5

0.01

0.02

g/l

0.27

732

Other ill-defined and unspecified causes of mortality

878

1.00

0.00

1.7

2.3

0.07

0.04

g/l

0.36

790

Benign leiomyoma with endometriosis

170

1703

1.00

0.00

2.2

0.01

0.03

g/l

0.65

152

1539

Benign neoplasm: Lip

209

1.00

0.00

3.0

2.4

0.00

0.03

g/l

0.50

191

Hypermetropia

548

1.00

0.00

2.7

2.2

0.00

0.01

g/l

0.51

508

Other benign neoplasm of uterus: Other parts/unspecified

479

1.00

0.00

3.4

2.2

0.00

0.07

g/l

1.01

425

299

2808

1.00

0.00

2.2

0.08

0.04

g/l

0.36

266

2486

Dementia due to Parkinson's disease

271

1.00

0.00

1.3

2.5

0.00

0.02

g/l

0.96

243

Generalized epilepsy, strict definition

137

1.02

0.00

1.3

2.2

0.00

0.04

g/l

0.50

129

Mental retardation, wide definition

238

1.00

0.00

1.7

2.2

0.00

0.02

g/l

0.50

223

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

1.0

—

0.00

—

Victim of lightning

0.00

0.0

4.7

—

0.00

—

Use of apomorphine

0.00

0.0

1.0

—

0.00

—

Kaschin-Beck disease

0.00

0.0

1.9

—

0.00

—

Glanders and melioidosis

0.00

0.0

1.0

—

0.00

—

Fracture of upper limb, level unspecified

0.00

0.0

3.4

—

0.00

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

0.0

1.0

—

0.00

—

Malignant neoplasm of gallbladder, including Hilmo

1.00

0.00

1.2

0.00

g/l

—

Malignant neoplasm of placenta, including Hilmo

0.00

0.0

1.0

—

0.00

—

Isolated patent ductus arteriosus

0.00

0.0

6.5

—

0.00

—

Progressive external ophthalmoplegia

0.00

0.0

1.0

—

0.00

—

Dextrocardia

0.00

0.0

1.0

—

0.00

—

Cardiovascular disorders originating in the perinatal period

0.00

0.0

1.0

—

0.00

—

Other disorders of diminished melanin formation

0.00

0.0

1.0

—

0.00

—

Pinta [carate]

0.00

0.0

1.0

—

0.00

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.0

1.0

—

0.00

—

Imperforate hymen

0.00

0.0

1.0

—

0.00

—

Smallpox

0.00

0.0

1.0

—

0.00

—

Serous carcinoma of ovary

0.94

0.00

1.2

1.4

0.00

0.09

g/l

—

Other degenerative disorders of globe

0.00

0.0

1.0

—

0.00

—

Calculus of urinary tract in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

0.00

—

Lupus erythematosus, drug-induced

0.00

-0.00

0.0

1.0

—

0.00

—

Pemphigus erythematosus

0.00

-0.00

0.0

1.0

—

0.00

—

Induced delusional disorder

0.00

-0.00

0.0

4.5

—

0.00

—

Calcific tendinitis

0.91

-0.00

4.0

1.8

0.00

g/l

—

Plasmodium vivax malaria

0.00

-0.00

0.0

1.0

—

0.00

—

Pseudopelade

0.00

-0.00

0.0

1.0

—

0.00

—

Miliaria rubra

0.00

-0.00

0.0

1.0

—

0.00

—

Pustulosis subcornealis

0.00

-0.00

0.0

2.7

—

0.00

—

Acné excoriée

0.00

-0.00

0.0

1.1

—

0.00

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

-0.00

0.0

6.6

—

0.00

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

0.00

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.0

—

0.00

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

1.9

—

0.00

—

Ascariasis

0.00

-0.00

0.0

1.3

—

0.00

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.0

—

0.00

—

Myoclonus, drug-induced

0.00

-0.00

0.0

1.0

—

0.00

—

Malignant neoplasm of vulva

0.90

-0.00

1.9

1.5

0.00

0.06

g/l

—

Other early complications of trauma

0.00

-0.00

0.0

5.0

—

0.00

—

Injury of nerves at ankle and foot level

0.96

-0.00

1.2

2.1

0.00

g/l

—

Melanoma in situ of eyelid, including canthus

0.00

-0.00

0.0

6.5

—

0.00

—

Malignant neoplasm of lip

0.84

-0.00

1.0

1.2

0.00

g/l

—

Traumatic amputation of part of head

0.00

-0.00

0.0

1.4

—

0.00

—

Toxic effect of metals

0.00

-0.00

0.0

1.3

—

0.00

—

Atrophoderma of Pasini and Pierini

0.00

-0.00

0.0

1.0

—

0.00

—

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.00

-0.00

0.0

1.0

—

0.00

—

Contaminated medical or biological substances

0.00

-0.00

0.0

1.0

—

0.00

—

Crushing injury of hip and thigh

0.00

-0.00

0.0

1.1

—

0.00

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

1.0

—

0.00

—

Sclerosis of liver

0.00

-0.00

0.0

1.0

—

0.00

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

-0.00

0.0

1.2

—

0.00

—

Murder, homicide, or other assault by handgun discharge

0.00

-0.00

0.0

7.0

—

0.00

—

Microtia (small ears)

0.00

-0.00

0.0

1.0

—

0.00

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.0

—

0.00

—

Other rickettsioses

0.00

-0.00

0.0

1.0

—

0.00

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.97

-0.00

2.1

1.6

0.00

g/l

—

Exposure to electric transmission lines

0.00

-0.00

0.0

8.7

—

0.00

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

4.5

—

0.00

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.0

—

0.00

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

-0.00

0.0

3.4

—

0.00

—

Trachoma

0.00

-0.00

0.0

1.0

—

0.00

—

Congenital heart conduction disorder

0.00

-0.00

0.0

1.0

—

0.00

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

0.00

—

Myiasis

0.00

-0.00

0.0

9.8

—

0.00

—

Medullary carcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

0.00

—

Other chronic cystitis, drug-induced

0.00

-0.00

0.0

2.3

—

0.00

—

Fetus and newborn affected by other complications of labour and delivery

0.00

-0.00

0.0

1.0

—

0.00

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

0.00

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

0.00

-0.00

0.0

1.3

—

0.00

—

Neurological devices associated with adverse incidents

0.00

-0.00

0.0

1.0

—

0.00

—

Other and unspecified firearm discharge, undetermined intent

0.00

-0.00

0.0

4.8

—

0.00

—

Ebstein's anomaly

0.00

-0.00

0.0

1.0

—

0.00

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.0

—

0.00

—

Sequelae of poliomyelitis

0.95

-0.00

2.2

2.4

0.00

g/l

—

Benign neoplasm: Aortic body and other paraganglia

0.00

-0.00

0.0

1.3

—

0.00

—

Melanoma in situ of lip

0.00

-0.00

0.0

8.3

—

0.00

—

Other specified air transport accidents

0.00

-0.00

0.0

1.0

—

0.00

—

Helminthiases

130

1.00

-0.00

3.5

2.1

0.00

0.04

g/l

0.50

121

Taeniasis

0.00

-0.00

0.0

1.0

—

0.00

—

Bilateral cryptorchidism (undescended testicles)

0.00

-0.00

0.0

1.0

—

0.00

—

Selective deficiency of immunoglobulin M [IgM]

0.00

-0.00

0.0

1.0

—

0.00

—

Short stature starting before birth

0.00

-0.00

0.0

1.0

—

0.00

—

Pseudohypoparathyroidism

0.00

-0.00

0.0

1.0

—

0.00

—

Sequelae of poliomyelitis

0.97

-0.00

2.4

2.5

0.00

g/l

—

Hookworm diseases

0.00

-0.00

0.0

1.0

—

0.00

—

Niacin deficiency [pellagra]

0.00

-0.00

0.0

2.7

—

0.00

—

Hookworm diseases

0.00

-0.00

0.0

1.0

—

0.00

—

Dietary calcium deficiency

0.00

-0.00

0.0

2.7

—

0.00

—

Defects in post-translational modification of lysosomal enzymes

0.00

-0.00

0.0

1.5

—

0.00

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

5.1

—

0.00

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

-0.00

0.0

1.0

—

0.00

—

Exposure to excessive natural cold

0.97

-0.00

1.6

3.1

0.00

g/l

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.0

—

0.00

—

Tularaemia

110

1.00

-0.00

1.0

2.5

0.00

g/l

-0.00

104

Other endophthalmitis

1.02

-0.00

2.6

1.8

0.00

g/l

—

Defect, injury or illness of face

0.00

-0.00

0.0

5.9

—

0.00

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS